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Abstract
Arterial Spin Labelling (ASL) MRI suffers from a phenomenon known as the partial
volume effect (PVE), which causes a degradation in accuracy of quantitative perfusion
estimates. The effect is caused by inadequate spatial resolution of the imaging system.
Resolution of the system is determined by point spread function (PSF) of the imaging
process and the voxel grid on which the image is sampled. ASL voxels are comparatively
large, which leads to tissue signal mixing within an individual voxel that results in an
underestimation of grey matter (GM) and overestimation of white matter (WM) perfusion.
PV correction of ASL images is not routinely applied. When PVC is applied, it usually
takes the form of correcting for tissue fraction only, often by masking voxels with a partial
volume fraction below a certain threshold. There are recent efforts to correct for tissue
fraction effect through the use of linear regression or Bayesian inferencing using high
resolution tissue posterior probability maps to estimate tissue concentration.
This thesis reports an investigation into techniques for PVC of ASL images. An extension
to the linear regression method is described, using a 3D kernel to reduce the inherent
blurring of this method and preserve spatial detail. An investigation into the application
of a Bayesian inferencing toolkit (BASIL) to single timepoint ASL data to estimate GM
and WM perfusion in the absence of kinetic information is described. BASIL is found to
rely heavily on the spatial prior for perfusion when the number of signal averages is less
than three, and is outperformed by linear regression in terms of spatial smoothing until
five or more averages are used.
An existing method of creating partial volumes estimates from low resolution data is
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modified to use a voxelwise estimation for the longitudinal relaxation of GM, which
improves segmentation estimates in the deep GM structures and improves GM perfusion
estimates.
An estimate for the width of the PSF for the 3D GRASE imaging sequence used in these
studies is made and incorporated into a complete solution for PVC of ASL data, which
deblurs the data through the process of deconvolution of the PSF, prior to a correction
for the tissue fraction effect. This is found to elevate GM and reduce WM perfusion to
a greater extent than correcting for tissue fraction alone, even in the case of a segmented
acquisition.
The new method for PVC is applied to two clinical cohorts; a Frontal Temporal Dementia
and Posterior Cortical Atrophy groups. These two populations exhibit differential patterns
of cortical atrophy and reduced tissue metabolism, which remains after PV correction.
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Chapter 1
Introduction
Perfusion is the delivery of nutritive arterial blood to the capillary bed. This supply is
essential to maintain homeostasis and is an important indicator of tissue viability. In fact,
abnormalities in perfusion are the underlying cause of neurovascular diseases such as
stroke. Therefore, the study and measurement of perfusion is of great clinical utility [21].
Arterial spin labelling (ASL) MRI is a non-invasive method of measuring perfusion. ASL
images are degraded by a phenomenon known as the partial volume effect (PVE), which is
manifest as a loss of contrast at a structural boundary due to inadequate spatial resolution.
The point spread function of the imaging system and the grid of voxels that the image is
sampled on together determine the resolution [22].
ASL imaging is based on tracking the passage of a tagged bolus of blood that requires
the use of fast imaging techniques such as echo planar imaging (EPI) or 3D (gradient
and spin echo) GRASE. These rapid imaging techniques allow one to take a ’snapshot’
of the brain magnetisation. An image is taken before the arrival of the tagged blood. A
second image is taken after the arrival of inflowing tagged blood, which reduces overall
magnetisation. A perfusion weighted image is created by subtracting one from the other
[23]. ASL imaging suffers from an intrinsically low signal to noise ratio (SNR), as the
volume of labelled blood is usually only about 1% of total cerebral blood volume. In
order to maximise SNR and acquire an image in clinically acceptable time frames, voxel
sizes are large, typically 60mm3.
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The extent to which an anatomical structure suffers from PVEs depends on its size, with
smaller structures more severely affected than larger ones. Consequently, the PVE is a
particular problem when using ASL techniques to measure cerebral blood flow (CBF)
due to the spatial scale of the cortex. Studies show that the cortical thickness varies from
1 to 4.5 mm, with an average thickness of 2.5 mm [5].
Given the relative size of an ASL voxel to cortical thickness, it is apparent that a typical
image will contain voxels with signal from more than one tissue type, i.e. grey matter
(GM) and white matter (WM), or grey matter and cerebral spinal fluid (CSF). The actual
measured signal will be a weighted signal from the structures contained therein, in
proportion to their volume and rate of blood flow.
Neurodegenerative disease is typified by progressive dysfunction and neuronal loss.
Atrophy, both through so called ’healthy ageing’ and disease, causes thinning of cortical
structures, which exacerbates the PVE.
Grey matter (GM) perfusion is approximately three times that of white matter (WM)
perfusion in adults, and up to 4 or 5 times for children [9]. Hence, in voxels where both
tissue types are present, GM perfusion will possibly be significantly underestimated, with
a corresponding overestimation of perfusion in the WM.
Partial volume correction (PVC) techniques aim to improve quantitative accuracy by
removing PVEs. This is a somewhat under-researched problem in ASL imaging,
although there is a larger body of work investigating the phenomenon in positron
emission tomography (PET).
The objective of this project was to and develop improved methods for PVC in ASL
imaging of cerebral perfusion, with the emphasis on post-processing techniques. This
has led to the final development, following a series of successive steps, of a new PVC
technique for ASL which combines a correction for tissue fraction in addition to the
incorporation of image deblurring techniques. This is analagous to PVC techniques for
PET data, but it is the first time these techniques have been jointly applied to ASL data.
21
1.1 Structure of the thesis
The thesis is structured to build a sequential picture of the partial volume correction
(PVC) strategies developed throughout my PhD. The thesis begins with a discourse on
the theory of ASL and existing methodologies for PVC. From a foundation of these
existing methods, I introduce novel developments in each chapter. Finally, the complete
PVC strategy is applied to two cohorts of dementia patients.
Chapter 2 provides an overview of the origins and theory of the ASL technique. The
pulsed and continuous methods of labelling and quantification methods are presented, as
well as a description of techniques to improve image quality. The recommendations of
the ISMRM perfusion study group for best practice with the ultimate goal of advancing
the use of ASL in the clinic are outlined, before concluding the chapter with a brief
description of the application of ASL perfusion imaging in neurodegenerative disease.
Chapter 3 is essentially a background chapter and begins with a description of the PVE
problem in PET imaging and the techniques that have been developed for it. Thereafter
follows a literature review of the current state of the art methods for PVC in ASL, with a
detailed description of the linear regression method.
Chapter 4 is a methods chapter and provides a description of the data acquisition and
image processing techniques used for what might be described as conventional PV
correction strategies for ASL. There is an account of the segmentation, registration and
parcellation methods used.
The previous four chapters described background, history and methods. Chapter 5 marks
the start of the section of the thesis which describes original work. This chapter contains
a novel extension to the existing kernel method for linear regression, before moving on
to applying a Bayesian inferencing method for PVC to single timepoint ASL for the first
time. Both techniques are investigated in a simulation study as well as applied to a cohort
of healthy controls.
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Chapter 6 describes the application of an existing method of fractional segmentation to a
3D GRASE saturation recovery sequence for the first time. The FRASIER (FRActional
Segmentation of InvERsion recovery) [8] method is further developed to include a
voxelwise estimation of the longitudinal relaxation of GM in order to improve partial
volume estimates for GM. This new technique is given the name SEPARATE -
SEPAration of Relaxation curves for ASL Tissue fraction Estimation.
Chapter 7 presents a derivation of the point spread function for the 3D GRASE read-out
technique used throughout the experimental work in this thesis and demonstration of a
deblurring technique to remove the degrading effect on ASL perfusion estimates.
Chapter 8 describes the application of a novel, complete PVC technique that corrects for
tissue fraction effect as well as deblurring to clinical data from a multi-centre study of
patients who are at risk for frontal temporal dementia and a posterior cortical atrophy
cohort.
Finally, chapter 9 offers a summary of the entire thesis and suggests avenues for future
investigation.
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Chapter 2
Arterial Spin Labelling MRI: An
Overview
The following chapter provides some background on the principles of creating a
quantitative map of cerebral perfusion by arterial spin labelling techniques, and a
discussion on current clinical imaging recommendations and their use within this thesis.
2.1 Blood flow to the brain
The delivery of blood to an organ is known as perfusion and is an essential factor in terms
of maintaining tissue health and as an indicator of tissue viability. A constant delivery of
nutritive arterial blood to the capillary bed is fundamental for homeostasis of the brain.
Perfusion in the brain is termed cerebral blood flow (CBF) and is the rate of flow of
arterial blood to brain tissue. CBF is defined as the volume of blood flowing to a mass of
brain tissue per unit time and is measured in units of ml/100g/min.
Abnormalities in perfusion are the underlying cause of neurovascular disease and
perfusion is irregular in many conditions of disease such as stroke and tumours.
Therefore, the study and measurement of perfusion assists with understanding disease
progression. Measurements of CBF can be used to generate quantitative maps of
regional perfusion which can highlight vascular disorders (see figure 2.1).
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Figure 2.1: Middle slices from a 3D perfusion weighted image showing a region of hyperperfusion
(marked with red arrows) in the temporal lobe, indicative of a tumour. Images acquired by E. De
Vita at the National Hospital for Neurology and Neurosurgery, London.
2.2 Arterial Spin Labelling and Perfusion Imaging
Measuring perfusion using ASL techniques offers distinct advantages over other methods,
such as Positron Emission Tomography (PET), Dynamic Contrast Enhanced (DCE) or
Dynamic Susceptibility Contrast (DSC) MRI. All other imaging modalities are invasive,
to a greater or lesser extent. In the case of PET imaging, a radioisotope is required which
is expensive to produce and a source of ionising radiation to the patient.
DCE and DSC MRI require the use of a contrast agent, generally based on a Gadolinium
chelate, the use of which must be limited in paediatric studies and avoided in patients
with renal problems as this can lead to nephrogenic systemic fibrosis [21]. Both these
techniques depend on the observation of a the passage of a bolus of contrast agent, with
DCE using T1-weighted imaging and DSC using T2 or T2*-weighted imaging.
DCE MRI studies tend to focus on the measurement of Ktrans which is the transfer
constant and characterises the diffusion of gadolinium chelates across the capillary
endothelium. This is an important parameter in characterising tumour biology and
response to treatment [24]. Ktrans in itself is not a measure of perfusion, but is sensitive
to it and with the appropriate pharmacokinetic modelling, an estimation can be made,
although this requires rapid imaging methods which are not widely available.
DSC MRI is the most popular MR perfusion technique in routine clinical practice. DSC
tracks the first pass of a contrast agent through a large artery and tissue, and by choosing
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voxels which are either in or close to a large vessel, such as the middle cerebral artery, it
is possible to estimate an arterial input function (AIF). The AIF is used to recalibrate the
experiment; meaning that CBF is measured relative to the AIF. These contrast based
methods of estimating perfusion have the advantage that they are able to offer an
estimation of cerebral blood volume (CBV), which ASL is unable to do. However, if the
blood brain barrier (BBB) is not intact (such as in stroke and inflammatory disease),
contrast agent can leak and care must be taken in interpreting results as contrast leakage
will lead to quantification errors in both CBF and CBV.
ASL offers the unique advantage that perfusion is estimated using an endogenous contrast
agent, which is totally non-invasive. ASL produces quantitative results and has better
temporal and spatial resolution than nuclear imaging modalities. As a result, ASL is
ideally suited to study healthy volunteers and poses no risk to patients taking part in
longitudinal studies.
Despite these advantages, ASL remains an under-utilised imaging technique in the clinical
arena. There has been an abundance of technical development in the twenty years since
the birth of ASL methods and vast improvements in the quality of perfusion maps realised
with them. However, this same cornucopia of labelling schemes, read-out options and
quantification models has led to a lack of standardisation amongst researchers and scanner
vendors, which has delayed acceptance in the clinical community.
2.3 Theory
Perfusion is observed by means of an endogenous contrast agent, which is created using
a combination of radiofrequency (RF) and gradient pulses to invert or saturate the
magnetisation of arterial blood water protons. The inverted arterial blood is delivered to
the tissue bed at a rate that reflects the tissue perfusion and decreases the overall
magnetisation of the tissue by an amount proportional to the delivery rate.
ASL perfusion imaging can be considered to be comprised of two parts. The first of these
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is the labelling, in which arterial blood is tagged using an RF pulse to saturate or invert.
The second component is the readout, in which the brain is imaged rapidly, using EPI or
3D GRASE. The labelling and readout portions of the sequence are quite independent.
The usual practice is to acquire two separate images, one that is known as the labelled
image and is acquired after the inflow of labelled arterial blood. The other image is
known as the control image and is acquired without any inversion of arterial blood. The
two images are then subtracted to obtain a perfusion weighted image, as shown in figure
2.2.
The lifetime of the signal is dependent on the longitudinal relaxation of blood, which is
usually within 1300 to 1750 ms at clinical field strengths of 1.5 or 3T [25]. This time
duration is comparable to a quantity known as the arterial transit time or ATT, which is
the time taken for the labelled protons to travel from the labelling plane to the tissue. A
short delay between labelling and imaging means little T1 decay, and therefore a higher
signal to noise ratio (SNR). However, a short interval may be insufficient for full arrival of
the labelled protons to the capillary bed. Furthermore, the ATT varies between individuals
and is known to increase with age. These considerations must be managed when choosing
an implementation strategy.
Figure 2.2: A perfusion weighted image is created from the subtraction of a control image and
a an image in which the arterial blood is magnetically labelled. The labelled image is acquired
after a certain duration during which the blood is assumed to have travelled to the capillary bed.
Adapted from [1].
The difference in intensity between the control and labelled images is very small, typically
only 1- 1.5% of the total signal. In order to increase the (SNR), it is usual to obtain
multiple measurements and take an average. In order to make many measurements in an
acceptable time frame, fast imaging techniques such as EPI or 3D GRASE are employed
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[12].
ASL was first proposed in 1992 by Detre et al [26] using a spin echo sequence to acquire
a single slice perfusion weighted image of a rat brain. Arterial blood was saturated with
a slice selective RF pulse applied to a plane in the neck, which exchanged with bulk
water in brain tissue upon reaching the capillary bed. A steady state between inflow and
T1 decay was established. An image was then acquired in which the measured signal
intensity within a voxel was attenuated according to the number of labelled protons that
had travelled to that voxel, since the labelled protons act to reduce net longitudinal
magnetisation.
However, this approach suffers from Magnetisation Transfer (MT) effects as the
off-resonance pulses used to saturate blood water also saturate macromolecules within
the imaging plane (or volume). This means that the acquired image is both perfusion and
MT-weighted. In order to obtain an image that is purely perfusion weighted, the solution
is to acquire an image with identical MT effects, but no perfusion weighting. This is
easily achieved in the control acquisition by applying the saturation pulse outside the
head, so that the imaging plane is equidistant between control and labelling planes.
When the labelled image is subtracted from the control image, the MT effects are
cancelled out, assuming identical MT weighting in both images. This is an effective
solution, but does not lend itself to multi-slice acquisitions. MT is an important
consideration is ASL imaging, as MT effects can considerably increase the apparent
signal difference between control and label images, leading to an overestimation of
perfusion.
2.4 ASL Implementations
There are two main camps that most ASL implementations belong to: continuous
labelling or pulsed labelling. These approaches differ in the spatial extent and duration
of the labelling pulse and both have their own strengths and weaknesses as a result.
28
2.4.1 Continuous ASL (CASL)
Also in 1992 Williams et al [27] developed and improved the technique further by using
an adiabatic pulse to invert rather than saturate arterial blood, thus doubling the perfusion
signal. This method came to be known as continuous ASL or CASL, due to the relatively
long duration of the labelling pulse (2s). In an adiabatic pulse, the frequency of the pulse
is swept from far off-resonance to resonance and beyond. This causes the effective field,
Beff to sweep from +z to -z (provided the pulse is applied for sufficiently long enough).
If this is done slowly enough, the net magnetisation follows Beff . Continuous inversion
uses the same principle, other than that it is not the RF pulse which is varied. Rather,
the resonant frequency of the spins is varied by the application of a gradient field in the
inferior-superior direction. This means that the resonant frequency of a proton varies with
position as it moves through the artery towards the head. The frequency of the RF pulse
is selected to correspond to a certain transverse plane in the neck or head.
Essentially, when the proton is far from the resonance plane, the RF pulse is off resonance
and the effective field is almost along the +z-axis. As the blood travels through the artery
towards the resonance plane, the z-component of the Beff is eliminated and lies almost
entirely along the x-axis. Further upstream from the plane, the proton is off-resonance in
the other direction and Beff tips down to the -z-axis. Again, if the sweep of Beff is slow
enough (driven by the velocity of the proton spins, rather than varying the pulse frequency,
in this application), then the magnetisation is said to follow Beff and become inverted.
This continuous labelling is very efficient at producing a steady stream of inverted blood
as it is relatively insensitive to magnetic field inhomogenities, due to the off/on resonance
sweep [2].
However, the implementation of CASL in humans proved challenging due to the need for
specialist hardware to produce a continuous RF pulse, alongside specific absorption rate
(SAR) restrictions. As such, CASL has not been routinely employed in clinical practice.
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Figure 2.3: CASL: the magnetisation of the arterial blood is inverted continuously while an RF
pulse is applied in the presence of a magnetic field gradient in the direction of flow. As the blood
passes through the inversion plane (where the RF pulse is on resonance), the magentisation is
inverted. A continuous stream of labelled blood is created, as long as the RF field is applied.
Adapted from [2].
2.4.2 Pulsed ASL (PASL)
One of the first examples of a pulsed ASL experiment was that performed by Kwong et
al in 1992 [28]. A slice selective inversion recovery image was acquired during a sensory
activation paradigm in humans. An estimate of the qualitative changes in CBF between
rest and activation was made by modelling the inflow of fully relaxed blood into the
imaging slice during the inversion time. This imaging protocol was later adapted to
provide quantitative measurements of CBF and termed Flow Alternating Inversion
Recovery, or FAIR, by Kim et al [29].
The FAIR sequence is a symmetric method that automatically compensates for MT
effects. A non-selective inversion pulse inverts all the blood in the transmitter coil that
during a time interval flows into the imaging volume. This is the basis of the tagged
blood signal. Conversely, the so-called slice-selective inversion inverts only the
magnetisation within the imaging volume. Non-labelled, fully relaxed blood flows from
outside of this volume into it, which means that an image acquired after this inflow of
blood will have no perfusion weighting. Subtraction of the labelled and non-labelled
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images produces a perfusion weighted image, which when scaled by the appropriate
scale factor results in a voxelwise quantitative map of cerebal blood flow.
Additional developments in the field of pulsed ASL came in 1994 with the advent of the
sequence developed by Edelman et al [30]. A 10-15 cm slab was labelled proximal to the
imaging plane using a single 180 ◦pulse. A control image was acquired using an inversion
slab sited outside the head to produce identical MT effects. This sequence was known
as Echo-Planar MR Imaging and Signal Targeting with Alternating Radio frequency or
EPISTAR (see figure 2.4). Due to the short duration of the tagging pulses (20-50 ms),
FAIR and EPISTAR labelling techniques came to be known as pulsed ASL.
A continuous ASL (CASL) pulse is typically 2s long, whereas a PASL pulse is much
shorter at around 20ms. This leads to CASL approaches offering a higher SNR due to
the greater volume of blood that has been labelled due to the much longer labelling pulse,
and contributing to the difference signal. However, PASL was the more popular imaging
technique due to ease of implementation on standard hardware. This is no longer the case
with the advent of pseudo-continous ASL, which is rapidly overtaking PASL in popularity.
Figure 2.4: PASL: EPISTAR and FAIR variations. In EPISTAR, the label is created with a spatially
selective inversion slab below the imaging plane. The control image has a similar inversion slab
above the imaging plane. In FAIR, the label is created with a non-selective inversion slab, with
everything in the coil inverted. The control image is created from a selective inversion of the
imaging plane.
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2.4.3 Pseudo-continuous ASL (pCASL)
In recent years, continuous ASL has enjoyed a renaissance with the advent of
Pseudo-Continuous ASL (pCASL) developed in 2008 by Dai et al [31]. A train of short
closely spaced RF pulses is used to invert arterial blood, which is comparable to the use
of constant RF amplitude in CASL, but avoids the duty cycle constraints and additional
hardware that is required for CASL. Thus pCASL sequences offer the advantages of
CASL, such as high SNR and labelling efficiency, but are readily implemented on
standard hardware.
pCASL combines the advantages of a CASL labelling scheme with the easier
implementation of PASL imaging and is considered to be the state of the art. It is the
labelling method of choice by the Perfusion Study Group (see section 2.7.2, although it
was not readily available across all vendors at the start of this thesis.
2.5 Quantification Models
In order to obtain a quantitative measure of perfusion the perfusion weighted difference
signal must be fitted to a suitable model. Two models in common use are discussed within
this section.
2.5.1 Alsop-Detre Model
Early efforts to build a model to quantify perfusion utilised the nitrous oxide tracer
clearance theory of Kety and Schmidt to produce a modified Bloch equation [26]:
dMt(t)
dt
=
M0 −Mt(t)
T1,t
+ f
(
Ma(t)− Mt(t)
λ
)
(2.1)
where Mt is the longitudinal magnetisation of brain tissue water in arbitrary units, M0 is
the fully relaxed value of Mt, λ is the blood brain partition coefficient, defined as
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(quantity of tracer/gm of brain tissue)/(quantity of tracer/ml of blood), T1,t is the
longitudinal relaxation time of brain water in the absence of flow or exchange between
brain and blood water, Ma is the magnetisation of arterial blood water in arbitrary units
and f is the cerebral blood flow in ml/g/s. This solution to the model assumes uniform
plug flow, instantaneous exchange of blood and tissue spins, i.e. a single, well mixed
compartment, and equal relaxation rates of arterial blood and tissue.
The original ASL experiments were in rats where the transit time of the tagged blood is
negligible [26]. However, this is a parameter that can vary quite significantly in humans,
both regionally within an individual brain and between subjects, even in a control
population. The most accurate way to quantify transit time is to measure the perfusion
signal at multiple time points and observe the wash in of the signal, although this
increases the overall experiment length. This introduces other issues, such as a greater
likelihood of motion artefact.
In order to reduce the dependency of the quantification model on variable transit time,
Alsop suggested the inclusion of a post labelling delay (PLD) between the end of the
tagged pulse and time of image acquisition, assuming the delay time is greater than the
ATT (δa). Although the inclusion of the PLD will result in a reduced perfusion signal
due to increased T1 decay, the benefit is that CBF estimates are relatively insensitive to
variable transit times, provided that the PLD is greater than (δa). Studies suggest that in
healthy volunteers the PLD should be selected to be around 1s and increased for patients
with cerebrovascular disease [32].
The Alsop-Detre model was thus modified to include new parameters: δa, δ which is
the tissue transit time and represents the time taken for labelled blood water to exchange
into tissue, T1a the longitudinal relaxation of arterial blood water, T1s the longitudinal
relaxation of tissue water during the control pulse, T1ns the longitudinal relaxation of
tissue water after the control pulse, using the notation from [32] where w is the PLD:
f =
−λ(M tag −M ctrl)
2αM0b
C(T1ns, T1s, T1a, δ, δa) (2.2)
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where
1
C
= T1nsexp(−δ/T1a)
[
exp(min(δ − w, 0/T1ns)(1− T1s
T1ns
]
+ T1a
[
exp((min(δa− w, 0)− δa)/T1a)− exp((min(δ − w, 0)− δ)/T1a)
] (2.3)
2.5.2 General Kinetic Model
Buxton et al [33] took a somewhat different approach and proposed the General Kinetic
Model. Within this model, Buxton describes the behaviour of the magnetisation difference
signal, ∆M , to be a function of delivery of magnetisation by arterial flow, clearance
by venous outflow and longitudinal relaxation. Three separate functions are defined to
described this behaviour:
c(t): delivery function which is the normalised concentration of ∆M arriving at a voxel
at a time t
r(t, t′): residue function which is the fraction of tagged water molecules that arrive at
time t′ which still reside in the voxel at time t
m(t, t′): magnetisation relaxation function which is the fraction of the original
longitudinal magnetisation carried by blood water to a voxel at time t′ which
remains at time t
The evolution of ∆M is described by combining these three functions into a convolution
integral:
∆M = 2M0Bf
∫ t
0
c(t′)r(t− t′)m(t− t′)dt (2.4)
∆M = 2M0Bf [c(t)⊗ r(t)m(t)] (2.5)
where M0B is the equilibrium magnetisation of blood.
This forms the basis of the standard kinetic model, which applies equally to PASL and
CASL, and in order to solve it one makes the assumption that the leading edge of a
temporally defined labelled bolus of blood of duration τ with inversion efficiency α travels
34
to tissue in the imaging plane in a time ∆t.
In order to solve equation 2.4, Buxton et al made the following assumptions:
1. Labelled arterial blood arrives as a uniform plug, such that before the transit time
∆t, no labelled blood is present. Between ∆t and ∆t+ τ uniformly labelled blood
arrives, with no labelled blood arriving after this time.
2. Tissue and blood exchange can be described by the single compartment model and
depends on the blood brain partition coefficient λ, which is defined as the ratio
between tissue and blood tracer (tagged blood) concentrations at equilibrium [34].
3. The longitudinal magnetisation of the labelled blood initially decays with the T1
of blood. It is assumed that all of the labelled water exchanges with tissue water
instantaneously on arrival at the voxel, so that the label then relaxes with T1 of the
tissue.
Thus, the PASL signal can be described as:
c(t) =

0 0 < t < ∆t
αe−t/T1b ∆t < t < ∆t+ τ
0 t > ∆t+ τ
(2.6)
∆M(t) =

0 0 < t < ∆t
2M0Bf(t− δt)αe−t/T1Bqp(t) ∆t < t < ∆t+ τ
2M0Bfταe
−t/T1Bqp(t) ∆t+ τ < t
(2.7)
where:
qp(t) =

ekt(e−k∆t−e−kt)
k(t−∆t) ∆t < t < ∆t+ τ
ekt(e−k∆t−e−k(τ+∆t))
kτ
t > ∆t+ τ
(2.8)
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k =
1
T1B
− 1
T1′
(2.9)
1
T1′
=
1
T1
+
f
λ
(2.10)
It is possible to quantify CBF from a measurement at a single time point or from
measurements made from a series of acquisitions taken at increasing time intervals after
labelling. For a single measurement, the appropriate equation listed above is solved for f
and calculated using the perfusion weighted image and relevant acquisition parameters,
with τ and ∆ t defined by the inclusion of additional saturation pulses. This is described
further in section 2.5.3. For a multiple time point acquisition, the ∆M measurements are
fitted to the appropriate PASL equation, which enables an estimation of f and also transit
time ∆t as depicted in figure 2.5.
Figure 2.5: Arterial spin labelling kinetic curve for an ideal difference signal as a function of
acquisition time for a pulsed ASL labelling scheme. Labelled arterial blood arrives in voxels after
a transit time,∆t, and continues to appear for the duration of the bolus τ .
Literature values are normally used for quantifying λ and the relaxation time of blood.
T1 and M0 maps of tissue can be created from fitting a model to a separate acquisition of
inversion/saturation recovery data, which is the approach taken within this body of work.
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2.5.3 Improved bolus definition using Q2TIPS
In PASL imaging there are two main causes of error in quantification; spatially varying
transit times and signal arising from the vasculature. PASL imaging differs from CASL
(where the duration of the tagged bolus is known) in that the tagged slab of blood has
spatially varying transit times for a particular imaging region, along with an unknown
duration for the bolus. Wong et al [35] sought to address these issues by using additional
saturation pulses to improve definition of the labelled bolus. This technique is termed
Quantitative Imaging of Perfusion using a Single Subtraction, and has two forms of
implementation: QUIPSS I and QUIPSS II, which refers to whether the saturation pulse
is applied to the imaging volume (QUIPSS I) or the labelling volume (QUIPSS II) after
an inflow time TI1.
The QUIPSS II approach shares a common goal with the model of Alsop and Detre
(discussed above) in that both techniques aim to define a tagged bolus of blood which is
imaged after a sufficient time delay to ensure the bolus has reached the capillary bed. In
theory, both approaches should make CBF quantification insensitive to transit time.
The imaging sequence used in this study makes use of a modification to QUIPSS II which
is termed Q2TIPS [3]. In this method the QUIPSS II saturation pulse is replaced by a
train of thin-slice saturation pulses at the distal end of the tagged bolus. This offers the
advantage of producing a sharper edge for the bolus cut-off than using QUIPSS II, due to
the thin sinc slice profile which better matched the sech inversion tagging pulse used in
PASL (see figure 2.6).
In a PASL acquisition with Q2TIPS thin-slice saturation, the kinetic model can be
simplified with certain assumptions.
For the condition ∆t+ τ < t, from equation 2.7:
∆M = 2M0Bfταe
−t/T1Bqp(t) (2.11)
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If we assume the T1 of blood and tissue to be the same and that f/λ « 1, q ≈ 1, we can
write:
∆M = 2αM0Bfτe
−t/T1B (2.12)
from which it follows, with M0B = M0λ where λ is the blood brain partition coefficient
[34]:
f =
∆Mλ
2αM0TI1e
− TI2
T1B
(2.13)
where TI1 is the bolus duration, TI2 is the inflow time, λ is the blood brain partition
coefficient, α is the labelling efficiency, T1B is the relaxation time of arterial blood at 3T.
The sequence is shown in figure 2.6.
Figure 2.6: Pulse sequence for Q2TIPS. Double in-plane presaturation pulses followed by a
sech inversion tagging pulse. Periodic saturation pulses applied from TI1 to TI1s. 3D GRASE
acquisition at TI2. Adapted from [3].
2.6 Background Suppression
ASL is an inherently low SNR imaging modality due to the fact that perfusion typically
replaces only 1% of brain water with inflowing blood water every second. This means
that a 2s bolus of blood will alter only about 1% of tissue magnetisation is a tissue voxel,
at best. Given arterial transit times and relaxation of the signal due to T1 decay, the
difference between control and tagged images is usually much lower.
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The most common source of artefact is patient motion, which can easily swamp the small
perfusion signal. This can be countered by decreasing the signal intensity of the static
tissue, without affecting the magnitude of the ASL difference signal, thus improving the
overall SNR obtained.
It is possible to achieve this using a combination of saturation and inversion pulses and the
technique is known as background suppression (BS), first demonstrated for ASL by Ye et
al [36]. The methodology is as follows: a saturation pulse is applied to the imaging region,
followed by one or more global inversion pulses (depending on how many tissue types are
to be nulled). The inversion pulses are timed such that the longitudinal magnetisation is
zero (or close to it) at the time of image acquisition.
The ASL signal is unaffected as the labelled blood does not experience the initial
saturation pulse as it has yet to reach the imaging plane. It does experience the inversion
pulses, but if the inversion is perfect and the pulse is instantaneous, merely the sign of
the magnetisation difference will be affected, rather than the magnitude. Therefore, the
signal from static tissue is suppressed whilst the perfusion signal is preserved.
In reality, the inversion pulses are not actually perfect: typically efficiency is about 95%.
As such, the magnitude of the ASL signal is reduced by 5% for each inversion pulse
experienced. This is an important consideration when selecting the number of tissue
types (and therefore number of pulses) to be suppressed.
A further consideration is that BS suppresses the signal from static tissue at one point
in time only. Therefore, BS is more suited to acquisition schemes that employ a single
excitation for each TR. For schemes which do not, for example multi-slice EPI, the BS
will only be optimal for a single slice. Hence, 3D volume acquisitions such as 3D GRASE
[12], are ideally suited to the use of background suppression.
The imaging protocols employed in this project use two background suppression pulses in
order to null the signal from static grey and white matter at the time of image acquisition.
Using the notation from [12]:
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τ1(TI) = TI +
2
R1opt
. ln((
1
2
+
1
4
) + (
1
2
− 1
4
).e1/2.T I.R1opt) (2.14)
τ2(TI) = TI +
2
R1opt
. ln((
1
2
− 1
4
) + (
1
2
+
1
4
).e1/2.T I.R1opt) (2.15)
Figure 2.7: Timing of background suppression pulses after initial saturation pulse. There are two
inversion pulses to null grey and white matter, with the image acquisition occuring shortly after
null points are passed for both tissues.
Three inversion pulses are used in this acquisition (one to label and two for static tissue
suppression). If a single inversion pulse efficiency is 95%, then the overall labelling
efficiency will be:
α = 0.95 ∗ 0.95 ∗ 0.95 = 0.86 (2.16)
which must be factored into the model.
2.7 Readout Approach
In addition to choosing a suitable labelling protocol, a decision must be made about the
readout module to be used. A rapid acquisition technique is required in order to capture
multiple measurements in a short time for averaging data and improving SNR.
Traditionally, either single or multislice single shot echo planar imaging (EPI) has been
used. However, the use of 2D EPI techniques is non-ideal for a number of reasons, and
there is a shift towards using segmented 3D sequences.
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Figure 2.8: k-space trajectory for single shot EPI sequences: the entirety of k-space is sampled
after one RF pulse by blipping the signal along the phase-encoding axis.
Multi-slice EPI is a 2D technique with slices acquired at different inflow times after
labelling of the arterial blood. These slices are usually acquired in a sequential manner
with an assumption that flow is from an inferior to superior slice. This is not necessarily
true, as vascular physiology is somewhat variable. The general QUIPSS II condition is
that TI2-TI1 should be longer than the longest bolus arrival time present in the slice. For
a multi-slice acquisition, this timing is slice dependent. Additionally, background
suppression (BS) is optimal at only one point in time, and therefore optimal only for one
of the slices in a multi-slice acquisition.
2.7.1 3D GRASE
Gradient and Spin Echo (GRASE) imaging was developed in 1991 by K. Oshio and D.
Feinberg as an alternative to EPI [4]. EPI uses the original k-space trajectory originally
proposed by Mansfield et al [37], in which multiple lines of k-space are acquired in a
single TR by rapid ’blipping’ of the phase encoding gradient (see figure 2.8).
EPI places great demand on MR hardware systems due to the requirement for rapid
switching of the gradient fields, as well as exhibiting chemical shift and signal dropout at
the air/bone interface in the frontal lobe due to eddy current and susceptibility effects.
GRASE was designed to minimise the above limitations by alternating between gradient
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Figure 2.9: GRASE pulse sequence adapted from [4]. s1, s2, s3 signals correspond to the lines of
k-space labelled in figure 2.10.
and RF pulses within the echo train. GRASE is in part based on the Carr Purcell
Meiboom Gill (CPMG) spin echo pulse sequence, but is a hybrid of gradient and spin
echo sequences. Multiple short duration gradient echo trains are created between
successive 180 ◦pulses, which means that chemical shift and field inhomogeneity effects
develop over a shorter time period between the 180 ◦pulses, compared to the greater time
of the EPI echo train. This results in reduced phase errors which produces T2 decay of
the echo train rather than the rapid T2* decay of EPI.
An RF-refocused echo train is formed, in which multiple lines of k-space are acquired
using gradient reversals. Each k-space line is encoded differently by the phase encoding
gradient pulses. The sequence is repeated with a different phase-encoding lobe, shown
with arrows in figure 2.9, with s1, s2, s3 signals corresponding to the lines of k-space
shown in figure 2.10. This trajectory scans over almost all of k-space within each RF-
refocused echo train, with multiple excitation pulses populate k-space with interleaving.
Applying additional phase encoding gradients on a second axis means that the long echo
train of GRASE imaging can be used to make single shot 3D images. This is known as the
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Figure 2.10: Trajectory through k-space for a GRASE acquisition. A different starting place is
used for each refocusing pulse.
second phase encoding axis and runs along the inferior-superior direction. Consequently,
3D GRASE is a true 3D imaging technique and is able to offer a higher SNR than 2D EPI
without the severe distortions or image quality problems which arise from attempting to
use EPI in a 3D manner (EVI: echo volume imaging) [38].
2.7.2 Recommendations from the ISMRM Perfusion Study Group
With a view to simplifying and encouraging the use of ASL in the clinic, there is a drive to
promote its use and standardise procedure, particularly in connection with applications in
imaging dementia. Currently, FDG-PET imaging is considered to be the ’gold standard’
for diagnosis of dementia. It is the expressed mission of a European-wide cooperative of
scientists and clinicians 1 to develop ASL as a cost-effective non-invasive alternative to
radiotracers in imaging dementia.
This has taken the form of a ’white paper’, which is a consensus report written jointly
by members of the ISMRM Perfusion Study Group and the European ASL in Dementia
consortium [39]. The goal of the white paper is to document the current recommendations
for optimal use of ASL imaging in the clinic and to encourage standardisation across
1http://www.cost.eu/COST_Actions/bmbs/Actions/BM1103
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scanner vendors and sites. The hope is that this approach will encourage new scientists
and clinicians to the field of ASL, rather than being overwhelmed by the vast array of
implementations options, as well as facilitating comparison studies between sites.
For the most part, the ASL imaging used in this body of work is aligned with the
recommendations from the white paper, other than where indicated. These are discussed
in detail in chapter 3.
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Chapter 3
Existing techniques for Partial Volume
Correction in ASL
This chapter opens with a discussion of the origins of the partial volume effect in ASL
and compares and contrasts correction strategies which are in existing use for another
perfusion imaging modality, namely Positron Emission Tomography. PET imaging is a
nuclear medicine modality for measuring metabolism, which is analogous to perfusion,
and suffers from similar imaging degradations. A review then follows on how these PET
techniques have been adapted for ASL, and what is the current state of the art in PV
correction for ASL.
3.1 Partial Volume Correction in ASL
There is a factor which arises due to the nature of ASL imaging that is particularly relevant
in studies where patient populations experience atrophy. This is the phenomenon known
as the Partial Volume Effect (PVE).
3.1.1 What is the PVE?
ASL suffers from an intrinsically low SNR, and in order to obtain an acceptable SNR,
voxels are comparatively large. Voxels are much larger than is usually obtained in an
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anatomical image, and typically around 60 mm3, with in plane dimensions of around 4
mm and often larger in the slice direction.
Partial volume effects manifest themselves as a loss of contrast at a structure boundary.
The PVE is caused by inadequate resolution of the imaging system, which is determined
by the point spread function and the voxel grid on which the image is sampled.
3.1.1.1 Spatial resolution
PV effects are a particular problem in neuroimaging due to the spatial scale of the cortex.
Studies show that the cortical thickness varies from 1 to 4.5mm thickness, with an overall
average thickness of 2.5mm. Cortical thinning is a hallmark of many neurodegenerative
diseases, as well as a product of normal ageing.
Given the relative size of an ASL voxel to cortical thickness, it is apparent that a typical
image will contain many voxels that have signal from more than one tissue type. As can
be seen from the histogram of cortical thickness figure 3.1, there are few areas of the
cortex that are thick enough that they will solely occupy the voxel volume.
Figure 3.1: Histogram of typical cortical thicknesses in a healthy subjected. Adapted from [5].
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Figure 3.2: The partial volume effect: when signal from more than one tissue type is contained
within a voxel due to inadequate spatial resolution. A weighted average of two (or more) signals
forms the voxel intensity. This is manifest as a loss of contrast at a tissue boundary. High
resolution structural image at 1mm resolution clearly shows GM/WM interface. The same region
from lower 4mm resolution ASL image suffers from PV effects.
Figure 3.2 highlights the effect. The red squares show the same region of tissue from
each image. The GM/WM boundary is clearly visible in the anatomical image due to the
higher resolution the image was acquired at. The much larger voxels in the ASL image
do not allow the tissue boundaries to be determined.
The actual measured signal in each voxel will be a weighted average of the signals from
the structures contained therein. Grey matter perfusion is approximately three times that
of white matter perfusion in adults, higher still in children [40]. Consequently, in voxels
where both tissue types are present, the observed signal will be a weighted average of
pure GM and WM perfusion levels. Studies on perfusion of WM are scarce, as the SNR
is considered to be too poor to produce meaningful results, due to the longer transit time
for the blood to reach the white matter and shorter T1 of WM [41].
Cortical atrophy exacerbates the PVE problem, and without appropriate partial volume
correction, there will be an apparent decrease in perfusion when none is actually present.
This is a serious confounding effect for longitudinal studies and it is of great importance
that PV correction is performed on ASL data where atrophy is occurring.
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3.1.1.2 Point Spread Function
The second contributory factor to PVE is the Point Spread Function, or PSF. The PSF is a
consequence of image formation and varies with the method of data acquisition. In short,
the point spread effect causes blurring in the acquired image, with signals being displaced
from their actual point of origin.
There appear to be no published articles addressing the impact of the PSF on the
quantification of perfusion by ASL methods, although there is recent work to quantify
the PSF in 3D GRASE imaging and remove the associated blurring.
This is discussed extensively in chapter 7.
3.2 PVC in PET studies
Positron Emission Tomography (PET) is an imaging modality that measures γ rays that
are produced from radioactive β decay of a nucleus. As a nucleus decays, a positron is
emitted. When the positron encounters an electron, both are annihilated and two γ rays
are produced. These γ rays are then detected by the scanner apparatus and information
about the location and intensity of radionuclide activity is acquired.
It is beyond the scope of this text to describe in detail PET image acquisition and
reconstruction. However, given the parallels with ASL imaging, it is worthwhile to
compare the partial volume effect and solutions that have been applied to this modality.
As in ASL imaging, the quantitative accuracy of PET measurements are degraded by
the PVE, which is caused by blurring due to the point spread function which in turn is a
consequence of the finite resolution of the imaging system and the rate at which the image
is sampled. PET is an intrinsically low resolution imaging modality with a resolution
typically between 5-6mm FWHM.
Factors which contribute to the PSF in PET are: the distance a positron travels before
meeting an electron to annihilate with, non-colinearity of emitted γ rays (due to
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scattering), attenuation of γ rays, detector configuration and reconstruction parameters.
Evaluation of the PSF usually involves imaging an object (point or line source of
radioactivity) considerably smaller than the assumed system resolution and measuring
the object width in the resultant image. As the PSF in PET imaging causes an
underestimation in radioactivity concentration, it is common to define a recovery
coefficient (RC), that is the ratio of the observed concentration in the observed image
and the real radioactivity concentration. An alternative to direct measurement of the PSF
is to simulate the RC for several PSF of different FWHM. Comparison of the measured
RC with the suite of simulated PSF/RC pairs will yield the actual PSF. This method is
particularly useful in situations where clinical reconstruction protocols do not meet the
Nuclear Medicine standardisation body’s requirement that voxel dimensions be one tenth
of the expected PSF FWHM [42].
Of these two causes of PVE (blurring due to PSF and voxel grid size), it is the blurring
caused by the PSF that is the primary target for PVC strategies in PET imaging. The PSF
causes a displacement of activity between neighbouring regions in the brain, known as
the ‘spill in, spill out’ effect, which is not necessarily balanced. The problem of multiple
tissues existing within the same voxel due to inadequate voxel grid dimensions is very
much a secondary consideration.
All existing PVC methods for PET images aim to correct for the spill-over effect caused
by the PSF. From these, a subset also attempt to correct for the tissue fraction effect using
structural information from a higher resolution MR or CT image. As such, PVC methods
for PET can be divided into two categories.
The first category of techniques requires anatomical information, as described above.
These include Meltzer’s method [43], Muller-Gartner (MG) method [44] and the
Geometric Transfer Method (GTM) of Rousset [45]. In general, methods which require
anatomical information correct for both blurring and tissue fraction effect, with the
exception of the GTM, which only corrects for blurring.
The second class of algorithms do not require anatomical data and are based on
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deconvolution techniques and attempt to account for PVE during image reconstruction.
However, these methods rely on an accurate estimation of the PSF, which in itself is a
difficult quantity to measure, although they offer the advantage that no registration or
segmentation of additional images is required. As no anatomical information is used,
these methods are not able to account for the tissue fraction effect.
The first category of PVC methods can be further be subdivided into two classes – those
which perform correction on a voxel-wise basis and those which are volume-based. As
the terms suggest, these methods either correct for PV effects on a voxel-wise basis, or on
a regional basis by segmenting the brain into non-overlapping regions. One method from
each of these categories is briefly described next as a prelude to techniques in ASL. The
Muller-Gartner method is described because of the parallels with an existing method for
ASL PVC, namely linear regression [22]. The Geometric transfer method is described as
this is an example of a technique which corrects for blurring, over ’spill over’, as it tends
to be called for PET imaging.
3.2.1 Muller-Gartner method
The Muller-Gartner (M-G) method [44] is a voxel-wise technique which corrects the PVE
in the grey matter (GM) only. Correction is performed using the following equation:
fGM(r) =
f(r)− [AWMPWM(r)]⊗ h(r)− [ACSFPCSF (r)]⊗ h(r)
PGM(r)⊗ h(r) (3.1)
where, f(r) is the observed image at voxel r, fGM(r) is the tracer uptake in the GM,
PGM(r), PWM(r) and PCSF (r) are the tissue posterior probabilities of GM,WM and CSF.
AWM is the estimated mean activity level in WM, ACSF is the estimated mean activity
level in CSF (typically assumed to be zero) and h is the PSF of the scanner.
AWM can be estimated from a white matter region that is assumed to be free of partial
volume effects. This assumes that WM activity is constant across all WM voxels, which
may not be the case, and is a potential drawback. The posterior probability maps are
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obtained from the segmentation of an anatomical MR image, which are then transformed
to the same space as the PET data. In order to avoid a zero term in the denominator, it is
usual to ’clip’ PGM(r) > 0.05, say, or use a binary mask for GM. A resultant image is
produced which is a voxel-wise correction for GM only which corrects for blurring due
to the PSF as well as tissue fraction effect.
3.2.2 Geometric Transfer Matrix method
The Geometric Transfer Matrix (GTM) method [45] operates on regions of the brain
which have been defined from the segmentation of an anatomical scan into
non-overlapping regions. This can be achieved using a tool like Freesurfer 1. Each region
is assumed to contain homogenous activity and a single value is produced for each ROI.
As such, correction by the GTM method does not produce an image in the way that the
M-G method does. The mean activity in each ROI is captured into a vector
r = [r1, ..., rn]. The GTM is defined as an n x n matrix G such that Gij contains the
fractional contribution of activity of region rj into ri . The reader is directed to [45] for
further details on the calculation of the matrix elements of Gij . Therefore, we can reason
that the ‘true’ activity T can be obtained by solving the inverse problem:
T = G−1r (3.2)
The GTM method corrects for spill-over between regions, but does not address the issue
of tissue fraction effect. A single activity value is obtained for each ROI, and it seems
intuitive that the more regions that are defined, the more ‘accurate’ any correction is likely
to be, and so the argument can be taken to the logical conclusion of there being one region
per voxel. However, as the number of regions grows, so does the GTM, which is likely
to become ill-conditioned and impossible to solve. Therefore, it is important to choose
the ROI with care so as not to violate the assumption of homogeneous activity within the
regions.
1http://surfer.nmr.mgh.harvard.edu
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3.3 PVC in ASL studies
PVC is a more mature field area of research in PET studies than in ASL, so it is helpful
to consider how the problems have been addressed using that modality.
Given that there is a significant degree of tissue signal mixing in an ASL image, it is
apparent that some form of correction for the tissue fraction effect is required, and by
implication, structural information in the form of a higher resolution anatomical image.
Broadly speaking, PET PVC methods are either applied as part of the image
reconstruction process or as a post-processing technique. It is difficult to envisage an
’ASL parallel’ with the former due to the differing methods of image formation.
Having said that, an investigation into removal of the point spread effect using
deconvolution techniques has been undertaken in this thesis and is described in chapter
7. This differs from the deconvolution techniques used in PET as the application to ASL
is a post-processing technique rather than incorporated during image reconstruction.
3.3.1 Existing methodology
There are few studies in which partial volume correction is performed on ASL data
[46, 22, 6, 9, 15], with no known studies whatsoever in which blurring from the PSF is
addressed as a contributory factor to the PVE. This is primarily because the PSF in MRI
is much better than that of PET, particularly in a 3D segmented acquisition as used in
this work. The dominating factor in causing partial volume effect in ASL is that of the
tissue fraction effect. Recently, there have been preliminary efforts at characterising the
PSF in 3D GRASE readouts and removal of associated blurring [47, 48]. Further details
are provided in chapter 7.
The most common approach to dealing with PV effects is to circumvent the issue by
only including voxels with a high GM content, typically over 80% [7]. The proportion of
GM in a voxel is deduced from posterior probability maps obtained from high-resolution
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anatomical images. This requires the probabilistic segmentation of the anatomical image
and transformation of these estimations to perfusion space. This is a non-trivial step in
itself, but moreover, this approach in general will still lead to an underestimation in
perfusion. Any approach which selects candidate voxels based on their GM content
makes comparisons between age groups difficult, as cortical thinning in elderly brains
means that many voxels would be excluded from the analysis compared to a young
person. Additionally, longitudinal studies where cortical atrophy is occurring are
unreliable with a potential apparent decrease in perfusion due to tissue loss, rather than
blood flow decreases.
At the start of this PhD, there existed two main methods for PVC in ASL; the linear
regression method published by Asllani et al in 2008 [22] and the Bayesian inferencing
method published by Chappell et al in 2011 [15].
3.3.2 Linear Regression
In 2008, Asllani [22] published a PVC method for ASL which borrowed some of the
principles of PVC from the world of PET and shares some principles with the previously
published Muller-Gartner method of PVC which is used for PET images [44]. A
description of the method follows.
If we begin from the assumption that the magnetisation in a voxel, M(ri), can be
described by the relationship:
M(ri) = PGM(ri)mGM(ri) + PWM(ri)mWM(ri) + PCSF (ri)mCSF (ri) (3.3)
where Pj(ri) are the posterior probabilities for the jth tissue type at voxel ri, and mj are
the separate tissue magnetisations sought after. The posterior probabilities of the three
tissue types are obtained from the segmentation of high resolution anatomical data as
described in section 4.2.3.
The relationship for cerebral blood flow is described as [2]:
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CBF =
∆Mλ
2αM0TI1e−TI2/T1B
(3.4)
Re-writing as:
CBF =
∆M
M0
.Fs (3.5)
where:
Fs =
λ
2αTI1e−TI2/T1B
(3.6)
As Fs is composed of sequence and tissue specific constants, it is clear CBF is
proportional to a ratio of two images, namely ∆M and M0, both of which are affected by
PV effects.
Assuming zero perfusion in CSF, the magnetisation in the difference image, ∆M can be
written as"
∆M = PGM(ri)mGM(ri) + PWM(ri)mWM(ri) (3.7)
For any particular voxel, whilst PGM , PWM and PCSF are known quantities, there remain
five unknowns - δmGM , δmWM ,m0,GM ,m0,WM andm0,CSF , which are the tissue specific
contributions to the difference and equilibrium magnetisation images, respectively. It is
not possible to solve for five unknowns with the two equations on hand.
As a solution to this, Asllani proposed that each voxel be the centre of a small region,
called a kernel, such as the 5 x 5 kernel shown in figure 3.3. If the assumption is made
that within this small region the GM, WM and CSF tissue signals are constant, (in both
δm and m0), we are able to write a series of simultaneous equations that will enable us to
solve for the unknown quantities.
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Figure 3.3: A 5 x 5 kernel for linear regression: the centre voxel (outlined in red) is solved by
assuming that GM, WM and CSF signals are constant over this region.
Consider the 5 x 5 kernel depicted in figure 3.3 and that it is a portion of an M0 image,
with three unknowns to be found, m0,GM , m0,WM and m0,CSF . (If the difference image
were being processed, the term representing CSF would be zero, with only two unknowns
to be found). The voxel for which the partial volume contributions are going to be found
is r13 with a neighbourhood comprised of voxels r1 to r25.
In matrix form, these 25 simultaneous equations can be written:

Mr1
...
Mri
...
Mr25

=

PGMr1 PWMr1 PCSF r1
...
...
...
PGMri PWMri PCSF ri
...
...
...
PGMr25 PWMr25 PCSF r25


mGM
mWM
mCSF

The left hand side of the equation consists of a column vector of magnetisations for the
entire kernel. The centre term is a 25 x 3 matrix containing the tissue posterior
probabilities for tissue type in the ith voxel. The number of rows in the matrix is
dependent on kernel size and is n2 for a kernel of side n. The number of columns is
dependent on how many different tissue types are being solved for (two or three, in our
application).
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More concisely, using M(ri) to denote either ∆M or M0, this can be written:
M(ri) = Pj(ri) ·mj(ri) (3.8)
mj can be solved for using the standard least squares solution where P T is the transverse
of P , and ((P T · P )−1 · P T ) is the pseudo-inverse of P:
m = (P T · P )−1 · P T ·M (3.9)
where m is a vector containing the separate tissue magnetisations for r13.
By sliding the kernel across the entire image, it is possible to solve for GM/WM (and CSF)
magnetisations in each voxel. The assumption that each tissue magnetisation is constant
over the kernel region introduces a degree of spatial blurring, although it should be noted
that this varies with kernel size and the data within in the kernel, which is changing on a
voxel by voxel basis.
There is an inherent trade-off in this method; a large kernel will contain many equations
with which to perform the regression and ensure that the matrix equations are not rank
deficient. The matrix equations must be rank 2 for a difference image and 3 for an
M0/control image. In order words, there must be at least two (or 3 for a control image)
independent equations describing the magnetisation. The larger the kernel, the more
likely this is to be true. However, spatial smoothing increases with kernel size as the
assumption about constant magnetisation breaks down.
The linear regression method for PVC of ASL data shares shares some common features
with the Muller-Gartner method used for PET, in that GM and WM tissue flows are
derived from tissue fraction estimates. However, there are crucial differences. A single
value is estimated for WM activity and used globally from an area of WM assumed to be
free from PV effects. It is not necessarily the case that there is homogeneous activity in
WM. As such, a correction is found only for GM regions. The linear regression method
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does produce a voxelwise correction in both GM and WM, although it should be noted
that it is matter of debate as to whether or not WM perfusion estimate obtained through
ASL are reliable due to the low SNR and longer transit times for WM [49].
Additionally, the M-G method incorporates a deblurring of the PSF, which the linear
regression method described here for ASL does not. In fact, no mention is made of
the PSF in the original methods paper, or any of the papers which has since applied the
method.
3.3.3 Studies applying Linear Regression for PVC
Although it is seven years since publication of the original linear regression method, it
is not the case that PVC is in common use in ASL imaging. Asllani published a further
paper in 2009 applying the correction method to ASL data obtained from a group of young
and elderly subjects in an effort to decouple CBF and atrophy. In contrast to the findings
reported in PET studies of perfusion that CBF does not decline with age after PVC, [50,
43] she reported PVE corrected GM CBF of 88.2± 16.1 and 107± 17.5 ml/100g/min in
the elderly (mean age 68.0± 6.2) and young (mean age 26.4± 2.9) groups respectively.
A continuous labelling (2000 ms) and EPI readout scheme were used for the acquisition.
The same post-labelling delay (800 ms) was used for the young and elderly group,
although there is likely a longer transit time for the elderly subjects, which has the
potential to cause an underestimation in CBF values for this group. However, the PVC
GM CBF values are considerably higher than that reported in other studies. The study of
Binnewijzend et al [46] reports a mean uncorrected CBF of 33 ± 5 ml/100g/min in the
elderly control group, with a PVC GM CBF of 49 ± 7 ml/100g/min. Chappell et al [15]
report a typical increase of 69-80% in GM CBF after correction in a young subject
group. Asllani does not state the mean uncorrected global GM CBF value of either the
young or elderly cohort, so it is impossible to assess the effect of the correction.
However, these quoted values are unusually high, particularly for an elderly cohort,
given that we are concerned with capillary and not vascular flow. An insufficient
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post-labelling delay time could lead to vascular signal contaminating the perfusion
signal, which is certainly possible given that a multislice EPI acquisition was used with
inflow times ranging from 800 to 1696 ms.
3.3.4 Modified Least Trimmed Squares applied to LR
In terms of extensions to the published linear regression method, Liang et al [6],
published an enhancement in late 2012 which applies a modified least trimmed squares
(mLTS) [51] regularisation to the kernel as a means of discarding outliers before
performing the regression to reduce the smoothing effect. Voxels from within the kernel
are placed in ascending order in terms of absolute difference in intensity from the central
voxel. A subset of voxels is selected from the original kernel, starting with those closest
in intensity to the central voxel, until the rank of the subset is 2. An initial estimate of the
partial volumes is obtained from this subset. The process is then refined further by
computing the residuals using the partial volume estimates and sorting into ascending
order in terms of difference from the central voxel once more. A subset of the voxels
with the smallest residuals is selected based on a trimming parameter, α, and the partial
volumes re-estimated. This process is repeated for a number of iterations until
convergence occurs.
Liang applies the PVC technique to the difference image alone and does not quantify CBF
or the increase in GM CBF that this method offers. The paper focusses on varying the
degree of trimming used for the cut-off of voxel difference and a comparison between the
original method of Asllani. Both techniques are applied to simulated data like that used
in [15] and in this thesis.
Satisfying results are observed in the simulation study, in terms of reduced edge blurring
of two areas of hypo and hyper-perfusion, as compared to the original LR method. (See
figure 3.4). There is clearly reduced blurring of these areas compared to the original LR,
but this is not surprising, as the trimming has effectively reduced the size of the kernel to
just contain voxels which are alike. With this simulated data, there is a clear demarcation
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between voxels which are alike and which are not.
Figure 3.4: PV correction using the modified least trimmed squares enhancement of LR for a
simulation study, from [6].
The results obtained from in vivo data are not as compelling and are displayed in figure
3.5. At the present time, it is believed that the hallmark of a good PV correction is that a
relatively constant value is found for the GM CBF across all PV ranges, or GM ∆M , as
has been PV corrected in this case. The expectation is that there is a linear relationship
between perfusion and partial volume which is removed after PV correction. Whilst it
can be seen that there is an uplift in the perfusion values in the three subjects shown in
Liang’s paper, there appears to still be a linear dependency on PV fraction which has not
been removed.
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Figure 3.5: Modified least trimmed squares method applied to in-vivo data, from [6]. The
uncorrected CBF is not linear across the PV fractions, as the theory suggests it should be. For
example, we expect the CBF to be higher in a 60-70% GM voxel, compared to a 50-60% one. The
GM CBF results appear to mirror the uncorrected mean CBF values, which suggests a dependency
on PV remains.
These in vivo results are quite different to those published by other researchers using
LR methods, albeit with the caveat that groupwise averages are quoted in those works
[7, 46]. Figure 3.6 shows a groupwise PVC result for both a young and older cohort, with
consistent GM CBF results across the PV fraction range for both cohorts.
It is possible that the data used in the Liang paper is particularly noisy, and that the
smoothing ’side-effect’ of linear regression has been negated somewhat by the reduced
kernel size, as the PV corrected results seem to mirror the raw data across the PV fractions.
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Figure 3.6: GM CBF results for a young and an elderly healthy control cohorts. The uncorrected
CBF shows a strong linear dependence on PV fraction, and a consistent result is found for GM
CBF after correction [7].
3.4 Partial Volume Correction by Bayesian Inference
The principal alternative to the linear regression method for PVC is Bayesian Inference
for Arterial Spin Labelling (BASIL), a technique which uses Bayesian inferencing and is
available from the FSL suite of tools from the FMRIB group 2. This section provides an
overview of BASIL.
3.4.1 BASIL
BASIL is a Bayesian inferencing framework for fitting perfusion data to the general
kinetic model [33] and was primarily designed for processing multi-timepoint data.
Acquisitions of this type sample the full time course of the kinetic curve (see figure 2.5.)
This offers an advantage over single timepoint data in that the separate GM and WM
tissue kinetics can be estimated, as well as bolus arrival time, which can be an important
indicator in stroke patients.
In this application, the goal is to find the normal distribution for parameters GM and WM
CBF and bolus arrival time having measured some data (perfusion at various time points).
This is dependent on the likelihood - P(data | parameters) - of which perfusion and the
2http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BASIL
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partial volume estimates contribute, multiplied by the prior probability (our beliefs about
physiological ranges for the parameters). Essentially, an answer is sought to the question:
if these values for perfusion are observed, given a set of partial volumes (from a high-
resolution T1 segmentation) and spatial priors, what is the most likely value for separate
GM and WM tissue perfusion?
3.4.1.1 Spatial priors
It is usual practice to fit the kinetic model to the data using a non-linear least squares
algorithm. BASIL makes use of spatial and non-spatial priors in a probabilistic non-linear
least squares method to arrive at a fit for the general kinetic model. The non-spatial priors
are the T1 of tissue, bolus arrival time and bolus duration, with these priors based on real
a priori knowledge. Including these priors in the model effectively restricts the range of
plausible values that these parameters can take. For example, in the case of bolus arrival
time, most voxels will be in a certain range as a result of the distance from labelling to
imaging location. Including this strong prior information will help make the estimates
more robust in the case of poor SNR.
There is no sensible prior for perfusion (due to subject variability), so a spatial
smoothness prior is used instead. The spatial prior provides a form of adaptive spatial
regularisation by encoding the belief that the GM or WM perfusion in one voxel should
not differ dramatically from its neighbours. Spatial priors are encoded in BASIL in the
form of a Markov Random Field (MRF). It is beyond the scope of this report to discuss
the implementation of MRF spatial priors in detail. The reader is directed to [52] for
further detail. Suffice to say, the spatial homogeneity of a parameter is captured by the
MRF and is adaptive, being determined from the data.
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Figure 3.7: Priors used in BASIL; non-spatial priors are on T1 of tissue, bolus arrival time and
bolus duration, normal distribution assumed. Spatial priors are used for GM and WM CBF, with
the spatial extent, σ, being defined from the data. Image courtesy of Michael Chappell.
A schematic of the spatial and non-spatial priors is shown in figure 3.7. The scale of the
spatial prior is the spatial extent, σ, which specifies how rapidly the spatial prior tails off
with the distance; nearest neighbours exert the most influence and σ can be considered to
define the size of the neighbourhood. The spatial prior is adaptive in that the parameter
which dictates the spatial extent of the smoothness is determined from the data. This
means that smoothing effect is dependent on the data in any given region and can vary
across the brain, depending on how informative the data is.
BASIL tries to explicitly model the noise in the data, which influences the smoothing
effect. If BASIL is unable to form a good estimate for the noise, less reliance will be
placed on the data and more on the prior. This results in more smoothing in the GM
and WM estimates, as the spatial prior essential tells us that the each voxel is like its
neighbour.
3.4.1.2 PVC using Bayesian inferencing
In terms of partial volume correction, BASIL uses the tissue kinetics of blood flow to
assist with separating perfusion into tissue type. GM CBF is known to arrive earlier than
WM CBF, and this is modelled using the general kinetic model in tandem with the model
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for PV:
∆M = PGMδmGM + PWMδmWM (3.10)
Bayes’ theorem states that the posterior probability for the parameters being modelled
having observed some data, is proportional to the likelihood of observing that data with
these parameters, multiplied by the prior information on the parameters.
In terms of perfusion:
P (parameters|data) = P (data|parameters)P (parameters)
P (data)
(3.11)
where:
P(data) = P(∆M , t, PVF)
P(parameters) = P(CBFGM , CBFWM , CBF, ATT, T1, )
and P(data|parameters) is known as the likelihood term and P(parameters) represents the
prior information. where CBFGM , CBFWM are the separate GM and WM tissue flows,
CBF is the uncorrected perfusion, ATT is the arterial transit time,  is the noise in the
data, t is the time at which the kinetic curve is sampled, T1 is the tissue longitudinal
relaxation time and PV F represents the partial volume estimates for GM and WM in
ASL space.
From equation 3.11, it can be seen that perfusion and the partial volume estimates are part
of the likelihood term, which is a description of how the data is generated for a given set
of parameters, subject to noise. This is weighted by the prior information, and the spatial
prior information is exploited to separate perfusion into GM and WM components.
BASIL is an iterative algorithm and requires initialisation. To begin with, an estimate is
made for GM flow only, with further parameters added as the algorithm proceeds. An
initial estimate is made for the WM component based on a fixed ratio of the GM value
(WM = 0.4 * GM [53]). Based on this initialisation, a further model fit occurs with the
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full model. At each iteration, all the voxels are updated and then the spatial parameter of
the spatial prior is updated before another voxelwise parameter update step. GM and WM
voxelwise perfusion values are arrived at from a combination of the time series in a given
voxel, the neighbouring perfusion values and the level of noise that has been observed in
the data.
As an aside, BASIL is designed to operate on the difference signal alone, it does not PV
correct an M0 or control image, as there is no third term for CSF in the model.
BASIL was designed for multi-timepoint ASL data and has not previously been applied
to single timepoint data, which possess no kinetic information. An investigation of the
utility of BASIL in this case was carried out and is described in chapter 5.
3.5 Fractional Segmentation from Inversion Recovery
data: FRASIER
This section describes an alternative method of creating partial volume maps from data
which is acquired at the same resolution as the perfusion data, thus removing the need for
registration and resampling of high resolution anatomical data to perfusion space.
3.5.1 Issues with registration and ASL data
Within the limited number of papers published on PVC of ASL data, the second most
recent is the paper by Petr et al published at the end of 2012 [9]. The PVC technique
described within the paper uses the linear regression method of Asllani in its original
form, albeit the PV correction is only applied to difference and not control images. The
difference in approach lies in the creation of the PV estimates – these are created from
saturation recovery data acquired using a Look-Locker read out, rather than from T1-
weighted anatomical data, as is usually the case.
Within our own group, at the time that this paper was published, we were in discussion
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about using saturation recovery data, rather than anatomical images, as the basis of a
segmentation method. As saturation data is acquired as part of the existing protocol,
using this data to create segmentation maps would not increase the scan time, provided
the same sampling points are used.
Registration of high resolution anatomical data to low resolution ASL data can be
problematic. PV correction methods usually require the registration of anatomical data
to ASL space (normally a control image) in order to apply this transform to the partial
volume estimates which are produced at anatomical imaging resolutions.
Figure 3.8: Partial volume estimates are transformed to perfusion space by registering high
resolution anatomical images to lower contrast and resolution ASL images. ASL on right,
MPRAGE on left.
As can be seen in figure 3.8, the low resolution ASL data is lacking in contrast and
spatial detail. This lack of strong features creates difficulties for registration algorithms.
The chances of success of this procedure can sometimes be improved by registering the
ASL image to the anatomical image, and then applying the inverse transform. However,
this cannot be guaranteed, and it fails sufficiently often that it is necessary to manually
check each registration, and if necessary, tweak the registration parameters to improve
the outcome. This is subjective, error prone and time consuming.
As the transformation obtained from this registration is then applied to the tissue
segmentation maps, it is vital that the transformation is accurate. Any errors in
registration will cause the transformed PV information contained in the maps to be
inaccurate, which renders any PV correction performed using these maps to be
unreliable.
A misalignment of even one voxel between the ASL data and the PV maps will have a
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large effect on the quality of the PV correction given that the cortex is less than one voxel
wide at the usual resolution of ASL data. The inherent spatial blurring introduced when
using linear regression methods for PVC tends to mask registration errors to a certain
extent, but it is likely that as techniques are developed to reduce spatial blurring, errors in
registration will become more apparent.
Figure 3.9: Ten middle slices of a grey matter CBF map showing a ‘ringing’ effect caused at
the brain boundary due to misalignment of partial volume maps and perfusion data. There is an
overestimation of GM perfusion due to the PV maps as the GM/CSF interface is not correctly
positioned.
A registration error is usually most apparent at the brain boundary and is caused by the
PV maps not being scaled correctly to the ASL data. An example of this is shown in
figure 3.9. The brain boundary is a region where we expect to find PV effects due to
voxels containing a mixture of CSF and GM. There is a ’blooming’ effect due to the brain
boundary voxels being scaled after correction to too high a value. This is due to the brain
edge voxels having the incorrect PV estimates assigned to them in the linear regression.
Voxels which actually contain a mixture of GM and WM are being treated as though they
contain a GM/CSF mixture, which causes the GM estimation to be artificially high as
there is no perfusion in CSF. A one voxel misalignment between the perfusion weighted
image and the PV estimates will cause this to happen.
With regards to the creation of the PV maps themselves, the segmentation algorithms that
are in general use rely on registering subject images to a standard atlas. These algorithms
tend to fail quite rapidly once a patient population with atrophy is encountered, as is
the case for either elderly or dementia patients – in fact the very groups where PVC is
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valuable. Therefore, a method of creating partial volume estimates without relying on
anatomical data is particularly useful in these cases.
Figure 3.10: Grey matter partial volume maps
after resampling to perfusion space. (a) has been
resampled using trilinear interpolation, and (b)
resampled using spline interpolation.
Moreover, there is no consensus in the
literature as to how the segmentations
should be resampled from anatomical
to perfusion space. Consider the GM
partial volume maps in figure 3.10.
Image (a) has been resampled using
trilinear interpolation whilst (b) has been
resampled using a spline interpolation.
The differences between the two maps are
subtle, but they are evident. Each map will produce a different weighting for tissue
fractions in the model that ultimately affects the partial volume correction.
Producing partial volume estimates directly at perfusion resolution removes the
requirement to resample, along with the associated decisions as to how to achieve the
resampling.
3.6 The FRASIER segmentation method
The ability to segment MRI brain images into tissue types is of great utility in the study
of structure and function. There are a number of packages which are freely available for
performing this task, such as the FAST tool from the FMRIB group at Oxford 3, SPM
from the Wellcome Trust Centre for Neuroimaging at UCL 4 and Freesurfer from the
Harvard group 5 to name some of the most commonly employed algorithms.
It is usual for brain segmentation tools to require a high-resolution T1-weighted image
as the input image, and thus rely on images with a single contrast. Whilst segmentation
3http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FAST
4http://www.fil.ion.ucl.ac.uk/spm/
5http://surfer.nmr.mgh.harvard.edu/
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methods have been developed which make use of multi-contrast MR imaging and the
associated additional information for voxel classification, the relatively long acquisition
and additional processing times have meant that images with a single contrast remain the
most widely used.
The primary issue with performing segmentations on single contrast images is that of
partial volume. Whilst the resolution of single contrast high resolution MR anatomical
images is considerably better than that used in ASL (1mm x 1mm x 1mm compared to
4mm x 4mm x 4mm typically), given the relatively small size of cortical folding and the
fact that the cortex can be as thin as 2mm in places, there is still the issue of multiple
tissue types occupying the same voxel.
Due to the limited information available with which to classify voxels from single contrast
images, it is usual to rely on a priori templates. These templates are generally created
from healthy controls, with limited relevance to elderly and or atrophied brains, which can
lead to inaccurate segmentation results. A further complication when using T1-weighted
images is that voxel intensity may be corrupted by a bias field (for further details see
section 4.2.1).
Alternative brain segmentation methods which make use of quantitative MR parameters
have been proposed, and in this vein, Shin et al [8] proposed a brain tissue classification
method based on quantitative T1. Shin termed this method ‘FRASIER’, from ‘FRActional
Signal mapping from InvErsion Recovery’. The basis of this method is that the dynamic
signal from an inversion recovery experiment is sampled at various time points, to which
a curve can be fitted, and thus the signal modelled. This curve is considered to be the sum
of three mono-exponential functions, which represent the recovery of GM, WM and CSF
tissue signals. Through a linear least squares estimation process, an estimate is found for
each of the tissue fractional signals, which is then converted to a fractional volume by
scaling the signals for tissue density.
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3.6.1 FRASIER algorithm
Shin used a Look-Locker inversion recovery EPI (IR LL-EPI) dataset in order to
characterise the relaxation of the signal. In the original paper, the signal from an
inversion recovery acquisition is fitted to a linear combination of three exponential
functions, which represent the relaxation curves of GM, WM and CSF.
Shin proposed that a fit is made to the model:
S(t) =
∑
i
Si(1− 2e−t/T1i) (3.12)
where Si is the fractional signal of tissue i with relaxation time T1i .
Consider an inversion recovery sequence of n time points with voxelwise signals:
Sobs = [S1...Sn]
T (3.13)
and define for each time point t such that X is a n x 3 matrix where n is the number of
time points,
X =

(1− 2e−t1/T1GM ) (1− 2e−t1/T1WM ) (1− 2e−t1/T1CSF )
...
...
...
(1− 2e−tn/T1GM ) (1− 2e−tn/T1WM ) (1− 2e−tn/T1CSF )
 (3.14)
Fs = [FS,GM , FS,WM , FS,CSF ]
T (3.15)
one can write
Sobs = XFs (3.16)
Fs contains the fractional signal for each tissue type, which can be calculated using a least
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squares estimation, provided the T1 for each tissue type is known:
Fs = (X
TX)−1XTSobs (3.17)
The fractional signal can be converted to a fractional volume, pi, by correcting for the
variable water density using the relationship:
pi =
Si
ρi∑
i
Sj
ρj
(3.18)
where ρj is the relative water density for GM, WM and CSF (0.89, 0.73 and 1.0
respectively[54].
3.6.2 Petr et al extension
Figure 3.11: Figure 1 from [8] which
demonstrates how a histogram created from a
quantitative T1 map can be used to estimate T1
of GM and WM. Four Gaussians are fitted to the
histogram: blue is WM, green is WM + GM, red
is GM and yellow is GM + CSF.
Petr et al extended the work of Shin by
using a Look-Locker saturation recovery
EPI sequence, rather than an inversion
recovery; more importantly this data is
acquired at the same resolution as the
perfusion weighted data. This adds some
complexity to the calculation of tissue
fractions.
The FRASIER method (though perhaps it
is not quite correct to use the acronym
‘FRASIER’ when saturation recovery data
is used) requires knowledge of the T1 of
GM, WM and CSF. Shin estimated the T1 of GM and WM by fitting a Gaussian Mixture
Model (GMM) to the histogram of a quantitative T1 map produced from the inversion
recovery sequence. Four Gaussians were fitted to the histogram which represented
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WM, GM, WM + GM, and GM + CSF. The average T1 values for WM and GM were
determined as the means of the two highest distributions. Due to the relatively low volume
of CSF compared to other tissues, a literature value of 4300ms was used for the T1 of CSF.
The resolution of the data used in the Shin paper is 1.7 x 1.7 x 4.0 mm3 on a 128 x 128
matrix. At this resolution it is possible to discern a peak in the histogram for pure GM
voxels (see figure 3.11). This is not possible at the usual resolution that ASL data is
acquired at, as there are very few (if any) voxels which contain 100% GM.
If the T1 of GM cannot be measured from the T1 map, it must be estimated. Petr proposed
an approach which estimates a global value for the T1 of GM by searching for the optimal
value through a process of gradient descent and iterative minimisation.
The procedure can be summarised as:
1. Use a literature value for the T1 of GM as an initial starting point.
2. Calculate the PV fractions that are obtained with this T1 value.
3. Calculate the total signal that would be obtained from these PV fractions.
4. Calculate the error between the modelled signal and the observed signal.
5. Adjust T1 of GM in order to minimise error in step 4.
6. Repeat until no further reduction in error in step 4 is obtained.
From this process, PV maps for GM, WM and CSF are produced at the resolution of the
perfusion data and without the need for resampling, although it is still necessary to co-
register the PV maps and perfusion data as the two datasets are not necessarily aligned,
as there may have been patient movement
Petr appears to obtain good results in terms of the PV maps produced in this way, although
there is the usual difficulty in determining ’better’ rather than ’different’, when there is no
gold standard for comparison.
In particular, he points out that the FRASIER WM PV map ( labelled (f) in figure 3.12)
contains more structural details than the anatomical image derived PV map, (d). Likewise,
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the deep GM regions in (e) are of a reduced intensity compared to (c). He claims that
the WM is very thin in this region and that this structural detail is not realised from an
anatomical segmentation resampled to ASL resolution.
Figure 3.12: (a) CBF map, no PV correction (b) CBF map, after recombining PV effects from
FRASIER maps (c) GM PV from anatomical image (d) WM PV from anatomical image (e) GM PV
using FRASIER (f) WM PV using FRASIER. Taken from [9].
This paper is the first published instance of PV estimates being created from saturation
recovery data obtained at ASL resolution, and applied in a PV correction. The limitations
of this study are that there is quite clearly reduced GM tissue concentration in the deep
GM areas compared with high resolution T1 segmentations, and also that a co-registration
of the PV maps to the perfusion data is still required.
3.6.3 FRASIER applied to QUASAR
The most recent paper to apply PVC techniques to ASL data is that published in the
second half of 2014 by Ahlgren et al [10].
In this study, the FRASIER technique is used as previously published by Shin [8], but
differs from Petr et al referred to above, in that the QUASAR (QUantitative STAR
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Figure 3.13: GM CBF results obtained using FRASIER applied to QUASAR data (green), and
also using T1 high resolution derived PV maps (red), uncorrected data (blue), from [10].
Labelling of Arterial Regions) sequence [55] is employed for perfusion imaging. The
advantage offered by using QUASAR is that the same sequence that is used for
estimating perfusion forms the basis of the PV maps. This means that there is no need
for registration of separate datasets, which will reduce a potential source of error.
However, the QUASAR sequence is not in common use in the ASL community and only
available on Philips scanners.
In terms of the linear regression, Ahlgren et al propose the use of a circular kernel, which
effectively removes the voxels which are greater than a certain distance from the centre
voxel. This is similar to the least trimmed squares method, except that voxels are removed
from the regression based on their distance from the centre voxel, rather than difference
in intensity from it.
A comparison is made of the GM CBF results obtained using the QUASAR-FRASIER
and the QUASAR-T1 anatomical methods, with the result shown in figure 3.13.
It is not stated which PV maps were used to create the mean uncorrected CBF values,
although it seems most likely that it was the MPRAGE derived maps, as there is a similar
trend of decreasing CBF from the 80% GM range. The QUASAR-FRASIER method
produces a consistent result across all PV fractions, in contrast to that with the MPRAGE
maps.
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3.7 Discussion
This chapter provides an account of the existing techniques and current state of the art
methods for PV correction of ASL data. It begins with a brief summary of the methods
used in PET studies, and how they may or not be applicable to ASL data.
A detailed description follows of the techniques currently in use for ASL, which can be
separated into two categories; using PV maps from high resolution anatomical data or
creating them from saturation recovery sequences using a Look-Locker read out. All of
the described methods require PV estimates at the resolution of the ASL data.
There are two distinct methods of using PV maps in PVC. They are either used in a linear
regression algorithm, or in a Bayesian inferencing iterative algorithm to produce separate
GM and WM tissue flows.
Both PVC methods are explored in further detail in chapter 5.
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Chapter 4
Image Processing Pipeline and General
Methods
This chapter describes the data acquisition protocol and general image processing
methods used in this thesis, before concluding with a detailed description of the
processing pipeline.
4.1 Data Acquisition
This chapter describes the data acquisition techniques used for both the healthy controls
imaged for the purposes of this study, and a study which is being conducted by the
Dementia Research Centre (DRC), which is a clinical department within the UCL
Institute of Neurology. This data is known as the ’GENFI’ cohort 1 and the reader is
directed to chapter 8 for a full description of the data and analysis.
For the most part, the imaging protocols and parameters used follow the recommendations
of the ISMRM Perfusion Study Group ’white paper’ [39], other than where indicated.
These recommendations and the actual implementations used in this body of work are
summarised in table 4.1.
The data acquisition can be considered to be comprised of two parts; the perfusion data
and supporting parameter estimations, and the anatomical data used for partial volume
1(http://genfi.org.uk/)
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correction.
4.1.1 Labelling Scheme
The scheme used throughout is single time point ASL with a QUIPSS II [35] saturation
to define the bolus length. The inflow time (TI2) is 2000 ms and the first saturation pulse
is applied at TI1 = 800 ms. The recommendations of the ISMRM Perfusion Study Group
are that a single time point pCASL labelling scheme is used. However, that labelling
implementation was not available on the Siemens Trio when our studies were performed.
In this event, the workgroup recommends the use of a pulsed labelling scheme and
QUIPSS II saturation pulses with the bolus cut-off at TI1 = 800 ms. This was the
approach taken.
4.1.2 Background Suppression
Background suppression was used to null static tissue signal. The theory behind the
technique is described in section 2.6. The study by Günther et al [12] recommends that
the nulling of the static tissue occurs 100 ms before acquisition time. This results in a
small static tissue signal at the time of acquisition, which assists with post-processing
techniques. Accordingly, the nulling was calculated to occur at 1900 ms.
A relaxation rate, R1opt, of 1/700 ms was used for the timing of the two inversion pulses,
where were calculated according to equations 2.14 and 2.15. The two non-selective
background suppression pulses were timed to occur at 754 ms and 1610 ms after the
labelling and imaging volume saturation pulse. These inversion pulses coupled with the
labelling pulse reduced the overall labelling efficiency to 0.86. (0.95 ∗ 0.95 ∗ 0.95).
4.1.3 Read-out
The 3D GRASE sequence was originally developed as a one shot technique, but it is now
common to use segmented acquisitions. A comprehensive description of 3D GRASE
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imaging can be found in section 2.7.1. The volume was acquired in eight segments and
was split such that one segment consisted of a 64 x 8 x 20 matrix, with the split along the
first phase-encoding direction (see figure 4.1).
Figure 4.1: 3D GRASE eight shot segmentation scheme. Each shot was 64 x 8 x 20 voxels, with
the segmentation along the phase-encoding direction. Figure adapted from [11] and shows a 32 x
32 matrix for illustration of segmentation scheme.
This was done to mitigate the effects of T2 decay along the partition direction, and
therefore reduce blurring along this axis. This phenomenon is described and investigated
in detail in Chapter 7.
Figure 4.2 shows the background suppression with 3D GRASE readout sequence used in
this study.
Figure 4.2: Sequence incorporating pulsed ASL with background suppression and a 3D GRASE
readout used in this thesis. The modulated saturation pulses produce two saturation bands on both
sides of the imaging region, in order to suppress signal from inflowing venous blood. From [12].
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4.1.4 Summary of ASL imaging parameters
Protocol/Parameter PSG Recommendation Used in this thesis
Field Strength 3T 3T
Receive Coil 8 or more channels 32 channels
Labelling Single PLD pCASL Single PLD PASL + QUIPSS II
PLD 2000 ms 2000 ms
Background Suppression 2 inversion pulses 2 inversion pulses
Read-out Segmented 3D read-out Segmented 3D GRASE
Quantification Model General Kinetic Model General Kinetic Model
Matrix 64 x 64 x 20
Resolution 3.75 x 3.75 x 3.8 mm3
Table 4.1: Summary of important imaging parameter and recommendations of the joint ISMRM
Perfusion Study Group (PSG) and European ASL in Dementia Consortium and those used in this
thesis.
An example of a perfusion weighted image obtained in this study using the above
parameters is shown in figure 4.3. This image has been created by subtraction of the
control and label images after registration.
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Figure 4.3: A perfusion weighted image obtained from a healthy control using the imaging
parameters in 4.1. The image consists of 20 slices of 64 x 64 voxels with a 3.75 x 3.75 x 3.8
mm3 resolution.
4.1.5 Anatomical data
As described in Chapter 3, PV correction methods usually require an estimate of the tissue
concentration in the form of posterior probability maps. These maps are created from the
segmentation of high resolution anatomical images and should be of as high a resolution
as possible to assist the segmentation algorithms.
Throughout this project an MPRAGE image protocol is used for the anatomical data. The
acquisition sequence is optimised to provide the best contrast between grey and white
matter in the brain. Figure 4.4 shows an example of the quality of the anatomical data
and the tissue probability maps obtained from segmenting that image SPM8 software,
as described later in this chapter. The acquisition details of the MPRAGE sequence are
shown in table 8.2.
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Figure 4.4: Typical MPRAGE image and associated tissue fraction maps. These are grey scale
images with intensities ranging from 0 to 1, which reflect the relevant tissue fraction within a voxel.
For example, a voxel intensity of 0.5 represents a tissue partial volume of 50%.
4.1.6 Summary of anatomical imaging parameters
Parameter Value
Acquisition matrix 208 x 256 x 256
Resolution 1.1 x 1.1 x 1.1 mm3
TI 900 ms
TR 2200 ms
TE 2.9 ms
Flip angle 10 ◦
Table 4.2: Summary of MPRAGE imaging parameters
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4.1.7 Saturation recovery data
As part of the CBF quantification, a proton density image is required for scaling of the
data. To achieve this, a series of saturation recovery images were acquired at three time
points and fitted to the following model:
M(t) = M0(1− eTR/T1) (4.1)
where M0 is the equilibrium magnetisation, T1 is the tissue longitudinal relaxation, and
TR is the repetition time.
The images were acquired at t = 1000, 3000, 5000 ms for the control subjects. In order
to produce maps of T1 and M0, each voxel was fitted to the above equation using a non-
linear least squares method in Matlab. Example voxel-wise T1 and M0 maps are shown in
figure 4.5.
Figure 4.5: Voxelwise (a) M0 and (b) T1 maps produced from fitting the saturation recovery
sequence to equation 4.1.
4.2 Image Processing
Most medical image analysis will require some form of image processing, either as a pre-
processing step, to apply a correction to an image (noise removal, bias field correction,
motion correction) or to aid analysis of the image itself. This is a vast area of research,
so the following sections focus on the image processing techniques which are required to
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perform the PVC techniques that are described within this thesis.
4.2.1 Bias field removal
Automated analysis of medical images using techniques from the computer vision domain
is an ever growing area of research. In MR imaging, a frequently encountered problem for
such tools is that of the bias field, which is a smooth, low frequency signal which corrupts
the image and leads to non-structural intensity variations within the same tissue class.
If I is the measured intensity in the image and I ′ is the ’true’ intensity, then the bias field
effect may be modelled by:
I = αI ′ +  (4.2)
where α and  represent the bias field and additive noise respectively.
Figure 4.6 shows a proton-density image acquired on a 3T scanner, alongside an estimate
of the bias field and its subsequent removal from the image. After removal, the image is
more uniform in intensity and no longer exhibits the bright central region shown in the
pre-correction image. Note that after filtering, the image histogram shows two clearly
defined peaks, which are far less apparent before. This clearly illustrates the importance
of bias correction for automomated image segmentation.
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Figure 4.6: (a) proton-density image acquired on a 3T scanner, (b) an estimate of the bias field,
(c) the image after bias inhomogeneity removal, (d) image histogram before and after correction.
Adapted from [13].
The most common causes of this source of inhomogeneity are radio-frequency (RF) non-
uniformity, caused by imperfections in the RF coils and interactions between the object
being scanned and its environment . This is a particular problem in any type of MR
imaging where surface coils are used, and is often apparent in neuroimaging due to the
proximity of the head coil to the brain. The existence of a bias field can greatly reduce
the accuracy of segmentation and registration techniques, and therefore the reliability of
any derived measured. Bias field removal is therefore an essential pre-procesing step in
the field of neuroimage analysis.
There are a number of techniques in existence to deal with the issue. If there is knowledge
of the bias field in the image domain, perhaps by imaging a phantom, it is a simple matter
to correct the image by division of the bias field. However, time constraints may make
this impractical. Additionally, a bias field calculated from a phantom image will not
necessarily be the same as that induced by a patient.
Another option is to acquire a body coil image and use that to generate coil sensitivity
maps for the array coils, in order to account for this inhomogeneity (’pre-scan
normalisation’ option on the Siemens scanner).
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It is also usual to derive the bias field retrospectively from the image, and there are a
number of competing tools in the field of MR image analysis offering this service.
Broadly speaking, bias correction methods can be assigned to one of the following three
models:
1. statistical: the bias field is assumed to be a random variable which can be estimated
statistically
2. low frequency: the bias field is composed of low frequency oscillations which can
be removed in the frequency domain using a low pass filter
3. hypersurface model: a map is fit to the bias field using a smooth function, the
parameters of which are estimated by regression
Commonly used tools for the estimation and removal of the bias field are:
1. FSL BET 2 contains a bias field removal option
2. Non-parametric Non-uniform intensity Normalization (N3) from Freesurfer 3
3. SPM bias correction 4
4.2.2 Brain extraction
Perfusion images, by the very nature of their creation, contain little non-brain tissue, such
as skin, muscle, fat and eyeballs. High resolution anatomical images of course contain all
of these things. Registration between perfusion and anatomical images can be made more
robust by the automatic removal of these features from the higher resolution image prior
to performing the registration.
In the literature, there are numerous approaches to the task of segmenting the brain into
brain and non-brain regions. It seems we can separate the various methodologies into
three distinct groups.
2http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BET
3http://surfer.nmr.mgh.harvard.edu/fswiki
4http://www.fil.ion.ucl.ac.uk/spm
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4.2.2.1 Manual segmentation
The first of these methods is manual segmentation by a trained neuroimaging analyst.
Interestingly, the author of the tool which is used extensively throughout the world (FSL
BET), Stephen Smith of FMRIB, states that manual segmentation of the whole brain
from non-brain tissue (as distinct from the segmentation of the brain into tissue classes)
is ’probably more accurate than fully automated methods are ever likely to achieve’
[14]. He states the reasons for this are that the size of the ’image neighbourhood’ is
essentially the entire brain image, with global information assisting with differentiation
between the cerebellum and neighbouring veins, unusual pathology, removal of optic
nerves, the external contours of gyri. A manual operator is able to take a somewhat
holistic approach to the task in a way that an automated algorithm cannot. However,
manual segmentation is non-ideal for the usual reasons of time involved and intra- and
inter- operator variability.
4.2.2.2 Thresholding
The second class of whole brain segmentation is based on a simple thresholding of the
brain in order to separate the image into foreground and background. Upper and lower
thresholds are selected such that the image is separated into bright parts (scalp and
eyeballs) and less bright parts, namely brain tissue, skull and air. Thresholding generates
a binary image, and theoretically, the largest contiguous non-background cluster should
represent the brain. This binary image is then applied as a mask to then original image.
The problems with this somewhat simplistic approach is that the voxel clusters
representing the brain are usually remain connected to other non-brain parts of the image
by high intensity voxels, effectively ’linking’ what should be two disparate portions of
the image. These connections must be broken and this process is often carried out using
morphological operators to erode and break the connections and then dilate the brain
back to its original size.
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This ’thresholding plus morphology’ technique is really a semi-automated method, as it
requires user intervention in the form of threshold selection, which may necessitate a trial
and error approach until a good segmentation is found.
4.2.2.3 Surface models
The final class of techniques is that of deformable surface models. A surface model of
the brain is constructed from a mesh of shapes, such as a tessellated mesh of triangles,
see figure 4.7. This mesh is then deformed to fit the brain by an iterative process which
applies two principal constraints to the fitting. Firstly, there is a smoothness condition that
is applied so that the mesh surface matches the smoothness of the actual brain surface.
Secondly, there is a constraint which matches the model to the relevant part of the brain
image, namely, the surface. This method offers an advantage over thresholding techniques
in that a large neighbourhood of information is considered for any point of interest, which
makes the technique more robust and easier to automate than thresholding methods.
Figure 4.7: A typical mesh surface used in surface model techniques for brain segmentation. From
[14].
4.2.2.4 Brain Extraction Tool - BET
By far and away, the most widely used automated whole brain segmentation tool is FSL’s
Brain Extraction Tool (BET). This tool is a hybrid of the two automated techniques
described above, and a comprehensive description is provided in [14].
An important parameter which affects the quality of the segmentation is the fractional
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intensity threshold, known as the ’-f flag’. This sets the intensity threshold for separating
brain and non-brain tissue. Larger values produce smaller brain volumes, and vice versa.
A study by Popescu et al systematically investigated a range of values for f, coupled with
other BET options, against manual segmentation methods. The conclusion of the study
was that values of 0.1 < f < 0.3 coupled with the bias correction facility and removal
of neck slices worked best, albeit applied to MS brains, which exhibit atrophy [56]. The
lower end of the range is more suited to atrophied brains; interestingly the default value
if f = 0.5, which is designed for healthy controls.It was found for this cohort of young,
healthy brains that the optimal value for f was 0.25.
4.2.3 Segmentation
Segmentation refers to the process of separating a whole brain volume into its GM, WM
and CSF components. Manual segmentation of brain volumes by a trained analyst is the
gold standard, but this is very labour intensive and can be subjective. Therefore, there is
a high demand for reproducible, accurate, automated brain segmentation algorithms.
Historically, approaches to automated brain segmentation have tended to fall into one of
two categories; either tissue classification or registration to a standard template based.
In the latter approach, a template brain is warped via a process of nonlinear registration to
match the brain image which requires segmentation. Prior to warping, regions or segments
of interest are defined on the template, which after registration are then overlaid on the
brain image to automatically identify structures.
Tissue classification algorithms aim to assign a voxel to a tissue class on the basis of
intensity. This approach requires that the intensity distribution for each tissue class is
defined. This is usually achieved by modelling the intensity distributions as a Gaussian
mixture model, or GMM.
The tissue classes (GM, WM and CSF) can be modelled using a histogram of the brain
image to be segmented. For this approach to be successful, it is essential that the image is
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preprocessed to remove bias field inhomogeneities and other sources of artefact, otherwise
it is likely that there will be no clear separation of the tissue classes.
An intensity distribution can be modelled by a mixture of K Gaussians. The kth Gaussian
is modelled by a mean µk and variance σ2k and mixing proportion γk where
∑K
k=1 γk = 1
with constraint γk ≥ 0.
For a GMM, the probability of observing voxel intensity yi given it is a member of the kth
Gaussian cluster and that the kth Gaussian has parameters µk and σ2k is:
P (yi)|µ, σ, γ) =
K∑
k=1
P (yi, ci = k|µk.σk, γk) (4.3)
If we assume that all the elements are independent, then the probability of all voxels y is:
P (y|µ, σ, γ) =
I∏
i=1
(
K∑
k=1
γk
(2piσ2k)
(1/2)
exp
(
−(yi − µk)
2)
2σ2k
))
(4.4)
This probability is then maximised with respect to µ, σ and γ by minimising an
appropriate cost function. The reader is directed to [57] for full details of the derivation.
Figure 4.8 depicts an intensity histogram for a typical brain image. A voxel from that
image is selected (in red box) and has intensity = 17203. Three tissue classes are modelled
for the GMM, with a class representing GM, WM and CSF. The GMM suggests relative
proportions of GM, WM and CSF for that voxel intensity. In this case, we can see that the
voxel is almost entirely composed of WM, based on purely on information about voxel
intensity.
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Figure 4.8: A Gaussian mixture model fitted to an image histogram. Three classes are fitted, to
represent GM, WM and CSF. The voxel seleced from the image has an intensity of 17203, which
would suggest that the voxel is composed almost entirely of WM.
However, if the only information from the intensity distribution is used, this can lead to
misclassification of voxels, for example scalp has a similar intensity to GM and can be
classified as such. Two of the most widely used brain segmentation techniques will be
briefly discussed, and their approaches to improving tissue segmentation using a GMM.
4.2.3.1 Statistical Parametric Mapping (SPM8)
More recent developments in neuroimaging analysis have seen a move towards an
’integrated generative modelling approach’ in which tissue classification and nonlinear
warping are combined within the same framework [57]. This is the approach taken for
the tool Statistical Parametric Mapping version 8, known as ’SPM8’ 5.
SPM8 is a well established tool in worldwide use developed at the Wellcome Trust
Centre for Neuroimaging at University College London and runs within a Matlab
installation. SPM8 uses an iterative procedure in which bias correction, spatial
normalisation and tissue segmentation are all part of the same GMM.
5http://www.fil.ion.ucl.ac.uk/spm/
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SPM8 improves tissue classification by incorporating spatial priors in the form of tissue
probability maps. These spatial priors are derived from a modified version of the ICBM
Tissue Probabilistic Atlas 6, and give the prior probability of a voxel in a registered image
belonging to one of the tissue classes, with the key point being that this probability is
irrespective of voxel intensity.
This additional a priori information can be factored into the model alongside voxel
intensity to aid in assigning a particular voxel to a class. SPM8 estimates tissue partial
volumes by using more than one Gaussian per tissue class in its model and iteratively
registering to the spatial priors to produce a highly accurate segmentation.
4.2.3.2 FMRIB Automated Segmentation Tool (FAST)
It could be said that the main competitor in the neuroimaging marketplace to SPM8, is
FAST, developed by the FMRIB group at Oxford University 7. FAST also models the
voxel intensities as a Gaussian mixture model, but does not register to spatial priors.
Instead, FAST uses spatial neighbourhood information in the form of a Markov random
field (MRF) to offer a likelihood about the class that a voxel belongs to [58].
Figure 4.9: Two possible voxel configurations for
a segment of a brain image. Image (b) is an
unlikely configuration and would be assigned a
low probability. Image (a) is more likely, and
would receive a higher prbability, given what is
known about brain anatomy.
The MRF encodes information which
suggests the class that a voxel may belong
to on the basis of the class of the
neighbouring voxels, by allowing voxel
intensity to vary smoothly, such that if
a neigbouring voxel is GM, say, this
would tend to suggest the voxel under
investigation is also GM.
To illustrate this point, in figure 4.9 two
potential voxel configurations are shown.
6http://www.loni.ucla.edu/ICBM/ICBMprobabilistic.html
7http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FAST
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The image on the right would be assigned a low probability, as this is an unlikely
configuration given what is known about brain anatomy. The left hand image would
be assigned a high probability, as a contiguous structure is shown which aligns with our
beliefs about brain structure.
This probability estimate can be combined with the GMM to incorporate spatial
information into the tissue classification, which makes the algorithm robust to noise. It is
then a matter for the user to tune the algorithm so that the correct balance is struck
between using voxel intensity and belief about tissue type based on the neighbouring
voxels to make a classification:
logP (ci) = logP (yi) + βP (MRF ) (4.5)
where P (ci) is the probability of belonging to class ci for a voxel of intensity yi, plus
some weighting β of the likelihood offered by the MRF [58].
Both FAST and SPM8 actually produce partial volume estimates, that is, they do not
produce hard segmentations of tissue classes, but produce an estimation of what fraction
of each voxel belongs to a particular class.
4.2.4 Image Registration
The process of spatially aligning two or more images of the same object is known as
image registration. Image registration is the technique of transforming one image to the
coordinate system of the other, with the images then said to be registered. Registration
between images can be of the same type, known as mono-modal. These images may
have been taken at different times in a longitudinal study to track disease progression, for
example, tumour growth or suppression after a therapy, tissue atrophy in
neurodegenerative disease. Other instances where mono-modal registration might be
required are motion correction and comparison of pre- and post-operative images.
Multi-modal registration is the technique of registering images from different image
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modalities, such as PET and CT, or PET and MRI. This is commonly done for the
purposes of using information from one modality to quantify a parameter in the other.
For example, using segmentations or regions obtained from a high resolution MRI
overlaid on a PET image to assess regional activity. Multi-modal registration is also used
in PET PVC techniques which correct for the tissue fraction effect.
The majority of ASL PVC techniques (with the exception of the FRASIER technique)
require high resolution MR images to be registered to perfusion images. As such, this is
a mono-modal registration, albeit a registration between images created by different MR
sequences, which creates some challenges, as will be discussed in this chapter.
The set of parameters which define the registration of one image to another is known as a
transformation and it is usual to speak of transforming one image to the space of
another. There three types of transformation which are commonly in used in medical
image analysis are: affine, rigid and non-rigid. It is helpful to define some terminology
which is in general use. A source image is the image which is deformed so as to
resemble as closely as possible the target image. The target image is fixed, with the
source image undergoing deformations (depending on the constraints imposed) until it
matches the target as much as is possible using a particular registration algorithm. A
brief description of the three types of transformation follows.
4.2.4.1 Rigid transformation
A rigid transformation rotates and translates the source image only. Using homogeneous
coordinates which are frequently used in projective geometry, this transformation can be
written as:

x′
y′
z′
1

=

tx
R ty
tz
0 0 0 1


x
y
z
1

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Rx =

1 0 0
0 cosα −sinα
0 sinα cosα

Ry =

cosβ 0 sinβ
0 1 0
−sinβ 0 cosβ

Rz =

cosγ −sinγ 0
sinγ cosγ 0
0 0 1

where x, y and z are the coordinates of the voxel to be transformed, tx, ty, and tz denote
the translation to be applied to each axis, with Rx, Ry and Rz representing the rotation
matrices around the three axes with R = Rx.Ry.Rz and α, β and γ the angles of rotation
around them [59].
A rigid transformation is appropriate for registering images of the same subject together,
such as in motion correction for a series of images, or images of different MR sequences.
4.2.4.2 Affine transformation
An affine transformation is as a rigid transformation, but with the additional possibilities
of shearing and scaling. As such, a rigid transformation is a special case of an affine
transformation.
A voxel or pixel is scaled from one image to another in the following way:
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
x′
y′
z′
1

=

Sx 0 0 0
0 Sy 0 0
0 0 Sz 0
0 0 0 1


x
y
z
1

where sx, sy and sz are the scaling factors for the three axes.
Shearing can be applied when an image is known to suffer from a distortion, such as may
occur in MR images in the presence of non-linear gradient fields.
Using the same notation, shearing can be described by:

x′
y′
z′
1

=

1 kxy kxz 0
kyx 1 kyz 0
kzx kzy 1 0
0 0 0 1


x
y
z
1

where kxy represents the shear due to x along the y axis, and so on.
4.2.4.3 Non-rigid transformations
In brain imaging, the rigid body constraint is satisfied to a good approximation.
Consequently global, rigid transformations are the most common type of registration
used in neuroimaging applications. Having said that, a correction for an EPI distortion
can commonly include a non-rigid registration.
A non-rigid or elastic registration describes a transformation in which local warping takes
place in order to align the source with the target image. Such a transform is non-linear
and not able to be described by a matrix operation. A non-rigid transformation may be
applied to an image to warp it into the space of a common template (e.g. MNI) in order
to make inter-subject comparisons.
In this body of work, affine and rigid transformations are used.
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4.3 Methods used in this thesis
This section focuses on the details of the implementations used from the available array
of image processing tools and techniques.
4.3.1 Brain extraction
As previously described, FSL’s BET is commonly used for the purpose of extracting brain
tissue from the head. This tool also has an in-built bias correction facility and outputs a
binary mask of the extracted brain. It was found for this cohort of young, healthy brains
that the optimal value for the thresholding parameter f was 0.25.
4.3.2 Segmentation
The PVC method requires estimates of the proportion of GM, WM and CSF within a
voxel. These estimates take the form of tissue posterior probability maps obtained from
the segmentation of a high resolution anatomical image.
After the application of BET, SPM8 was used to further segment the extracted brains into
GM, WM and CSF tissue probability maps. These are partial volume estimates where
the fraction of the voxel occupied by a particular tissue type is given. Three maps are
produced, one for each tissue type, with the data in the range 0 to 1 and the three maps
summing to 1 for each voxel. SPM8 is widely used throughout the medical imaging
community and was chosen as the segmentation tool as it has been used by others in
PV correction work [7, 40, 6]. Additionally, in a direct comparison between SPM8 and
FAST, SPM8 was found to outperform FAST on both simulated data from Brain Web
and an array of challenging clinical data in terms of the Dice coefficient overlap with the
automated method and a manually segmented reference image [60].
Tool used: SPM8 - tissue segmentation
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4.3.3 Registration
4.3.3.1 Target image
The target space for the partial volume correction is perfusion space, at the resolution of
the ASL data. This requires transformation of the anatomical data to perfusion space, and
also potentially, motion correction of the ASL and saturation recovery sequence images.
Registration of perfusion data is non-trivial as it is usually low resolution and low
contrast. The saturation recovery images are not background suppressed, unlike the
control/tag images, and contain more static tissue signal and stronger features for
registration algorithms to lock on to. As such, the TR = 5000 image was chosen as the
target image in perfusion space.
4.3.3.2 Perfusion image
Three averages were acquired for each subject for the control/tag pairs in order to increase
SNR. Difference images (subtraction of control and tag pair) are produced automatically
on our scanner. The three difference images were rigidly registered to the target image
and a mean difference image created from these three. Registering control/tag pairs to the
mean control image and creating difference images from the subtraction of the registered
pairs was also investigated, but this was found to be less reliable than registration of the
scanner-created difference images.
This is somewhat surprising, as the control and tag images have considerably better SNR
than the difference images and so one would expect registration of the former to be more
easily accomplished than that of the latter. Most likely, the scanner created difference
images are a straight subtraction without registration as they are acquired in quick
succession. As for registering to the target image, it may be that the background
suppression has reduced image contrast to the point that the difference image register
better. In any case, the difference images from the scanner were registered to the target
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image.
Tool used: FSL FLIRT - rigid registration
4.3.3.3 Partial volume estimates
The GM, WM and CSF partial volume maps are created in high resolution anatomical
space and it is necessary to transform these to perfusion space.
A mean control image was created by registering the three acquired control images to
the target image and taking the mean. The mean control image was registered to the
MPRAGE ’BET’ image using a rigid transform. This transform was then inverted to
provide the transformation from anatomical to perfusion space. This was done because it
was found that results were more robust in registering the lower resolution image to the
higher one.
The inverted transform was then used in a resampling algorithm to transform the GM,
WM and CSF probability maps to perfusion space. This is an important step and care
must be exercised when choosing the tool with which to perform this task. At present, the
only freely available tool which correctly transforms anatomical information to perfusion
space is FSL applywarp. This is the only resampling tool which does not use a linear or
nearest neighbour (NN) interpolation. Neither of these approaches will transform the PV
information correctly.
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Figure 4.10: Interpolation schemes. The black lines represent the larger ASL voxels and the red
dotted lines the smaller MPRAGE voxels. Nearest neighbour will assign the value of the voxel
nearest to new, smaller voxel. This will assist with preserving sharp edges in an interpolated
image. A linear interpolation will calculate a new value that lies between the existing voxel values.
Figure 4.10 shows the larger ASL voxels from perfusion space overlaid on the smaller
anatomical image voxels. We require a single value for the ASL voxel (black outline)
based on the underlying values from the smaller voxels underneath. A NN interpolation
scheme will choose the value of the voxel coloured in dark green, and a linear
interpolation scheme will calculate a value that lies between the four highlighted voxels.
Neither of these schemes will reflect the entire partial volume information that underlies
the ASL voxel, as no information is taken from the other voxels in the region.
To ensure that the PV maps at ASL resolution reflect the PV information across the entire
higher resolution region, the transformation (rotation and translation) is first applied to
the PV maps, with the target (ASL) image at a four times super-sampled resolution of the
ASL data. A spline interpolation of the high resolution PV maps to the super-sampled
ASL image is employed, with the PV maps in the lower resolution ASL space derived
by integration over the appropriate region. In essence, this amounts to calculating the
mean PV of the smaller voxels in anatomical space that equate to a large ASL voxel. This
sounds a rather tortuous procedure; fortunately it is achieved in one step using the FSL
tool ‘applywarp’. As an aside, it should be noted that spline interpolation was used with
applywarp, in a like manner to the work in [15] and [9]. Given that the most accurate
method of interpolation is apodised sinc, it may be appropriate to make use of the sinc
interpolation option available with applywarp, as inaccurate registration is likely to result
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in artefacts in the transformed PV maps [61].
The use of applywarp underpins the use of FLIRT as the registration algorithm.
applywarp is only compatible with FLIRT, so it is not possible to use another registration
tool. Nonetheless, FLIRT is a well-established registration tool in worldwide use.
Tool used: FSL applywarp - resampling
4.3.4 Partial Volume Correction
Following the above steps results in motion-corrected perfusion data and PV maps in
perfusion space. It is then possible to apply a PV correction method (e.g.BASIL, linear
regression) which will produce separate GM and WM perfusion maps. It should be noted
that the common pre-processing step of smoothing is not applied to the perfusion data, as
the linear regression method for PVC introduces an inherent spatial smoothing.
The initial paper proposing the use of linear regression for PV correction by Asllani et al
stressed the importance of applying the method to both the difference image and the
control or M0 image. This of course doubles the processing time, and moreover, the M0
or proton density scaling image is not always available from a clinical scanner. An
investigation into the difference between applying the correction to ∆M and M0 or
directly to the CBF map is provided in section 5.5.
The PV correction results are presented in this thesis in such a way that two separate
perfusion maps are produced, one for GM and one for WM CBF. These maps present
the perfusion as though each voxel contained 100% GM or WM. Note, the values are not
scaled by tissue fraction, as is sometimes the case [9, 7]. This is a detail that can lead to
confusion, so for the sake of clarity, an example is given here.
Consider a voxel of intensity 40 A.U. with partial volumes of 0.5 GM and 0.5 WM within
an uncorrected image. After partial volume correction, separate GM and WM maps are
produced with intensities of 60 and 20 respectively for that voxel. These values represent
the unscaled intensity for GM and WM. If these maps were then scaled by the partial
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volume fraction, the same voxel would have values of 30 and 10 respectively in the GM
and WM maps; the product of the corrected intensity and the partial volume for each
map. This approach allows one to readily envisage the contribution oof each tissue to the
observed voxel value (e.g. for the 40 A.U. voxel, 30 A.U comes from GM and 10 A.U.
from WM), but it does offer any information about the pure actual tissue flow, so is not
the methodology used in this thesis.
4.4 Regional Analysis
It can be appropriate to consider mean regional values rather than global mean values, in
order to assess the impact of deblurring and PV correction algorithms on a local basis.
4.4.1 Parcellation using FreeSurfer
Regions of interest (ROI) were obtained by performing a parcellation of a subject
anatomical scan using the FreeSurfer package 8. FS is an automated software suite for
analysis of anatomical MR data. Parcellation is the process of dividing an anatomical
image into a set of labelled regions which provide some sort of description of the image.
In the application used in this work, parcellation has been used to divide the brain into
volumes of interest which represent anatomical areas and is distinct from a segmentation,
in which only three tissue regions (GM, WM and CSF) are produced.
Like segmentation, parcellation is achieved by registering the subject anatomical image
to a standard space, such as the MNI or Talairach space. It is beyond this scope of this
thesis to provide a detailed description of FreeSurfer; suffce to say, the parcellation takes
place in standard space, but is propagated back to subject space, so that a subject specific
parcellation is produced.
FreeSurfer produces a very detailed parcellation containing several hundred individual
regions. These have been combined into a superset of larger regions, as this level of detail
8Martinos Centre for Biomedical Imaging, Harvard, MA, USA
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is not required. Parcellation is an incredibly intensive process, which takes on the order
of 24 hours for a single subject, even for quad core machines.
The parcellations must be transformed to ASL space. This is done in the same way as for
the transformation of the PV maps, which one notable difference. As the labelled regions
produced by FreeSurfer need to be transformed in such a way that their integer values are
preserved, that is, the integer label of region, as they are in fact masks. A linear or spline
interpolation would produce non-integer values, so a ’nearest neighbour’ interpolation is
used.
4.4.2 Regions of Interest
The detailed FreeSurfer parcellations were combined into larger ROI for analysis. These
took the form of 9 masks, consisting of 9 GM regions and 1 WM region. It was considered
sufficient to combine all WM voxels into one region and consider them as a whole for two
reasons. Firstly, whether or not it is possible to measure WM perfusion using CBF is still
a matter of debate, given the low SNR due to long transit times compared to T1 relaxation
of blood, so is of questionable utility.
Secondly, the PVC correction methods developed in this thesis were applied to a cohort
of patients who are either at risk of cortical atrophy, or are diagnosed as suffering from
dementia, so the ROIs were chosen with this application in mind. These are the same ROI
as used in [16] and were chosen by clinicians as relevant regions in terms of propensity
for atrophy in dementia patients, such as the frontal, parietal and temporal lobes.
One of the FreeSurfer outputs is a file called aparc+aseg.mgz, which is where the
parcellation results can be found. This file contains the FreeSurfer labels which have
been combined to produce the larger region masks as detailed in table 4.3.
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4.5 Processing pipeline
This chapter describes the image processing and general methods which constitute the
ASL PVC processing pipeline. A schematic can be seen in figure 4.11. The elements
coloured yellow represent high resolution images, the low resolution images are pink,
with processes coloured blue.
The partial volume correction pipeline is essentially a post-processing technique, and is
heavily reliant on a successful registration of high resolution anatomical data to much
lower resolution perfusion space. The pipeline involves segmentation, registration,
resampling and linear regression. Numerous options exist for each step of the pipeline,
and a successful outcome is dependent on choosing the correct tool. This chapter
describes the tools used in this thesis along with the rationale for doing so.
Chapters 5, 6, and 7 describe novel developments to the pipeline which improve the
accuracy of GM and WM perfusion estimations.
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Figure 4.11: Schematic of the processing pipeline for the image processing techniques used for
pre-processing prior to PV correction.
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Chapter 5
Improvements on Linear Regression
method for Partial Volume Correction
This chapter presents a novel extension to the 2D kernel linear regression method for PVC
published by Asllani et al [22]. An investigation into a Bayesian inference model for PV
correction is applied to single time point ASL data for the first time, and a comparison
made between that and the improved LR method.
This work was the subject of oral presentations at ESMRMB 2012 and 2013 and a poster
at ISMRM 2013.
5.1 Introduction
The linear regression method for PV correction causes an inherent blurring in the
produced GM and WM CBF maps due to the assumption that magnetisation and
perfusion is constant over the linear regression kernel region. The larger the kernel, the
greater the smoothing effect; the smoothing is equivalent to the application of a Gaussian
smoothing kernel of FWHM 5mm and 9mm for a 5 x 5 and 15 x 15 kernel respectively
for voxels of in-plane resolution 3.4 x 3.4 mm2 [22]. Nonetheless, a larger kernel results
in more equations being available, and so there is a trade-off between these
considerations.
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5.2 Development of 3D kernel applied to PVC
5.2.1 Theory
The linear regression method of PV correction is designed to solve a system of linear
equations for two or three unknowns. It would seem reasonable that a 3 x 3 square kernel
would provide sufficient information to solve the inverse problem, as this offers nine
equations for the regression. In practice, there are boundary conditions which mean that
a kernel containing so few voxels is not suitable.
Recall the equation from chapter 3 for separating the voxelwise magnetisation signal into
GM, WM and CSF components:
M(ri) = Pj(ri) ·mj(ri) (5.1)
where M(ri) is the total voxel magnetisation, Pj(ri) is a vector containing the posterior
probabilities for all 3 tissue types and mj(ri) is the tissue specific magnetisations.
Solving for mj is accomplished using the standard least squares solution:
mj = (P
T
j · Pj)−1 · P Tj ·M (5.2)
where (P Tj · Pj)−1 · P Tj is the pseudoinverse of P .
If either of the following situations is encountered:
1. The Moore-Penrose pseudoinverse of Pj is singular
2. The LR kernel contains less than 3 non-zero voxels (as can occur at the brain
boundary)
then some form of special case handling must be applied.
Asllani handled these cases by imposing the condition that the central voxel in the kernel
107
(i.e. the one that is being PV corrected) be set to zero when either of these two situations
occur. It was found that in the case of a 3 x 3 kernel these two situations are frequently
encountered on the brain boundary. Asllani reports that the smallest useful kernel is 5 x
5, although there is one instance in the literature where the authors describe using a 3 x 3
kernel without any reported problems [9]. The authors do not state whether they used the
same criteria as above, or how they handled these cases.
5.2.2 From a 2D to a 3D kernel
It is proposed that the radius of the linear regression kernel may be reduced, yet retain
sufficient information, by moving from a 2D form to a 3D embodiment. Theoretically,
this novel idea facilitates a reduction in the radius of the kernel whilst retaining the number
of voxels and therefore information within the kernel.
This idea is depicted in figure 5.1. The image on the LHS shows a 2D 5 x 5 kernel, which
is the smallest kernel recommended by Asllani and the one usually implemented for LR
PVC. It is proposed to replace this with the 3D 3 x 3 x 3 kernel on the RHS.
Figure 5.1: Comparison of 2D and 3D kernel. An equivalent number of voxels are contained
within each kernel, although the 3D kernel has a smaller radius than the 2D kernel.
Minimising kernel radius reduces the associated blurring effect of PVC by LR, which is
important to preserve spatial detail. From table 5.1 it can be seen that in a 3 x 3 x 3
kernel, there are 27 voxels with a kernel radius (at the furthest point) of
√
3 compared to
√
8 for a 2D 5 x 5 kernel. Therefore, there are a comparable number of voxels (and thus
equations), but the kernel has a smaller radius that will translate to reduced blurring in the
PVC images.
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Kernel size 2D voxels 2D Max radius (A.U.) 3D voxels 3D Max radius (A.U.)
3 9
√
2 27
√
3
5 25
√
8 125
√
12
7 49
√
18 343
√
27
11 121
√
50 1331
√
75
Table 5.1: Comparison of the number of voxels and subsequent kernel radius for 2D and 3D
kernels.
The use of a 3D kernel is particularly suited to isotropic 3D data, as has been acquired
in the studies presented in this thesis. It is not uncommon for voxels to be larger in the
slice direction; if a 3D kernel is used in these cases, it is likely that a greater amount of
blurring will occur in this direction, than in-plane. Additionally, as each image slice has
a different inflow time for 2D EPI data, this means that a 3D kernel will require a more
complex treatment when applied to this type of data. (A potential solution to this problem
is to perform the PV correction directly to a CBF map; the validity of this approach is
discussed in section 5.5).
It should be noted that the use of a 3D kernel does not impose any additional
computational load over that of the original linear regression method. With the advent of
3D image acquisitions, it is a simple matter to apply a 3D kernel to the perfusion images.
5.3 Application of the 3D kernel for PV correction
5.3.1 Simulation study
In order to properly assess the performance of an algorithm, a ground truth is required.
A simulated data set was based on vivo data in order to quantify the performance of the
PVC algorithm using the existing method of a 2D kernel and compare it to the new method
using a 3D kernel.
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5.3.1.1 Creation of simulated data
GM and WM posterior probability maps from a subject from the in vivo data were
transferred to ASL space and resolution as previously described in chapter 3. The
resolution of these maps after transformation was 3.75 x 3.75 x 3.8 mm3 on a 64 x 64 x
20 voxel grid. The creation of the simulated data was modelled on that in [15, 6]. The
GM voxels intensities were set to 60 A.U. in GM, 20 A.U. in WM, with a hyper- and
hypo- intense spherical regions (radius = 5 voxels) of 100 A.U. and 20 A.U. located in
GM.
Previous studies investigating the noise characteristics of CBF images suggest that there
is little to no autocorrelation in the noise and that it can essentially considered to be white
[62]. More recently, researchers investigating image blurring caused by the point spread
function (PSF) propose that it is possible to determine the PSF from the autocorrelation of
the residuals obtaining from fitting perfusion data to a model, which would suggest that
the noise is correlated [15, 47]. This work is discussed in section 7.2.3.2.
However, for the purposes of this simulation study where the data is generated from
structural data without any blurring, it is appropriate to assume a Gaussian noise model.
Accordingly, white noise of amplitude = 5 was generated using the Matlab function
randn which generates a pseudorandom number from a normal distribution with mean of
0 and standard deviation of 1. This was added to the image, such that the SNR was 20 for
a 100% GM voxel of intensity 100. Partial volume effects were introduced according to:
∆M = PGM(ri)mGM(ri) + PWM(ri)mWM(ri) (5.3)
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Figure 5.2: Creation of simulated data. Ground truths for GM and WM were created with
simulated hypo- and hyper-perfusion lesions of radius 5 voxels in the GM ground truth. Partial
volume fractions were applied to the ground truths and the images combined along with Gaussian
noise of SNR = 20 for the hyperperfused lesion.
5.3.1.2 Method
In the model (see equation 5.3), the perfusion in CSF was set to zero, therefore the GM
and WM intensities are the only unknown quantities. Kernel sizes of 3,5,7 and 11 in both
2D and 3D format were used to PV correct the simulated data. The root mean square error
(RMSE) between the PV corrected result for GM and the GM ground truth was calculated
for all pixels.
To assess the level of smoothing introduced by the smallest kernels, 3 x 3 x 3 and 5 x 5,
a line profile was taken through the hypo- and hyper-perfusion regions and compared to
the line profile through the same regions in the ground truth.
5.3.1.3 Results
Kernel size 2D voxels RMSE for 2D 3D voxels RMSE for 3D
3 9 4.16 27 3.96
5 25 4.04 125 4.08
7 49 4.15 343 4.23
11 121 4.35 1331 4.60
Table 5.2: Root mean squared error between simulated GM ground truth and PVC results using a
2D and 3D kernels of sizes 3,5,7 and 11.
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In table 5.2, the ’Kernel size’ column indicates the kernel side length in number of voxels
and columns 2 and 4 show the total number of voxels that would be contained in the
kernel, if the kernel was 2D or 3D. It can be seen that the lowest RMSE, that is difference
between the ground truth and recovered GM image is for the 3D 3 x 3 x 3 case. Broadly
speaking, as the kernel size grows, whether 2D or 3D, the RMSE increases. However,
there is a decrease in RMSE in moving from the 2D cases of 3 x 3 to 5 x 5, despite an
increase in kernel size. The reason for this is that the boundary conditions are invoked
frequently for the 3 x 3 case, which has the effect of stripping away voxels at the brain
edge, as the value of the voxel is set to 0.
The smallest RMSE is observed for a 3D 3 x 3 x 3 kernel, as predicted by the hypothesis.
The 3D 3 x 3 x 3 kernel contains 27 voxels, which is comparable to the 25 voxels in the
2D 5 x 5 kernel, yet the kernel radius is smaller, which leads to less in-plane smoothing
in the PV corrected images and therefore a closer recovery to the ground truth values.
Figure 5.3: Profiles taken through the hyperperfused lesion (RHS) and hypoperfused lesion (LHS)
of the simulated data. The ground truth data is shown by the blue line and is a step function. The
3D kernel PVC result is shown in green, with the 2D in red. The 3D kernel result is closer in
profile shape than the 2D kernel.
Line profiles through the hyper- and hypo-intense regions for both the ground truth and
the GM recovered regions are shown in figure 5.3. The ground truth is marked in blue and
shows a step change in intensity associated with the simulated lesions. It can be seen that
the 3 x 3 x 3 is closer in profile to the ground truth than the 5 x 5 kernel, which translates
to reduced blurring of edges.
This finding is also demonstrated in figure 5.4 which shows the same middle slice through
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the ground truth, the GM PV fraction map, the simulated data and the attempts to recover
the ground truth using a 3 x 3 x 3 and 5 x 5 kernel. It can clearly be seen that by using the
3 x 3 x 3 kernel the edges of the simulated lesions are better preserved. This difference
can be quantified by considering the FWHM of the intensity profile for the slice shown.
The lesion diameters at FWHM for the hyperperfused region are: ground truth = 28.1
mm, 2D kernel = 31.9 mm, 3D kernel = 29.4 mm. For the hypoperfused region: ground
truth = 31.9 mm, 2D kernel = 33.8 mm, 3D kernel = 30.6 mm. Both PVC methods
overestimate the lesion diameters for the hyperperfused lesion, but at the FWHM, the 3D
kernel slightly underestimates for the hyperperfused one, compared to the 2D case. This
result is a consequence of the reduced blurring with the higher intensity region around it
in the 3D case.
Figure 5.4: Simulated data and result. (a) Ground truth (b) Partial volume fraction GM (c)
Simulated data (d) 3x3x3 kernel PVC GM result (e) 5x5 kernel PVC GM result.
5.3.1.4 Discussion
This piece of work focused on an attempt to modify an established method of partial
volume correction for ASL data in order to reduce the inherent spatial blurring which
occurs as a consequence of the assumption that perfusion is constant over the linear
regression kernel. It has been shown that the smallest viable 2D kernel is 5 x 5, although
this still introduces blurring in the recovered pure tissue maps equivalent to smoothing
with a 5mm FWHM Gaussian kernel.
Use of a 3D kernel allows the kernel radius to be reduced whilst preserving total voxel
numbers, and therefore equations for the linear regression method. A 3D 3 x 3 x 3 kernel
offers 27 equations, compared to 25 for the nearest 2D equivalent. The smaller radius of
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the 3D 3 x 3 x 3 kernel compared to the 2D 5 x 5, which results in reduced blurring in the
recovered GM and CBF pure tissue maps.
Consequently, the 3D kernel is better at preserving spatial detail, in particular high
contrast edges. This is a useful and important finding, which has potential applications in
patient groups. If PV correction techniques are to be applied to pathological cases, it is
important that disease features are not smoothed away during post-processing
techniques.
For example, Multiple Sclerosis (MS) patients present with lesions throughout the brain
that are a result of inflammation and demyelination. Studies have shown decreased
perfusion in cortical lesions compared to normally appearing GM [63, 64, 65]. As an
additional feature of MS is brain atrophy, it is important for longitudinal studies that a
PV correction is performed in order to compare perfusion across time points. Lesion
volume is used as a surrogate marker of disease progression. Clearly, it is also important
that the boundary of these lesions is preserved, rather than blurring any significant
changes in perfusion out into the surrounding healthy tissue.
5.3.2 In vivo study
Previous studies have demonstrated the efficacy of the linear regression method in
correcting for the tissue fraction effect [6, 9, 22, 7, 46]. This investigation sought to
characterise the difference, if any, between recovered GM CBF maps using a 2D and a
3D kernel, and to assess how the reduced smoothing effect seen using a 3D kernel on
simulated data, translates to in vivo data.
5.3.2.1 Theory
The simulation and theoretical considerations suggest that less smoothing will be present
in PV corrected maps of GM CBF using a 3D kernel. When using in vivo data, no
ground truth is available, which makes the assessment of results obtained using different
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methods difficult. That being said, there is a parameter that we wish to optimise (level
of smoothing) and it is possible to make a comparison study between the two methods
which assesses this.
With this goal in mind, the spatial gradient is introduced. This can be regarded as a
measure of retained spatial detail in the image and borrows from the field of computer
vision with its gradient edge detectors [66].
Edge detection is a mathematical technique which is applied to an image in order to detect
regions where the image intensity changes rapidly, such as at a boundary or some strong
image feature and be accomplished using first or second order derivatives.
The mathematical tool of choice for detecting both edge strength and direction at a
particular location (x, y, z) in an image I is the gradient, denoted ∇I and is defined as
the vector:
∇I = grad(f) =

gx
gy
gz
 =

∂I
∂x
∂I
∂y
∂I
∂z
 (5.4)
where ∂I
∂x
, ∂I
∂y
, ∂I
∂z
are the numerical gradients along the first, second and third dimensions
of the image.
As ∇I is a vector quantity, it offers information about direction and magnitude of the
greatest change of image intensity. For the purpose of assessing retained spatial detail in
a image, it is sufficient to be concerned with the magnitude of∇I:
G = mag(∇I) =
√
gx2 + gy2 + gz2 (5.5)
which represents the rate of change of intensity in the gradient vector. G is a voxelwise
representation of the gradient of image I and as such is an image the same size as I .
If the GM CBF image obtained using a 3D kernel contains a larger magnitude of spatial
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gradient than that from a 2D kernel, this suggests that there is more retained detail in the
image.
5.3.2.2 Method
Perfusion and anatomical data were collected using the imaging protocol described in
chapter 4. The control group consisted of 4 females and 2 males with ages ranging from
23 to 31 years (mean age 26.3 ± 3.1 years).
The processing pipeline as described by figure 4.11 was utilised to produce separate maps
of GM and WM perfusion. The PV correction algorithm was applied to the M0 and ∆M
images separately, before combining to a single image of either GM or WM perfusion.
The images were PV corrected using a 2D 5 x 5 and 3D 3 x 3 x 3 kernel.
The mean CBF prior to correction and mean GM CBF, using a 2D and 3D kernel for
correction were calculated across the whole brain, after masking at GM PV fraction 0.1.
It is commonly accepted practice to exclude voxels with PV fractions less than 0.1, as
there is too little tissue within the voxel for the LR to be reliable [15, 6].
In order to quantitatively assess the correction using the 2 kernels, the consistency of the
mean GM CBF was calculated across the range of GM PV fractions, in a manner like
that described in [22, 15]. The GM probability map was split into nine binary masks
containing 10-20%,20-30%.....90-100% GM PVF. As the GM PV maps are quite
heterogeneous, these masks represent a pseudorandom sample across the brain. The
mean CBF and GM CBF was calculated within each 10% range.
Additionally, the GM was separated into 9 regions using a Freesurfer parcellation,
representing frontal, central, parietal, temporal, occipital, cingulate, insula, deep GM,
and hippocampal regions. The mean CBF and corrected GM CBF was calculated in
these contiguous regions.
To make a quantitative comparison of smoothing resulting in the PV corrected maps, the
magnitude of the spatial gradient of the GM CBF maps was calculated for each voxel
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using equation 5.5. The large gradient obtained at the brain boundary was removed by
image erosion, prior to masking at GM PV fraction > 0.1 to exclude low GM regions. The
mean spatial gradient and standard deviation was calculated over the remaining voxels for
both the 2D and 3D cases.
5.3.2.3 Results
The global mean of the standard, uncorrected CBF map, and 2D and 3D kernel PV
corrected GM CBF maps is listed in table 5.3. Comparing the GM CBF after PV
correction using both a 2D and 3D kernel, there is little difference between the mean
values, calculated across all voxels after excluding voxels which have less than 10%
GM, in accordance with the recommendation in [15]. The ratio of PV corrected GM
CBF to uncorrected CBF ranged from 1.2 to 1.6 for 2D, and 1.3 to 1.6 for 3D.
2D 3D 2D 3D
Subject CBF (ml/100g/min) GM CBF (ml/100g/min) Spatial Gradient (/voxel)
AA 49.6 ± 22.6 61.3 ± 14.4 62.9 ± 17.1 12.7 ± 11.1 13.7 ± 10.4
HH 43.1 ± 24.6 62.3 ± 20.8 62.0 ± 22.5 10.7 ± 7.3 12.0 ± 7.8
MS 39.5 ± 16.9 55.8 ± 17.3 55.8 ± 19.0 9.0 ± 7.1 10.2 ± 7.5
MV 37.6 ± 18.5 61.3 ± 22.0 60.8 ± 22.6 14.0 ± 10.9 14.7 ± 11.5
RR 39.4 ± 21.7 62.7 ± 21.1 61.9 ± 19.3 11.2 ± 8.9 12.4 ± 9.4
SK 34.9 ± 15.2 53.4 ± 16.2 53.0 ± 18.2 9.3 ± 7.6 10.5 ± 7.9
Table 5.3: In vivo data results: Uncorrected CBF, PV corrected GM CBF and spatial gradient
using a 2D and 3D kernel for the PV correction. All values are mean of the remaining voxels after
excluding GM PV fraction < 0.1.
The correction on a regional basis is shown in figure 5.5 and table 5.4. Of the six
subjects, four had greatest perfusion both before and after correction in the occipital
region (AA, HH, MV, RR). Of the remaining two, MS showed greater perfusion in the
hippocampal region both before and after correction, with SK showing greater perfusion
in the occipital region prior to correction, but marginally greater perfusion in the
hippocampus after correction with a 3D kernel. The correction using a 2D kernel was
greatest in the occipital region.
The correction across the GM PV fractions relative to the uncorrected CBF can be seen
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Figure 5.6: Axial middles slices from six control subjects of the uncorrected CBF map, GM CBF
PV corrected maps using a 2D and 3D kernel. Also shown is the spatial gradient magnitude
image for the 2D and 3D kernel GM CBF maps. The 3D kernel case shows less blurring, which is
supported by the greater intensity in the spatial gradient image.
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in the line graphs in 5.5. The dependency on PV fraction for the uncorrected CBF map is
apparent for all subjects, with CBF increasing as GM PV fraction increases. The greatest
increase post-correction is of course seen at the lower end of the PV range. Both 2D and
3D kernels follow the same trajectory in terms of correction, although it can be seen that
the 2D kernel offers a slightly larger estimation than the 3D one in the 10-20% GM PV
range.
Subject AA showed a slight difference from the other subjects in that the uncorrected
CBF was fairly stable from GM PV 40% onwards. The increase in CBF from GM PVF
40-50% to 90-100% was 1.2 ml/100g/min, which was not observed in the other subjects,
and cannot be readily explained.
Figure 5.6 shows a middle slice from the uncorrected CBF map, alongside the same slice
from the PV corrected GM CBF maps for the 2D and 3D kernel correction methods, as
well as the corresponding spatial gradient maps for all six subjects.
Whilst the mean GM CBF results may not differ much depending on whether a 2D or 3D
kernel is used, visual inspection of the resultant GM CBF maps does show a variation in
signal distribution. There appears to be less blurring or smoothing, and therefore more
retained spatial detail in the maps produced using a 3D kernel.
This can be quantified by comparing the spatial gradients of the GM CBF maps, which
are reported in table 5.3. It can be seen that the 3D case has a consistently higher spatial
gradient than the 2D case, which supports the hypothesis and visual inspection of the PV
corrected maps.
5.3.2.4 Discussion
The effectiveness of the linear regression method for PV correction is accepted, and
indeed it is seen that the application of the method has resulted in mean GM CBF
measurements 1.2 to 1.6 times greater than mean CBF values obtained without PV
correction. There is an inherent trade-off in the linear regression method which results in
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spatial smoothing of the recovered GM CBF maps, and the goal of this project was to
reduce the smoothing and provide more accurate quantitative results for GM perfusion.
It can be seen that the mean GM CBF values obtained after PV correction obtained using
a 2D or 3D kernel are consistent with each other, both when the means are calculated on
a regional, contiguous basis and also on a pseudorandom sample of voxels with the same
GM PVF.
The difference in results produced by the 2 kernel types is shown in the distribution of
signal. The larger 2D kernel causes greater blurring in the PV corrected maps than the 3D
kernel and this is manifested by the greater mean spatial gradient obtained from the 3D
kernel case. This suggests that the 3D kernel is better suited to preserving spatial detail.
All subjects show a comparatively high perfusion in the occipital region, both before and
after correction. The fact that it is common across all subjects would suggest that it is a
feature of the imaging sequence.
A finding of note is that shown in figure 5.5, which charts the dependency of uncorrected
CBF on GM PVF, and also the GM CBF post-correction. The assumption that perfusion
is relatively constant throughout the brain leads to a conclusion that the corrected GM
perfusion will show consistency across all GM fractions after correction, and indeed this
general trend is displayed in the aforementioned figure.
Figure 5.7: Simulation study results using BASIL
from [15]. Note excellent agreement between
PV corrected result and uncorrected CBF at GM
PVF > 0.9. Standard = uncorrected, Spatial PV
= BASIL in legend.
Theory suggests that as the GM PVF
approaches 100%, the mean uncorrected
CBF value for voxels which contain this
proportion of GM will approach the GM
CBF corrected value. That is, that the
uncorrected CBF value rises to meet the
corrected GM CBF value, for voxels
which are close to 100% GM. Chappell
et al [15] performed a simulation study
using three differing datasets, the results
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of which can be seen in figure 5.7. The
uncorrected CBF (called ’standard’ in this
figure) for GM PVF 90-100% coalesces
with the corrected GM CBF value, which
is constant across all PV ranges. This
is not seen on the in vivo data presented
in our study, which shows a definite
offset due to the uncorrected CBF not
meeting the GM CBF value. This same
finding is observed for all six subjects, and
throughout the reported studies of other researchers, including the in vivo data used in
Chappell’s paper, which is discussed in the next section [22, 6, 7].
Given that Chappell finds perfect agreement in his simulation study, at first glance this
would suggest that the mismatch at high PVF is due to an imperfect registration between
the perfusion images and PV estimates. For the simulation, the ’perfusion’ data is
generated from the PV estimates, and as a consequence is perfectly registered with the
PV estimates, which are used in the linear regression.
Registration of perfusion and anatomical data is notoriously problematic due to the low
contrast and spatial detail in perfusion images. Add into the mix the requirement to
downsample high resolution tissue partial volume estimates to the much lower resolution
of perfusion images, it is to easy to attribute the offset to these problems.
The same pattern of consistently higher GM CBF is seen whether the ∆M and M0 are
both PV corrected, or just the ∆M image, (or for that matter the CBF map) which would
rule out an explanation based on elimination of the CSF signal in the M0 image causing
GM CBF to be elevated. Misregistration of high PV fraction GM voxels by displacing
them to overlap regions of CSF would result in lower GM CBF values (as these would
be voxels in the perfusion image with low intensity), whereas low fraction GM voxels
displaced to the CSF receive a ’boosting’ of their true value, which is very obvious in a
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PV corrected image (see figure 3.9).
What is clear is that the issue affects GM CBF across the entire PV range, as evidenced
by the constant value of GM CBF. Whilst it is difficult to hypothesis as to what exactly is
causing the problem, Chappell’s simulation study shows that the offset is not there when
simulated data which is created from perfectly registered PV maps is used. Along with
the perfect registration, constant values were used for GM and WM perfusion, for which
the assumption that perfusion is constant within the kernel is true. It is possible that a
violation of this assumption is occuring with in vivo data, which is elevating GM CBF
estimates.
Having said that, it is also the case that registration challenges contribute to this problem,
with difficulties in registering the different imaging modalities and creating reliable PV
estimates being the motivation behind the work of Shin [8] and Petr’s application of it
to PV correction using linear regression [9]. This is discussed in chapter 3 and a novel
extension to these ideas in described in chapter 6.
5.4 Bayesian Inference applied to single time point ASL
As described in chapter 3, BASIL was designed for multiple timepoint data acquisitions
and uses kinetic information to infer values for GM and WM flow and bolus arrival time.
In a single timepoint experiment, the kinetic curve is sampled at one time point only; as
such, the full time course cannot be characterised. However, it is still possible make use of
the spatial prior information which encapsulates the belief that voxels near to each other
are likely to be alike to estimate separate GM and WM flow. The aim of this study was to
investigate whether using the spatial prior alone without tissue kinetic information would
offer any advantage over the use of linear regression for PVC. This study is believed to be
the first to apply BASIL to single timepoint ASL data.
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5.4.1 Simulation study
5.4.1.1 Methods
The same digital phantom as previously described in section 5.3.1 was used to quantify
the performance of BASIL on single timepoint data. The required format for the input
data to BASIL is in the form of a 4D time series, ordered in ascending time points. It is
possible to present BASIL with data that has been averaged to a single image per time
point, or with each measurement at each time point, should more than one have been
acquired.
Essentially, BASIL requires PV maps at ASL resolution, an ASL difference image and a
calibration for M0 to correctly scale the perfusion maps. There are a number of tools
which sit on top of BASIL to assist the user with getting the data to this state, and
development is ongoing.
In order to test the effect of the presentation of the data to BASIL, the simulated data
was inputted to BASIL as a series of n = 1 to 9 averages at the same time point, with
a different random noise pattern for each ‘average’. It is usual practice to acquire more
than one signal average at a timepoint, whether the experiment is a multiple or single
timepoint study. Thus, it is appropriate to investigate the output of BASIL as a function
of the number of averages provided as input.
The RMSE between the PV corrected result and the ground truth for GM were calculated
and plotted against number of volumes, or signal averages, in the stack. For comparison
purposes, the result obtained using linear regression with a 3 x 3 x 3 kernel is shown as
a flat line across all volumes. The LR method must be applied to a single image, and
requires a mean image to be created from all multiple measurements.
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5.4.1.2 Results
The RMSE between the GM CBF PV corrected result and the input ground truth is shown
in table 5.5 and figure 5.8. BASIL does not produce a lower RMSE than that of the
LR method between the PV corrected result and the ground truth until five averages are
presented to it. The RMSE continues to decrease with increasing averages, but the rate of
decline falls sharply after three volumes and plateaus after five.
BASIL LR
No. of averages/volumes RMSE RMSE
1 11.5 3.6
2 9.2 3.6
3 4.3 3.6
4 3.7 3.6
5 3.5 3.6
6 3.4 3.6
7 3.3 3.6
8 3.2 3.6
9 3.1 3.6
Table 5.5: Root mean squared error between simulated GM ground truth and PVC results for
BASIL using an increasing number of averages. BASIL does not outperform LR until 5 image
averages are presented to it.
The images in figure 5.8 are revealing; BASIL requires three images as input before the
PV corrected result begins to capture what are actually extremely coarse spatial features.
With one volume, BASIL largely fails to recover the hyper- and hypointense simulated
lesions. If two volumes are used, the spatial variation in intensity for the lesions starts to
appear, but the edges are ill-defined and the result is somewhat blurred. In line with the
RMSE result, BASIL requires a three-volume input before an output is observed which is
comparable to that obtained using the LR method.
5.4.1.3 Discussion
The oversmoothing of the PV corrected output for BASIL was an unexpected result which
had not previously been observed when applied to multiple timepoint data. The reason
for this is tied up in the way BASIL estimates the noise component of the ASL signal.
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Figure 5.8: Comparison between BASIL and linear regression on a simulated dataset. BASIL does
not recover gross spatial detail until 3 or more averages are used.
When less than three volumes of data are inputted to the Bayesian algorithm, BASIL is
not able to estimate the noise contained within the signal and relies heavily on the spatial
prior, rather than the data, which states that voxels near to each other are like each other,
which produces a very smooth result, losing spatial detail. The simulated lesions in the
ground truth have a five voxel radius, so can be considered to be a large spatial feature,
given that a voxel is of side length just under 4mm.
With single-TI data, it is quite possible that a user may present BASIL with one volume of
perfusion data (it is unusual to have only one measurement in perfusion experiments, but
multiple measurements at the same TI may have been averaged to produce a single image
for a particular time point). With multi-TI data, even averaging the multiple measurements
at the same TI to a single image (although this is not recommended, as BASIL is able to
infer more about the noise content of the data if it is unaveraged), it is likely that there
will be multiple image volumes for BASIL to operate on as it is entirely normal to acquire
multi-TI data at more than three timepoints; notably, Chappell [15] acquired perfusion
data at ten timepoints throughout the kinetic curve.
This is clearly a feature of BASIL that researchers using single timepoint ASL
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acquisitions need to be aware of. The main claim, as it were, of BASIL is that the
resulting estimates of tissue perfusion are adaptively smoothed, with the level of
smoothing very much related to the amount of spatial detail in the input images [15].
Additionally, BASIL is more complicated than LR methods for PVC, both conceptually
and practically, as well as more time consuming in execution. These factors should be
considered alongside the finding that BASIL relies heavily on prior information when
low numbers of data volumes are available, when making a decision about what method
of PVC to apply.
5.4.2 In vivo study
Armed with the knowledge that at least three data volumes are required to recover gross
spatial detail, a comparison was made of the performance of BASIL and LR on in vivo
data.
5.4.2.1 Method
BASIL was designed for the specific ASL sequences used at the FMRIB lab at Oxford
University; namely, pulsed labelling with a multiple time point 3D GRASE readout with
a global value used for the M0 calibration based on the CSF signal. As such, BASIL
incorporates a PVC correction for the difference images only. This is contrary to the
approach of Asllani in [22], where it is stated that the voxelwise measurements of
perfusion are a ratio of two images, each of which are affected by voxel heterogeneity.
For comparison purposes, BASIL was applied to a stack of three difference images, and
LR using a 3D 3 x 3 x 3 kernel was applied to the difference and M0 images. It might be
argued that a fair comparison would be to apply the LR only to the difference images;
however, we wished to investigate the differences between the full application of the
method published by Asllani et al and BASIL.
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5.4.2.2 Results
Table 5.6 shows the global mean CBF before PV correction and after using BASIL and a
3D kernel for LR. The difference between the two GM CBF groups is not significant (p
= 0.26), with the difference between BASIL and LR mean GM CBF usually only a 1-2
ml/100g/min apart. The difference was more pronounced for subject AA, with the BASIL
result some 9.6 ml/100g/min lower than for the LR method.
Subject Mean CBF GM CBF (3D kernel) GM CBF (BASIL)
AA 49.6 ± 22.6 62.9 ± 17.1 53.3 ± 30.1
HH 43.1 ± 24.6 62.0 ± 22.5 60.8 ± 30.3
MS 39.5 ± 16.9 55.8 ± 19.0 56.1 ± 22.4
MV 37.6 ± 18.5 60.8 ± 22.6 58.0 ± 31.3
RR 39.4 ± 21.7 61.9 ± 19.3 58.4 ± 22.0
SK 34.9 ± 15.2 53.0 ± 18.2 55.7 ± 24.5
Table 5.6: Mean CBF, GM CBF after PV correction using a 3D kernel with linear regression, GM
CBF using BASIL. All measurements in ml/100g/min after masking at GM PVF > 0.1.
Table 5.7 shows a comparison between the 3D kernel LR method for PVC with BASIL,
with the mean value given for the same Freesurfer brain segmentation regions as in the
2D and 3D kernel comparison.
Global and region mean GM CBF values alone do not reveal the full story. Figure 5.9
shows middle slices from the six subjects in a like manner to the comparison that was
made for the LR method between 2D and 3D kernels. Clearly, the BASIL results are
more heterogeneous than the LR ones, which is evidenced in the mean GM CBF results
by the greater standard deviation for BASIL. Visual inspection of the data supports this,
with a less smooth appearance in the images.
Moving on the comparison across the GM PVF range, the same pattern is observed for
all subjects; the mean GM CBF BASIL result appears to peak in the 40-60% GM range.
There is an upward trajectory from the lower PV fractions of 10-20%, rising to the highest
GM CBF values at the mid-range, before decreasing and dropping to a mean GM CBF
which is consistently below that of the LR method at 90-100% GM. The LR method is
more consistent across all PV fractions, as can be observed in the graphs in figure 5.10.
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Figure 5.9: Middle slices from six control subjects showing a comparison between the GM CBF
obtained by using the 3D kernel LR method and BASIL. Whilst global mean values for GM CBF
are in agreement between the two methods, the BASIL method produces GM CBF maps with more
spatial variability.
Finally, as for LR, it is noted that BASIL also does not converge to the uncorrected CBF
result at high GM PV fractions, despite the downward trajectory mentioned above.
5.4.2.3 Discussion
This section focused on a comparison between the LR method for PV correction using
a 3D kernel and an alternative method, BASIL, which uses Bayesian analysis to infer a
result for GM CBF.
BASIL claims to be able to ’provide PV corrected GM CBF estimates whilst maintaining
underlying spatial structure...the new method is shown to protect spatial features in the
CBF images, avoiding the introduction of added smoothness to the boundaries of regions
of hypo or hyper perfusion’ [15]. It is proposed that this is achieved by applying an
adaptive smoothing to the CBF and GM CBF estimation which is derived from the data
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itself, which may offer an advantage over LR methods at regions of high spatial variation,
such as tissue boundaries or pathology.
However, the simulation study described within this chapter has shown that the output of
BASIL is strongly weighted by spatial priors when the data input is less than three images,
which actually leads to a result which smoothes away large spatial features. The study
offered three input volumes to BASIL, to avoid this oversmoothing ’feature’, and it can be
seen in the results that the BASIL GM CBF images are indeed more heterogeneous than
the LR. As to to whether or not the increased spatial variation in the GM CBF BASIL
images represents true spatial features is open for debate. The images appear to contain
more noise than the original CBF images, unlike LR, where one useful side-effect of the
inherent spatial smoothing is noise removal. Could it be that the BASIL outputs simply
contain more noise than the LR images, rather than an increase in retained spatial detail?
In terms of a comparison between LR and BASIL, whilst the mean GM CBF values for
both are in broad agreement, it can be seen in the pseudorandom samples across the GM
PVF ranges shown in figure 5.10 that the BASIL result is not linear, showing a distinct
rise around the mid PVF ranges.
There is only one other published paper to date which uses the BASIL method for PV
correction, and this is Chappell’s original paper describing the technique [15]. The in
vivo data section presents the same result as observed here, shown in figure 5.11, where
the ’Spatial PV’ method referred to is BASIL.
Figure 5.11: Variation in GM CBF across PV range obtained using BASIL published in [15].
Chappell does remark on the in vivo data results within his paper, which are notably worse
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than those observed in his simulation study. He suggests that the differences may be ’due
to inaccuracies in the PVE and residual effects of the T2 blurring’. As to the former
suggestion, of course the LR method has been executed using the same PV estimates as
BASIL, so one would expect the LR result to follow a similar pattern if that were the
reason. The LR result is not flat across all PV fractions, and in three out of four cases the
mean GM CBF drops sharply in the 90-100% range mirroring the BASIL result. However,
in contrast to the BASIL result, the LR result appears to be more consistent across most
of the PV range.
Towards the suggestion that T2 blurring is causing some kind of ’residual effect’, the
data used within our study uses 3D GRASE data obtained in eight segments which
minimises T2 blurring. The through plane blurring observed with this kind of acquisition
is explored in chapter 7 and it can be seen that it is greatly reduced compared to the
one-shot acquisition used by Chappell. However, the same pattern of non-linearity for
the BASIL GM CBF results across the PV range are observed in our study with
segmented data, so this hypothesis is not supported by our data.
Chappell makes the point that BASIL is highly dependent on the accuracy of the PV
estimates obtained from a segmentation of a T1-weighted structural image, which is likely
to be poor in highly myelinated and deep GM areas. Of course, the same is true for LR
and any method which relies on a correction using structural information.
This is an inherent weakness of both these methods, and there is recent work to move
away from using structural data to inform about PV estimates. Petr et al [9] present an
alternative method for obtaining these estimates which is described in chapter 3 and a
novel extension to that is presented in chapter 6.
In conclusion, BASIL does not appear to offer any advantage over LR for PV correction
of single timepoint data, and in the case of limited image volumes for input, may be
at a distinct disadvantage. Given the complexity and increased computational running
time of BASIL, it is recommended that BASIL be reserved for multiple timepoint data,
where is can generally be guaranteed that there will be sufficient input data to prevent
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oversmoothing.
5.5 PV correction applied to CBF maps
This remainder of this chapter is devoted to an investigation of the feasibility of applying
the LR PV correction method directly to a CBF map, rather than separately to the
difference and control images. Asllani’s assertion is that perfusion images are actually a
ratio of a difference and a magnetisation image, both of which are affected by partial
volume and a correction must be applied to both.
The need for this investigation arose from being presented with some data from a General
Electric (GE) scanner, for which the protocol at the time produced scaled CBF maps as
its output, rather than difference and control data. This is non-ideal for a few reasons. It
poses issues for motion correction, lack of transparency as to the assumptions which have
gone into calculating the CBF map, as well as not providing access for PV correction to
the component image inputs to the CBF map. GE now provide the difference and M0
images by default.
It is also worthwhile to perform this investigation as there is a lack of consensus amongst
researchers. Asllani’s approach has not been widely adopted by others in the field. In
some cases, [15, 6, 9] the PV correction is applied only to the difference image, as a
voxelwise magnetisation image is not acquired and a global value based on CSF is used
to scale perfusion values. Another group have applied the correction directly to CBF
maps [46]. In short, there is no standard recommended procedure and no investigation
has previously been undertaken to ascertain the effect of applying PV correction to
difference and equilibrium images and combining them, compared to directly applying
the correction to CBF maps.
134
5.5.1 Method
A CBF map was calculated using the general kinetic model for the same six subjects
previously described. As with all the data used within this thesis, the voxel dimensions
are 3.75 x 3.75 x 3.8 mm3, so a significant PV effect can be expected.
In this instance there is no mean control image to act as the target for registration of the
higher resolution PV estimates, so the PV maps were registered to the CBF map. For the
difference and M0 images, the PV estimates were registered to the mean control image as
previously described.
The CBF map, difference and M0 images were PV corrected using a 3D 3 x 3 x 3 kernel
for LR. The difference and M0 images wee combined along with the appropriate scale
factors to produce separate maps of GM and WM tissue flow. No scaling was required for
the flow maps produced from the CBF map.
5.5.2 Results
Table 5.8 shows a global mean GM CBF produced by applying PV correction to the
difference and control magnetisation images, compared with applying it directly to the
CBF map. In all but one case, applying the correction solely to the CBF map resulted in
a lower mean GM CBF value.
Subject Mean CBF GM CBF (∆ M/M0) GM CBF (CBF)
AA 49.6 ± 22.6 62.9 ± 17.1 58.7 ± 20.1
HH 43.1 ± 24.6 62.0 ± 22.5 63.9 ± 17.6
MS 39.5 ± 16.9 55.8 ± 19.0 53.9 ± 15.0
MV 37.6 ± 18.5 60.8 ± 22.6 59.9 ± 14.4
RR 39.4 ± 21.7 61.9 ± 19.3 57.8 ± 16.3
SK 34.9 ± 15.2 53.0 ± 18.2 49.7 ± 13.3
Groupwise mean 38.4± 19.7 57.2 ±19.9 53.9 ± 18.6
Table 5.8: Comparison between applying PV correction to difference and control magnetisation
images with applying directly to CBF map. All measurements in ml/100g/min with GM CBF maps
masked at PVF > 0.1 prior to calculations.
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A two-sample paired t-test of the two groups of PV corrected data showed there to be no
significant difference in the means at the 5% significance level.
5.5.3 Discussion
Registration of the PV maps to the CBF map was found to be problematic. Normally, the
control image (or TR = 5000 ms saturation recovery sequence in our study) would act as
a target for the registration of anatomical data to perfusion space (or vice versa, with the
inverse matrix applied), which contains more spatial detail. However, one group which
applied the LR method directly to CBF maps report registering the PV maps directly to
the CBF maps with success, although the CBF maps were at a higher in-plane resolution
(1.7 x 1.7 mm2 ) than that used in our study, which may account for this [46].
A misregistration which causes high GM PV fraction voxels to be displaced to CSF region
smay account for the reduction in global mean GM CBF values observed with this ’single
image’ method of PV correction. Whilst the mean values for GM CBF are lower in five
out of the six cases, the difference is not found to be significant. From this it may be
concluded that it is legitimate to apply the LR PVC method directly to a CBF map, rather
than to separate images of ∆M and M0, if they are not available. However, given the
difficulty with registering CBF or difference images, it is clearly preferable to have access
to control and tagged images.
5.6 Conclusion
In summary, this chapter has presented an extension to the LR method for PVC of ASL
data proposed by Asllani et al, with the stated aim of reducing the inherent blurring which
is produced in the separate tissue maps. This method has been termed the ’3D kernel’ and
is found to be effective at reducing blurring, whilst not increasing computational intensity.
An investigation was made into the use of a Bayesian inferencing method for PV
correction of ASL data applied to single timepoint data and whether there was any
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advantage in using this tool when kinetic information is unavailable, as the case for
single timepoint data. This tool, BASIL, was found to be heavily dependent on the
volume of data presented to it, with fewer than three volumes causing the algorithm to
rely heavily on priors and smooth away spatial detail in the output images. It is
concluded that BASIL be reserved for scenarios where multiple measurements are
available, either for single or multiple timepoint acquisitions.
Finally, given the lack of consensus about which component images should be PV
corrected, a study was undertaken to ascertain the effect of applying PVC to difference
and control images, as Asllani suggests is the correct approach, or directly to just the
difference or CBF map. It would seem that applying the correction directly to the CBF
map may result in a small underestimation compared to the two image correction
technique, but that the discrepancy is not significant.
It is evident that any PVC will only be as good as the data allows; both BASIL and LR
methods are heavily dependent on the registration of high resolution anatomical data to
low resolution perfusion space. This is error prone and difficult to achieve.
Chapter 6 proposes an alternative method for acquiring PV estimates in perfusion space,
obviating the need for troublesome registrations.
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Chapter 6
Separation of relaxation curves for ASL
tissue fraction estimation: SEPARATE
This chapter describes a novel extension to the ideas originally proposed by Shin and Petr
[67, 8, 9] to create partial volume estimates from low resolution inversion or saturation
recovery data. This work formed the basis of an oral presentation at ISMRM 2014 [68].
6.1 Introduction
The FRASIER method for creating partial volumes estimates from inversion recovery data
using a Look-Locker readout was originally proposed by Shin et al [67, 8], and adapted
for use with saturation recovery data at standard ASL resolution by Petr et al [9]. The
basis of the FRASIER method has been described in detail in chapter 3, along with Petr’s
method for estimating the T1 of GM, for which it is not possible to apply the Shin method
of estimating this value from a Gausssian mixture model of a T1 map due to the low
resolution of the data.
6.1.1 Fractional segmentation using 3D GRASE data
Previous researchers utilised Look-Locker inversion or saturation recovery EPI sequences
for data collection. In contrast, we suggest the use of a saturation recovery 3D GRASE
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sequence, which simplifies matters considerably. The Look-Locker data must be acquired
at two different flip angles to compensate for B1-field inhomogeneity; this correction is
not required for 3D GRASE data, which is one of the advantages of acquiring the data in
this way.
The second advantage of using 3D GRASE for data sampling is that Lock-Locker
sequences impose restrictions on the sampling intervals that can be used. Typically,
regularly spaced sampling determined by the image acquisition time is used. This is not
the case with a 3D GRASE readout, where each time point is independent of the others,
which offers the advantage that the relaxation curve can be sampled more densely when
the signal is changing rapidly. In addition, it allows us to use the same readout for both
ASL and PV correction.
We believe this is the first time that 3D GRASE data has been used to produce partial
volume estimations.
6.1.2 Voxelwise estimation of the T1 of GM applied to fractional
segmentation
Petr uses a process of iterative minimisation to arrive at a global value for the T1 of GM.
This would seem a reasonable approach, given that a global value is used for the T1 of
WM and a literature value for the T1 of CSF. However, it is important that the values
for GM, WM and CSF are as accurate as possible in order to get a correct fractional
segmentation. Having said that, since the volume of CSF is substantially smaller than that
of the GM or WM, it is usual practice to use a literature value and not estimate from a
Gaussian mixture model.
Petr achieves plausible results, and claims to visualise structure in the WM partial volume
map which does not survive the transformation and resampling from a high resolution
structural image. Figure 6.1 shows an extract from the Petr paper with the GM and WM
PV maps marked as PVT1 and PVLL for the maps created from high resolution and Lock-
140
Locker sampled data, respectively. For the WM, there is more structural detail in the
PVLL map at the locations marked with red arrows. However, for the GM PV map, the
PVLL map clearly shows deep grey matter adjacent to the ventricles of lower intensity,
and therefore lower GM tissue fraction, than that in the PVT1 map, also labelled with red
arrows. 1
Whilst Petr’s hypothesis about the increased WM structure in the Look-Locker data is
reasonable, this cannot explain the reduced intensity seen in the deep GM.
Figure 6.1: PV maps produced from a high resolution anatomical segmentation downsampled to
ASL resolution (PVLL) and from a Look-Locker saturation recovery sequence, acquired at ASL
resolution (PVT1), from [9]. Red arrows mark regions of greater intensity in the deep GM for
PVT1 and more structural detail for the WM in PVLL.
It is useful to refer to a high resolution anatomical image to obtain an insight into which
GM PV map is accurate. Consultation with neuroanatomy texts would suggest that these
voxels represent the head of the caudate nucleus, and are rightly identified as GM in the
PVT1 map . This is depicted in figure 6.2, with the caudate nucleus marked in red.
This would suggest that the PV maps which are derived from an anatomical image are
more accurate for this particular structure. It is hypothesised that the lower intensity
1It should be noted that PVT1 and PVLL is the notation used by Petr et al and is replicated in this section
to be consistent with that paper. The equivalent notation used in this chapter is to PVMPRAGE and PVASL,
respectively.
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Figure 6.2: Transverse view of the caudate nucleus (highlighted in red) in a structural MRI. Image
credited to Geoffrey Hall, McMaster University, Canada.
observed in the fractional segmentation derived PV maps is due to the fact that a global
value for the T1 of GM has been used to derive the segmentations. The T1 of GM is
know to vary, particularly between the cortex and the basal ganglia, of which the caudate
nucleus is part [69].
As such, we sought to improve the fractional segmentation method by utilising a
voxelwise measure of the T1 GM, rather than estimating and applying a global value of
T1 GM. We propose the acronym SEPARATE to describe this novel technique:
SEPAration of Relaxation curves for ASL Tissue fraction Estimation.
6.2 Method
Eight healthy controls ranging in age 25 to 43 years with mean age 34.9 ± 5.7 took part
in the study. The same high resolution anatomical image and perfusion data was acquired
as in described in chapter 3.
In terms of solving equation 3.12 by the fractional segmentation method, there are six
unknowns; the T1 of GM, WM and CSF and the partial volume fractions (FS,GM , FS,WM ,
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FS,CSF ). The T1 of WM will be estimated directly from the T1 map as there are sufficient
100% WM voxels to ensure this estimate is reliable, and a literature value will be used for
the T1 of CSF. This leaves four unknowns which must be solved for.
Figure 6.3: Figure 3(B) from [8]. Shin
et al sampled the recovery curve over
a 10s period, with 25 time points.
Conversely, Petr et al used 13 time
points and sample to 3640 ms only.
Our original acquisition paradigm for the saturation
recovery sequence for calculating whole voxel
M0/T1 maps consisted of sampling the data at TI
= 1000, 3000, 5000 ms. At least one additional
time point is needed to be added to the acquisition
strategy in order to solve for the four unknown
quantities.
Petr used 13 time points, beginning at TI = 40
ms with intervals of 300 ms. In contrast, Shin
sampled over a 10 s period, with intervals of 400
ms providing 25 time points. Theoretically, only
four time points should be required, but both groups
used a much larger number to improve the accuracy of the estimations.
For this study, we acquired a data set was acquired with time points at TI = 100, 200, 300,
400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800,
1900, 2000, 2200, 2400, 2600, 2800, 3000, 3500, 4000, 4500, 5000, 6000, 8000 ms. The
images at these time points were acquired in a pseudo-random, rather than sequential,
order.
A higher density of sampling is used at the early stage of recovery (100 - 2000 ms) with
larger intervals between the time points as the relaxation progresses. A saturation recovery
curve for one of the subjects from the study is shown in figure 6.4 for all 31 time points as
detailed above. Compared to the regular 40 ms sampling used by the Shin group shown
in figure 6.3, it can be seen that there is a greater sampling density in the rapidly changing
part of the curve. The increased sampling density does of course increase overall scan
time, but this was carried out in a comprehensive manner as a proof of principle and is
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not necessarily optimally efficient.
Figure 6.4: Tissue relaxation after saturation recovery inversion for one voxel through the full 31
time points, ranging from 100 ms to 8000 ms. The curve is more densely sampled during the rapid
recovery portion than in previous studies.
6.2.1 Voxelwise estimation of T1 GM
Petr estimated the T1 of WM by making an a priori assumption about the likely range of
acceptable T1 WM values at 3T and thresholding the T1 map to include only voxels with
these values. The mean was then found from these candidate voxels and used alongside a
literature value of T1 CSF of 4300 ms to jointly estimate a global value for the T1 of GM
and voxelwise fractional segmentations.
We propose an alternative to this method of T1 WM and GM estimation, which does not
rely on any a priori assumptions for WM, and produces a voxelwise estimation for the T1
of GM, for which it is hypothesised will produce more accurate GM PV maps.
T1 and M0 maps were calculated from the saturation recovery sequence as described in
equation 3.12. A three Gaussian mixture model was fitted to a histogram of the T1 map,
under the assumption that there are no pure GM voxels at this resolution and the mixtures
represent WM, GM + WM and GM + CSF. The peak of the Gaussian with the lowest
mean value represents the T1 of WM.
A voxelwise value for T1 GM is estimated by adapting Petr’s method of alternate
estimation of the PV fractions and T1 GM by selecting a 3 x 3 x 3 kernel from the
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saturation recovery sequence and performing the estimation over this neighbourhood
only, rather than estimating a global T1 GM value which minimises the objective
function. This kernel is slid over the entire image, with the central voxel being the one
for which the T1 of GM is found.
A form of regularisation was used on the estimation of T1 GM by applying boundary
conditions from the Gaussian mixture model step, described above. The lower bound
for T1GM was set to the T1 of WM and the upper bound set to the mean value of the
GM/CSF mixture. In regions of the image where there is no GM (for example in 100%
WM regions) the algorithm is unable to estimate the T1 for GM and these voxels are
flagged for the subsequent processing step. This GM T1 map is then refiltered by using a
3 x 3 x 3 kernel and any voxels which were flagged in the proceeding step are replaced by
the mean of a neighbourhood of ’good’ values which fall in the range defined above. This
step is repeated until all flagged voxels are replaced. If this second pass failed to replace
any remaining flagged voxels, the kernel size was increased ( 5 x 5 x 5 ). In practice, it
was only necessary to repeat this step for one of the subjects (JF).
Equation 3.12 is then solved to produce tissue fractional signals using a linear least
squares fit with global values of T1 WM and CSF, and a voxelwise value for T1 GM.
The tissue fractional signals are converted to fractional volumes by applying equation
3.18 in order to correct for the water density of the different tissue types. These maps are
denoted as PVsat_rec.
Partial volume maps were also created from the segmentation of anatomical MPRAGE
data transformed to ASL space as previously described. These are denoted PVMPRAGE .
6.2.2 PV correction of CBF maps
Cerebral blood flow (CBF) maps for the eight subjects were calculated using the Buxton
model (see equation 2.7) for pulsed ASL data; these are referred to as ’acquired CBF
maps’. These CBF maps were partial volume corrected using a 3 x 3 x 3 kernel for linear
regression in order to separate the signal into GM and WM components, as described
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in chapter 5. The PV correction was applied directly to the calculated CBF maps in
accordance with the finding in chapter 5 that this approach is legitimate. The partial
volume correction was performed twice; using the PVsat_rec and PVMPRAGE maps.
6.2.3 Validation
After PV correction, the separate GM and WM CBF maps were recombined by
multiplying by the partial volume fractions and summing them to attempt to recover the
CBF map which was the input to the PVC procedure, as in equation 6.1
CBFrecomb(r) = ∆CBFGM(r).PGM(r) + ∆CBFWM(r).PWM(r) (6.1)
where ∆MGM , ∆MWM are the partial volume corrected flows for GM and WM, and PGM
and PWM are the partial volume fractions for GM and WM at voxel r.
Figure 6.5: Validation of PVC results: the pure GM and WM flows are recombined with their
respective partial volume fraction maps to recreate the CBF map. Any differences between the
‘recombined’ CBF and calculated CBF are attributed to errors in the partial volume fraction
maps.
The basis of this validation is that any departure between the CBF values obtained from
recombining the separate GM and WM flows and the actual CBF values will be
attributable to errors in the PV maps. The linear regression method for PVC does
introduce spatial blurring, but an assumption is made that this effect will be similar for
both the PVsat_rec and PVMPRAGE maps.
Accordingly, the correlation between the recombined CBF maps and the acquired CBF
maps was calculated. In this case, as a one to one correspondence between the recombined
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CBF and the acquired CBF is the desired result, the sum of absolute difference (SAD)
between the two over all voxels was also computed.
Both sets of PV maps were used to created pseudorandom regions of interest of GM % as
previously described in order to investigate the dependency of GM CBF on GM PVF.
6.3 Results
6.3.1 T1 relaxation times
The mean global T1 relaxation times derived from the saturation recovery data were 1150
± 53 ms for WM and 1608 ± 51 ms for GM, respectively. It was found that using these
global values for T1 GM produced GM PV maps much the same as those of Petr, that is,
that there is reduced intensity in the deep GM structures compared to the GM PV map
from segmentation of a high resolution MPRAGE image.
Figure 6.6 shows three sets of tissue partial volume maps for one of the subjects. The
top row shows PVF maps derived from an MPRAGE segmentation and registration to
perfusion space, as has been used previously in this thesis. The middle row shows those
from a 3D GRASE saturation recovery sequence, assuming a single global value for GM
T1 and those deep GM structures which have a lower PVF value as described above are
marked with red arrows. Using a voxelwise T1 GM value increases the PV estimate for
these regions, making them consistent with high resolution anatomical imaging. This is
shown in the bottom row.
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Figure 6.6: Top row: PV fractions derived from MPRAGE segmentations. Middle row: PV
maps from a saturation recovery sequence using a 3D GRASE acquisition and original FRASIER
segmentation method. Bottom row: PV maps from same saturation recovery sequence as middle
row, but voxelwise T1 GM values are used in the fractional segmentation. Red arrows mark regions
where FRASIER and MPRAGE differed on GM maps. The SEPARATE method produces greater
PVF in these regions.
6.3.2 Validation of PV maps
Figure 6.7 shows the voxelwise correlation for the same subject between the acquired CBF
maps and the recombined CBF maps after PV correction for the PVsat_rec and PVMPRAGE
maps. There is a wider scatter for the PVMPRAGE maps, along with a systematic offset,
evidenced by points lying along the x-axis. These points represent voxels which have a
non-zero value for the acquired CBF map, but after recombination from the PVMPRAGE
maps, the equivalent voxel has a zero value. This is strongly suggestive of a misalignment
between the two CBF maps, indicative of a registration error in the PV maps. This is not
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seen in the recombined 3D GRASE maps.
However, for both scatter plots, the line of best fit does not go through the origin, in fact
there is an intercept of similar magnitude on the recombined CBF axis in both cases. This
would suggest that the recombined CBF voxels, measured over all voxels, are of a higher
value than the counterpart acquired CBF voxels. Figure 6.8 shows a middle slice from the
acquired CBF and recombined CBF maps. Blurring is evident in both of the recombined
maps, compared to the acquired CBF map, which is a possible explanation for the offset
on the correlations plot.
Table 6.1 shows both the correlation and sum of absolute differences (SAD) of the
recombined CBF maps as compared to the acquired CBF maps calculated according to
the Buxton model. There is better correlation (R2) and lower SAD using the 3D GRASE
data for all subjects, with a mean (R2) of 0.80 and 0.44 for the 3D GRASE and
MPRAGE groups, respectively. The mean SAD are 2.39 x 105 and 3.87 x 105 for 3D
GRASE and MPRAGE. This is indicative of a better registration between the 3D
GRASE derived PV maps and the perfusion data, than with the MPRAGE derived PV
estimates.
Correlation (R2) SAD (x105)
Subject GRASE MPRAGE GRASE MPRAGE
ED 0.84 0.59 1.98 3.25
JF 0.73 0.35 3.54 5.48
JM 0.81 0.24 2.28 4.26
JT 0.81 0.52 1.82 2.81
KL 0.80 0.44 2.33 4.09
NZ 0.83 0.37 2.44 4.61
RL 0.79 0.38 2.94 5.10
RO 0.82 0.64 1.82 1.38
Mean 0.80 0.44 2.39 3.87
Table 6.1: Voxelwise correlation between CBF maps generated after recombining GM and WM
CBF flows with acquired CBF maps. Sum of absolute difference (SAD) reflects difference between
these recombined maps and the acquired CBF map.
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Gradient Offset %
Subject GRASE MPRAGE GRASE MPRAGE
ED -0.0065 ± 0.0049 0.054 ± 0.061 7.8 9.2
JF -0.085 ± 0.0051 0.040 ± 0.013 11.7 36.7
JM 0.036 ± 0.010 0.017 ± 0.011 14.3 42.1
JT 0.040 ± 0.013 0.0070 ± 0.016 11.3 25.7
KL -0.088 ± 0.0047 0.037 ± 0.0063 12.9 29.4
NZ -0.010 ± 0.0043 0.051 ± 0.012 25.1 37.3
RL 0.030 ± 0.011 0.060 ± 0.012 14.3 37.7
RO 0.026 ± 0.0084 0.035 ± 0.017 12.2 24.5
Table 6.2: Gradient of line of best fit with 95% confidence intervals for the GM CBF mean values
across the PV 10% GM bin ranges, shown in figures 6.11 and 6.12.
Figure 6.9: Box plot of the gradient of GM CBF best fit line for two groups; using 3D GRASE PV
maps and MPRAGE PV maps. Lines link same subject in each imaging group. The box plot shows
a greater spread in gradients for the 3D GRASE imaging compared to MPRAGE, but the mean
gradient is closer to zero. The median values are -0.0083 and 0.039 for 3D GRASE and MPRAGE
respectively.
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Figure 6.10: Box plot of the percentage offsets of the 90-100% GM CBF and uncorrected CBF
values as a fraction of uncorrected CBF. Lines link same subject in each imaging group. The
mean % offset for the MPRAGE data is more than twice that obtained using 3D GRASE data, with
individual % offsets higher with MPRAGE imaging in every case. Median values are 12.6% and
33.1% for 3D GRASE and MPRAGE respectively.
6.3.3 Partial volume correction of CBF maps
Figures 6.11 and 6.12 show the dependency of mean uncorrected CBF and mean GM
CBF after PV correction across the PV range, as seen in chapter 5. There are two graphs
for each subject in this case, as the PV fractions differ depending on which GM PVF map
they were generated from.
As expected, the uncorrected CBF shows a dependency on partial volume fraction, as
calculated from both sets of PV fractions. There is a theoretical expectation that the
dependency is linear, and that as the GM PVF approaches 100%, the mean CBF value
will overlap that of the PV corrected GM CBF, which is expected to be constant across
all PV ranges. There are therefore two metrics to consider in assessing the quality of the
PV correction; gradient of line of best fit of the GM CBF and the offset at 90-100% GM
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PVF between uncorrected CBF and GM CBF.
It was shown in chapter 5 that close agreement between uncorrected CBF and GM CBF
mean values is not observed, even at high GM PV fractions, unless simulated data is
used. This suggests that the cause of the offset is mis-registration between the perfusion
data and PV maps. Therefore, it follows that a smaller offset between the two means for
the 90-100% GM PVF bin is indicative of an improved registration. The offset between
the GM CBF and uncorrected CBF for the 90-100% range as a fraction of the uncorrected
CBF value in the same range, as a percentage, is shown in table 6.2, alongside the gradient
of the line of best fit of the GM CBF.
This information is displayed graphically in the box plots in figures 6.9 and 6.10 and . For
the offsets, the median values are 12.6% and 33.1% for the 3D GRASE and MPRAGE
respectively. There is one outlier for the 3D GRASE group, (NZ (3D GRASE) = 25.1%)
and whilst this greater than the rest of the cohort, it is still reduced compared to the
MPRAGE offset (NZ(MPRAGE) = 37.3%). The other offset values fall into the range 7.8
- 14.3% for 3D GRASE and 9.2 to 42.1% for the MPRAGE.
In terms of the gradient across the GM CBF, there are three subjects for whom the gradient
is closer to zero for the MPRAGE maps; JF, JM and KL. For the cases of JF and JM, the
uncorrected CBF maps are somewhat flat across the entire PVF range, with the corrected
GM CBF lines lying almost parallel. This is symptomatic of misalignment of the data and
PV maps. To a lesser extent, the same is true for all subjects using the MPRAGE maps,
whereas a linear rise for mean uncorrected CBF is seen when using the 3D GRASE maps.
Therefore, when assessing the quality of the PV correction, it is appropriate to consider
the gradient and offset metrics in tandem; the hallmark of a good PV correction is a
consistent value for GM CBF across all PV ranges, as well as this value being close to
the mean uncorrected CBF value at the 90-100% GM PVF range. From this small sample
size, it would seem that an offset of around 10% is reasonable.
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Figure 6.11: Subjects ED, JF, JM, JT : Mean uncorrected CBF and GM CBF binned into GM
partial volume fractions. The left hand side shows PV corrections using PV estimates generated
from 3D GRASE data, whilst the right hand side shows corrections using MPRAGE derived partial
volume estimates. Lines of best fit and associated equation for the GM CBF are shown. Error bars
are 95% confidence intervals on mean estimation.
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Figure 6.12: Subjects KL, NZ, RL, RO : Mean uncorrected CBF and GM CBF binned into GM
partial volume fractions. The left hand side shows PV corrections using PV estimates generated
from 3D GRASE data, whilst the right hand side shows corrections using MPRAGE derived partial
volume estimates. Lines of best fit and associated equation for the GM CBF are shown. Error bars
are 95% confidence intervals on mean estimation.
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6.4 Discussion
This study has demonstrated that it is possible to use 3D GRASE saturation recovery
data in a fractional segmentation algorithm to produce PV maps. The FRASIER method
has been adapted to estimate the T1 of GM on a voxelwise basis, which improves the
estimation of the PV of GM in the basal ganglia, compared to the original FRASIER
method. This is the first reported study to apply 3D GRASE data to this technique and to
use a voxelwise estimation for the T1 of GM.
The goal of a partial volume correction algorithm is to remove the dependency of the voxel
intensity on tissue fraction. If the assumption that separate GM and WM perfusion are
constant holds true, it is expected that the a best fit line as shown in figures 6.11 and 6.12
would have a zero, or close to zero, gradient. Additionally, there should be in agreement
between the uncorrected and GM CBF maps at the 90-100% GM PV fraction. Therefore,
the hallmark of a successful PV correction is a consistent value across all tissue fractions,
which the uncorrected CBF values tend towards. Conversely, for PV maps which are well
registered to the perfusion data, there will be a smooth linear increase in CBF across the
PV range.
The PV corrections performed using the 3D GRASE data showed a median gradient closer
to the zero and a smaller median offset between the GM CBF and uncorrected CBF means
for the 90-100% GM PVF. This means that, in general, the PV maps obtained from 3D
GRASE data are better registered to the perfusion data than the MPRAGE maps and
produce results which better fit the model.
For the three subjects where the gradient of best fit of the GM CBF is closer to zero
in the MPRAGE case, the offset at 90-100% GM PVF is still lower for the 3D GRASE
case. Moreover, the voxelwise correlations and SAD between the acquired CBF maps and
recombined CBF maps are significantly better for the PVsat_rec maps (R2 = 0.73, 0.81,
0.80 (3D GRASE) and 0.35, 0.24, 0.44 (MPRAGE) ), so it would seem that even in the
case of a poor or difficult registration, saturation recovery derived PV maps are still the
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superior choice.
The voxelwise correlation between the acquired CBF and recombined CBF maps
demonstrate the difficulty in registering the high resolution MPRAGE PV maps to the
much lower resolution ASL space. The correlation for the PVMPRAGE maps is
consistently poorer, with the scatter plots (see example in 6.7) indicating a misalignment
between the acquired and recombined CBF maps.
Whilst the PVsat_rec maps are generated from data which also needs registering to
perfusion weighted data, the two datasets (saturation recovery and perfusion weighted)
are of the same resolution so no resampling is required, which eliminates one potential
source of error.
Thirty-one time points were used for sampling the saturation recovery data in order to
estimate the PV fractions. This invites an investigation into the optimal number of data
points and sampling interval, with a view to minimising scan time. More sample points
not only increases acquisition time, but increases the possibility of motion artefact and
registration misalignment. This is an avenue for future work.
Unlike in the study of Petr et al, fat suppression was not used during the saturation
recovery sequence acquisition. The result of this is that as fat has a longitudinal
relaxation time close to that of WM, for some of the subjects (see figure 6.6 WM PV
map from 3D GRASE data), there is a ring of voxels encircling the brain in the WM PV
map. In terms of PV correction, this does not affect the results as these fat voxels are
outside of the brain; however, the resultant WM PVF map is not accurate and it would be
an improvement on the technique if fat suppression was incorporated.
In all cases, the CSF PV map from the saturation recovery sequence is of a lower intensity
than that for the MPRAGE derived maps. For practical purposes, this is not important as
the CSF PV map is not used as part of the PV correction. This is most likely a reflection
of the literature value of 4300 ms which was used not being accurate for the 3D GRASE
sequence. There are not enough voxels containing 100% CSF at the resolution used in
this study for direct measurement of the T1 of CSF, so would be beneficial to obtain an
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estimate of the T1 of CSF acquired under the same conditions as that of WM and GM
in order to assess if T1 of CSF being used in the estimation is accurate. This is most
important if a PV correction is being performed on an M0 image, for which there is a
contribution from CSF.
6.5 Conclusion
The importance of a good registration for reliable PV correction cannot be overstated,
yet is difficult to achieve, particularly when trying to register images of greatly differing
contrast and resolution, as is the case with perfusion and anatomical images. Moreover,
segmentations of anatomical data usually rely on registration to a healthy template atlas,
which can be inappropriate for cohorts which exhibit atrophy.
The SEPARATE segmentation method offers a reliable alternative, which does not rely
on registration and resampling of high resolution anatomical data. However, the
SEPARATE (or FRASIER) method requires multiple data points from a saturation or
inversion recovery acquisition, which may not be acquired as part of a routine clinical
examination, whereas it is usual to acquire an anatomical image. This will produce
difficulties for retrospective analysis and post-processing.
The inclusion of the voxelwise estimates for the T1 of GM improves the PV estimates
obtained from a fractional segmentation method compared to using a global T1 for GM
and produces PV maps with fewer registration errors than those from an anatomical
segmentation. This in turn produces more accurate partial volume corrections.
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Chapter 7
Image Deblurring
This chapter describes the origin of the point spread effect in 3D GRASE imaging and
the use of a theoretical derivation of the point spread function (PSF). Image restoration
through a process of deconvolution of the PSF is incorporated into a complete and novel
solution for PV correction of ASL 3D GRASE data.
7.1 The Point Spread Function
In both PET and ASL perfusion imaging, PV effects are caused by inadequate spatial
resolution, which is a consequence of the voxel grid the image is sampled on and some
degree of blurring due to the PSF of the imaging process.
The PSF of an imaging system describes the mapping of a perfect representation of a point
object to the actual observed image. In a linear, shift invariant system, knowledge of the
PSF can be used via the process of convolution to predict the image of an object. The PSF
determines the smallest resolvable object, and therefore the sharpness of an image.
In ASL, the PSF has the undesired effect of tissue signal blurring which impacts perfusion
quantification due to cross contamination of the higher GM signal with the much lower
adjacent WM signal and vice versa. This phenomenon contributes to increased partial
volume effects.
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The fact that there are two contributory elements to the PV effect is well understood and
explored in PET imaging [44, 43, 70, 71]. State of the art PET scanners have a PSF of
around 2-3 mm, but historically this has been much larger; typically around 5-6 mm full
width at half maximum (FWHM) and known to adversely affect perfusion quantification
[72]. Consequently, all PV correction methods for PET data involve a correction for the
effect . This is not the case with ASL perfusion imaging. It remains uncommon to account
for PV effects at all, and if any correction attempt is made, this usually takes the form of
correcting for tissue fraction only.
One of the possible reasons for this may be that as the PSF in MR imaging is usually
narrower than that of PET imaging, it is assumed that its effect can be ignored. However,
as will be discussed later in the chapter, when fast imaging techniques are employed, it is
appropriate to consider the effect of the PSF.
7.1.1 Definition
The standard definition of the PSF, H(r; r0), follows from the image appearance at r due
to an ideal point source δ(r0). If we make the assumption that the system is shift-invariant,
we may write H(r − r0), so that H is strongly dependent on r − r0 rather than just on r0
[73].
Provided linearity and shift-invariance are both true, the observed image, Iobserved(r), is
described as a convolution of the actual image, Iactual(r), with the PSF, H(r):
Iobserved(r) =
∫
allspace
Iactual(r
′)H(r − r′)dr′ (7.1)
or more concisely,
Iobserved(r) = Iactual(r) ∗H(r) (7.2)
where ∗ denotes convolution.
In the frequency domain, or k-space as it is known in MR imaging, the PSF transforms
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as the modulation transfer function (MTF), and can be considered to act as a weighting
function on the acquired signals, given that the Fourier transform (FT) of convolution in
the spatial domain is multiplication in the frequency domain.
As such the ideal PSF is a delta function, which will cause all acquired frequencies to be
equally weighted. However, in practice this is never the case, and the width of the PSF is
sequence dependent (see figure 7.1).
Figure 7.1: The ideal PSF is a delta function, which has a constant value in k-space. In reality,
this is never the case, and the acquired frequencies do not experience equal weighting.
Whilst it is the case that the tissue fraction effect can be mitigated by sampling on a
smaller voxel grid, there is a trade-off in terms of SNR, which is especially problematic
for estimating the lower WM perfusion. Moreover, blurring in the partition direction is a
feature of 3D GRASE imaging which cannot be alleviated by this approach.
This investigation was undertaken to ascertain whether blurring due to the PSF in ASL
perfusion imaging is a significant cause of quantification error, as with PET imaging.
Whilst there are a very limited number of articles investigating the effect of blurring due
to the PSF on image quality [15, 47], there are no published articles addressing the role
of the PSF in ASL partial volume correction.
7.1.2 Blurring Effect
The degree to which a structure is affected by the PSF depends on its size. Brain structures
which are smaller than twice the FWHM of the PSF are most strongly affected [70].
As the cortex ranges in thickness from 2 to 4 mm in a healthy brain, and can be less than
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half this in an atrophied brain, PV effects caused by the PSF are a significant cause for
concern in PET imaging and a potential source of error in ASL imaging.
The relationship between PSF and structure size is shown in figure 7.2. Two structures of
width (a) 10 mm and (b) 30 mm are convolved with a Gaussian PSF of FWHM 10.5 mm
figure 7.2. The smaller structure is on the order of the PSF and suffers more attenuation
in maximum value than the larger structure.
Figure 7.2: Ilustration of relationship between structure size and PSF width. The same PSF
(FWHM = 10.5 mm) is convolved with two structures of different widths. Plot (a) shows the effect
on a structure of width 10 mm and (b) shows the effect on a structure of 30 mm. The smaller
structure suffers a greater reduction in intensity. Taken from [16].
The implication of this is that the cortical ASL signal will suffer some attenuation, the
extent of which will depend on the tissue thickness and the width of the PSF, while the
WM signal will be largely preserved.
7.2 The PSF in MR imaging
Measurement of the PSF of an imaging system can be accomplished by imaging a ’test
object’, for example a fluorescent bead in microscopy, which is considered to be a point
source object. However, in MR imaging, determination of the PSF is more complicated as
it is dependent on the object, the sequence parameters and post-processing methods. Care
is usually taken to try and minimise the width of the PSF and therefore preserve image
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resolution.
Figure 7.3: Perspex block filled with
an aqueous solution and a ’comb’
pattern of varying spatial frequency in
order to assess the minimum resolvable
distance by the imaging system. Taken
from [17].
Nevertheless, attempts to characterise the PSF in
MR using test objects have been made. Such an
example is shown in figure 7.3. A perspex object is
filled with an aqueous solution or gel to provide a
source of protons. A pattern of bars of decreasing
separation is used to determine the minimum spatial
frequency which can be resolved by the system.
However, this method only offers a rough
estimation of spatial resolution and it must be noted
that the test object being used to measure the PSF
may actually influence it (susceptibility effects, T2
rate alterations) [17]. These considerations mean
that actual measurement of the PSF in MR imaging is non-trivial.
7.2.1 The PSF in ASL perfusion imaging
ASL imaging requires the use of fast acquisition methods such as EPI or 3D GRASE.
Knowledge of the PSF is particularly important for fast imaging techniques in order to
produce images of good quality.
EPI is of lower resolution than conventional imaging and more prone to artifacts due to
susceptibility effects at air/bone interfaces, eddy currents from rapidly switching gradients
and T2∗ relaxation which takes place during the acquisition period.
Like EPI, 3D GRASE imaging is usually acquired at comparatively low resolution. For
3D GRASE, we are concerned with the effect of the PSF in the partition direction due to
the length of the echo train that is employed relative to T2 decay times. This manifests
itself as an echo train which follows a smooth T2 decay throughout k-space and appears
as blurring in the partition direction in the image.
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It has been found that measurements of mean GM CBF using EPI acquisitions for the
read-out are higher than those obtained using a single-shot 3D GRASE sequence, and
vice-versa for WM CBF. It has been proposed that the discrepancy is due to PV effects
caused by the wide PSF along the partition direction for single-shot 3D GRASE [74].
The decay of the echo train signal is exponential, which means the 1D PSF along the
z-axis for 3D GRASE imaging has a Lorentzian form, with literature values ranging
from 1.5 to 1.9 voxels FWHM for a single shot acquisition [15, 74]. The width of the
PSF depends on how long the acquisition takes, with longer echo trains producing more
blurring.
7.2.2 Segmented acquisitions
Through-plane blurring in 3D GRASE can be reduced be using a segmented acquisition,
which is the recommended acquisition strategy of the ISMRM Perfusion Study Group
[39], although the greater the number of segments, the higher the risk of artifact due to
subject motion during the overall longer period required to acquire a full k-space data set.
Boscolo Galazzo et al [47] recently published work investigating an optimisation of the
number of the segments used to acquire the whole brain and the time taken to do so, how
many averages it was possible to acquire as a consequence of the number of segments,
versus a deblurring post-processing method. For a field of view 240 x 240 mm2 with a
voxel resolution 3.5 x 3.5 x 5.0 mm3, 20 partitions in the second phase encoding direction,
it was found that a four shot acquisition offered the best trade-off in terms of image quality,
motion sensitivity and SNR, as twice as many signal averages can be obtained in a four
shot acquisition compared to an eight shot acquisition.
Nonetheless, the paper recommended that a deblurring algorithm be applied even in the
case of an eight shot acquisition, which is the method used in our study, as improvements
to image quality were still found. The through-plane blurring observed with an eight shot
acquisition using the imaging parameters used for the studies is this thesis is shown in
figure 7.4.
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Figure 7.4: Example perfusion data acquired in this thesis. Eight shot acquisition schemes still
exhibit through plane blurring, visible in the coronal (top right) and sagittal (bottom right) views.
7.2.3 Methods for theoretical estimation of the PSF
Given the difficulties described above with regards to an empirical measurement of the
PSF, it is common to employ methods which estimate the PSF based on sequence
parameters or by calculation from the acquired data. There are two reported methods in
the literature of estimating the PSF of 3D GRASE sequences.
The first of these has its origins in the Extended Phase Graph (EPG) method of Hennig
[75].
7.2.3.1 Extended Phase Graph (EPG) algorithm
The EPG, or coherence pathway diagram, is a technique to predict the echo formation
from a train of RF pulses. After every RF pulse, magnetisation is flipped to both the
transverse and longitudinal planes which produces a free induction decay (FID), a
potential echo formation as well as retaining magnetisation for future RF pulses to
refocus.
For the sake of simplicity it is usual to consider one component of the transverse
magnetisation only, rather than all of the isochromats fanning out over the transverse
plane. This can be plotted on a phase coherence diagram with phase measured on the
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ordinal axis and time on the abscissa.
It is beyond the scope of this text to describe the EPG in detail; suffice to say after the
application of each RF pulse, the magnetisation splits into three portions:
1. a portion which continues to dephase
2. a portion which is converted to longitudinal magnetisation and does not dephase
further
3. a portion for which the phase is reversed, and either continues to dephase or rephase
Whenever one of the lines crosses the zero phase axis, an echo is produced. This
formulation enables the prediction of timing and amplitude of stimulated echoes as well
as spin echoes. An example EPG with first spin echo and stimulated echo are marked on
figure 7.5.
Knowledge of the amplitude of the evolving signal allows for a theoretical calculation of
the PSF, as will be described in detail in the Methods section.
Figure 7.5: Phase coherence pathway adapted from [18]. Fn represents the dephased state of an
isochromat after n dephasing periods induced by the gradient pulse. Spin echoes and stimulated
echoes occur at the time the zero phase axis is crossed (red squares) .
7.2.3.2 PSF by autocorrelation of residuals
A more recent method is that described by Chappell et al [15]. This method relies on
multiple ASL measurements, be they either from a single timepoint with multiple
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averages, or a multi-timepoint acquisition. The important point is there must be more
than one measurement.
These multiple measurements are fitted to the general kinetic model [33] and the residuals
to the fit are measured. The mean of the residuals in the x and y directions is subtracted
from each voxel to produce a 1D series in the partition direction.
The autocorrelation of this series is then calculated, with the assumption that if there
is no blurring the residuals will be random and the autocorrelation function will be a
delta function. However, if there is blurring there will be shared information between the
residuals and the autocorrelation function will reflect this.
A Lorentzian was fitted to the autocorrelation function, which is the 1D PSF for the
sequence. In order to improve robustness, Chappell recommends averaging the PSF
across all subjects, as it is sequence, not subject specific.
7.2.4 Deblurring using Richardson-Lucy deconvolution
Deblurring an image via deconvolution of the PSF is a common technique from the
domain of computer vision and is a well developed field.
The Richardson-Lucy (RL) algorithm is an iterative method for image restoration using
Bayes’ theorem by treating the real image, degraded image and PSF as probability density
functions. The R-L algorithm is a suitable algorithm for image deblurring when there is
knowledge of the PSF, and functions effectively in the presence of noise.
If an assumption is made that the system is a linear, shift-invariant one with a position
independent PSF, then the relationship between the observed image and the ’real’ image
may be described by:
g(x, y, z) = f(x, y, z) ∗ h(x, y, z) + n(x, y, z) (7.3)
where h(x, y, z) is the 3D PSF, f(x, y, z) is the true voxel value, and g(x, y, z) is the
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blurred voxel and n(x, y, z) is some additive noise.
This can be written as a summation:
gi =
∑
j
hijfj (7.4)
where gi is the observed value at location di in the image, hij is the PSF which describes
the signal at i which comes from j and fj is the latent voxel value we wish to recover.
Estimation of the most likely value for fj given the observed gi and known hij leads to
the iterative form:
fn+1j = f
n
j
∑
i
gi∑
j pijf
n
j
pij (7.5)
where n is the number of iterations and converges to the maximum likelihood solution for
fj .
This can be written in terms of convolution as:
fn+1 =
(
g
fn ⊗ h ⊗ h
T
)
fn (7.6)
The R-L equation requires an initial estimate and as long as the first estimate of the
restored image is non-negative, the estimations will remain non-negative for all n
iterations. The algorithm is sensitive to the initial estimate which also influences the
performance. As such, it is usual to provide an initial smooth ’guess’ for f0, which also
helps avoid the amplification of high frequency noise, as although the R-L algorithm is
constrained it is not regularised.
The R-L algorithm terminates when a prescribed number of iterations is reached. The
RMSE between the restored image and true image decrease with increasing number of
iterations until a minimum is reached; beyond this point the algorithm begins to fit to
noise, known as ’overfitting’ [76].
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7.3 Methods
7.3.1 Characterisation of the 1D PSF in the partition direction for
3D GRASE
The value of the magnetisation signal at each of the 15 generated echoes (TE = 15ms, 6/8
partial Fourier, flip angle = 130 ◦) was estimated using an EPG algorithm simulation as
described in section 7.2.3.1. The imaging volume was acquired in eight segments, with
the split along the first phase encoding direction, i.e. each segment is 64 x 8 x 20 in the
x, y and z directions respectively. This was factored into the simulated echo amplitudes
by the reduction in the echo train length. In accordance with the assumption that the ASL
signal originates from the capillary space, the T1 and T2 times for arterial blood at 3T
were used in the calculation (1500 ms and 200 ms respectively).
As a centre-out phase-encoding scheme with 6/8 partial Fourier was employed, it was
necessary to reorder the magnetisation decay values according to their partition index.
The correspondences between echo number and partition index is shown in figure 7.9.
The first five partition indexes were filled with echoes 20, 19, 18, 17 and 16 to mimic the
partial Fourier reconstruction.
The 1D PSF in the partition direction was calculated from the MTF described above. The
MTF was Fourier transformed, the modulus calculated and zero frequency component
shifted to the centre of the spectrum.
7.3.2 Simulation study
In order to assess the efficacy of the deblurring algorithm, a simple 1D data vector was
created as a digital perfusion phantom. The data vector was 20 elements long to reflect
the number of sampled data points in the partition direction. The intensity of the elements
were chosen to reflect typical perfusion values for GM and WM, albeit without any PV
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effects. The pattern of the values was chosen to simulate the values which might be found
for region which is at the interface between the GM and WM. The digital phantom is
shown in figure 7.6
Figure 7.6: Digital perfusion phantom for testing the deblurring algorithm. Phantom created with
voxel intensities to represent typical GM and WM values, with no PV effects.
The basic aim of this simulation was to verify that, for the simple 1D digital flow
phantom, the process of blurring with a known PSF introduced PV effects between the
GM and WM voxels by blurring their respective signals, the effect of which could be
reversed by application of the deconvolution procedure. This also offered the opportunity
to investigate the optimal number of iterations after which to terminate the algorithm.
This vector was convolved with the Lorentzian PSF previously calculated for the 3D
GRASE imaging sequence used in this work to simulate the blurring which occurs
during acquisition.
The Richardson-Lucy deblurring algorithm was then applied with the known PSF. The
Matlab implementation was used with the number of iterations ranging from 5 to 35. The
optimal number of iterations was defined as that after which the RMSE converged.
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7.3.3 Application to in vivo data
In the strictest sense, any deblurring algorithm should be applied to the ’raw data’, namely
the control and label pairs, as well as to the M0 image, should one be present. Applying
a deblurring technique directly to the CBF map assumes that the PSF propagates linearly
and is unaffected in the difference and ratio of these images.
7.3.3.1 Deblurring correction
In order for the partial volume information derived from anatomical images to be applied
to the correct voxel intensity, blurred CBF signals must be reassigned to where they
belong. It is for this reason that the deblurring must take place before any correction for
tissue fraction effect. Consequently, an investigation of the effect of deblurring CBF
maps in isolation from any other form of post-processing was made.
As a proof of concept, the deblurring algorithm was applied to a representative CBF map
from a healthy volunteer, using a theoretical PSF calculated from the EPG. The PSF was
calculated using this technique as a goal of this thesis was to apply to PV correction
techniques to a cohort of single timepoint clinical data, for which only one measurement
is available. This makes it unsuitable for calculation of the PSF by autocorrelation of
the residuals. The number of iterations used was 25, as indicated as optimal from the
simulation study. Whilst our data does not exhibit the same degree of blurring as a one-
shot acquisition, there was still an expectation that some degree of ’sharpening’ of the
data would occur.
7.3.3.2 Tissue fraction effect correction
In order to assess the effect of this additional step of deblurring perfusion images as
part of a complete PV correction solution, a comparison was made of the separate PV-
corrected GM and WM CBF results obtained with and without deblurring preprocessing.
The original and deblurred CBF maps were both PV corrected using linear regression
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with a 3D kernel using the procedure described in chapter 5.
The results were investigated on a regional basis by calculation of the mean GM and
WM CBF in the regions as defined in section 4.4.1 created from a Freesurfer parcellation.
Prior to segmentation into the nine regions, both GM and WM CBF maps were masked
to remove voxels with tissue fractions of less than 10% for which PV correction results
are unreliable due to the small quantity of tissue in the voxel.
7.4 Results
7.4.1 PSF determination
7.4.1.1 Phase graph and echo train amplitude
The phase graph calculated for the sequence used is shown in figure 7.7. The population
in the different F states (transverse magnetisation) as the echo train develops is shown.
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Figure 7.7: Extended phase graph diagram calculated for the 3D GRASE sequence used in this
study. Graph created using Matlab.
The evolution of the echo train is shown in figure 7.8. The second echo is of greater
amplitude than the first due to the fact the second echo has combined spin and stimulated
echoes, whereas the first echo has only a spin echo contribution. After the second echo, a
smooth decay due to T2 effects is seen.
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Figure 7.8: Echo train as calculated using the EPG algorithm over 15 echoes with TE=15ms.
7.4.1.2 Description of the modulation transfer function (MTF)
The echo train amplitudes obtained in section 7.4.1.1 are reordered according to their
partition index in order to characterise the MTF. For example, echo number 1 from figure
7.8 is from the centre of k-space and corresponds to partition 11 due to the centre-out
acquisition. This is marked ’1’ on figure 7.9. Subsequent echoes from 2 to 15 are also
marked. As a 6/8 partial Fourier acquisition was used, partitions 1 to 5 were not acquired,
so these are filled with the values of echoes 20 to 16, as is the usual practice.
Figure 7.9: Modulation transfer function calculated from the magnetisation decay depicted in
figure 7.8. Partition indices 1 to 5 are filled with 20 to 16 to simulate the partial Fourier
reconstruction. Numbered arrows denote the echo number.
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7.4.1.3 Calculated PSF
The FT of the MTF gives the PSF, which is shown in figure 7.10. This was fitted to a
Lorentzian function, which gave a FWHM of 1.3 voxels, or 4.9mm.
Figure 7.10: The 1D PSF in the partition direction for this 3D GRASE acquisition. The FWHM is
1.3 voxels.
7.4.2 Simulation study
After blurring using the Lorentzian PSF calculated in section 7.3.1, it can be seen in figure
7.11 that the higher intensity voxels (chosen to represent GM) are diminished to a peak of
around 40, whereas the ’WM voxels’ are elevated slightly above 20. The mean intensity
of the five GM voxels drops to 41.8 after blurring, whereas the mean of the WM voxels
rises from 20 to 24.2.
Therefore, the intensity of the ’GM voxels’ suffers more modification than for the WM
voxels, due to the fact the cortex is usually only one voxel wide at typical ASL resolutions.
This means that the signal from the GM voxels is being blurred to WM voxels, whereas
the WM voxels will blur to other WM voxels as the WM region is comparatively wide.
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Figure 7.11: Intensity profile of 1D simulated data (blue) and after blurring with Lorentzian PSF
of FWHM = 1.3 voxels (red).
7.4.2.1 Estimation of optimal number of iterations
The algorithm was initially run with five iterations, and it can be seen in figure 7.12 that
the peak values in the profile are not recovered with so few iterations. It was found that
the RMSE converges to 0.95 at 25 iterations, and this was used in the subsequent in vivo
study.
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No.of iterations RMSE
5 3.7
10 1.5
15 1.1
20 0.98
25 0.95
30 0.95
35 0.95
Table 7.1: RMSE error of deblurred data and data versus number of iterations for the Richardson-
Lucy deconvolution algorithm. The RMSE converges at 25 iterations.
Figure 7.12: Effect of varying number of iterations of Richardson-Lucy deconvolution algorithm.
Twenty five iterations was found to be the optimal number of iterations in terms of smallest RMSE
before convergence.
7.4.3 In vivo study
Middle slices of a CBF map from a healthy subject are shown in figure 7.13, before and
after deblurring. Whilst the mean of the CBF map is unchanged after deblurring, the
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standard deviation has increased; the deblurring procedure clearly increases noise. After
deblurring, the image is considerably less smooth. This is a known trade-off of deblurring
procedures.
Figure 7.13: Axial, sagittal and coronal slices from a representative CBF map for (a) original
CBF map (b) deblurred CBF map. Richardson-Lucy algorithm used to deblur with 25 iterations.
Data Mean CBF
Blurred CBF 36.6 ± 21.9
Deblurred CBF 36.9 ± 31.4
Table 7.2: Mean CBF and S.D. of blurred and deblurred data, measured in ml/100g/min.
7.4.4 Effect of Deblurring and PVC by Linear Regression
PV correction by linear regression using a 3D kernel was performed on both the CBF map
and the deblurred CBF map. Mean GM and WM CBF were calculated after removal of
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voxels with PV fractions less than 0.1. The results are shown in table 7.3 for the Freesurfer
parcellations defined in section 4.4.1.
Mean CBF ± S.D. (ml/100g/min)
ROI No voxels in ROI No deblurring With deblurring
Frontal 2381 54.5 ± 17.1 57.0 ± 20.4
Central 630 63.0 ± 16.2 66.3 ± 20.1
Parietal 1683 65.2 ± 15.2 69.3 ± 19.9
Temporal 1423 57.0 ± 15.7 60.5 ± 19.5
Occipital 704 64.8 ± 19.1 69.7 ± 24.4
Cingulate 347 60.7 ± 11.5 66.2 ± 14.5
Insula 251 48.0 ± 10.9 51.8 ± 13.7
Deep GM 800 43.3 ± 21.4 49.1 ± 28.3
Hippocampus 139 43.2 ± 24.4 52.8 ± 32.4
WM 9893 21.8 ± 9.2 19.3 ± 10.1
Table 7.3: Comparison between mean GM an WM CBF after PV correction, with and without
deblurring. Difference between blurred and deblurred data signifcant for both GM and WM,
Wilcoxon signed rank test p = 0.039. Masked at PVF > 0.1.
Figure 7.14: Mean GM CBF in each of the nine GM regions and mean of WM region. Error
bars show standard deviation. GM is increased in every region and overal WM decreases with the
incorporation of deblurring to the PV correction technique.
For the CBF map without deblurring, after PVC, the mean GM across all regions was 54.4
± 17.1 ml/100g/min and WM was 21.8± 9.2 ml/100g/min. The deblurred CBF produced
a mean GM of 58.8 ± 21.7 and a WM of 19.3 ± 10.1 ml/100g/min after PVC.
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Figure 7.15: Partial volume corrected GM and WM CBF results for one subject. Deblurred group
has had deblurring procedure applied prior to PV correction. Greater CBF values are observed
in the deep GM with the application of deblurring.
181
Although all GM structures exhibit an increase in perfusion with the inclusion of
deblurring, the cingulate and hippocampus show marked increases in perfusion when
deblurring is applied. Respectively, the hippocampus and cingulate show a 22% and 9%
increase in perfusion. The increased perfusion in the deep GM structures is visible in the
deblurred GM CBF images in figure 7.15.
As predicted, WM CBF decreased with deblurring procedures, although the effect is not
as dramatic as for GM. This is unsurprising, as the WM is a comparatively large structure
and suffers less attenuation as a result. Deblurring causes a consistent increase in the
standard deviation of the CBF measurement, suggesting that the deblurring procedure is
introducing some noise.
A Wilcoxon signed rank test found the difference to be signicant between the regions with
and without deblurring, p = 0.039.
7.5 Discussion
The hypothesis that blurring due to the PSF contributes to the PVE is based on the
assumption that blurring displaces GM and WM signals, causing increased signal
mixing. This phenomenon is responsible for suppressing GM and elevating WM CBF
values, over and above that which is corrected for as part of the PV correction for tissue
fraction. The PV fraction maps obtained from anatomical data carry no information
about blurring and are unable to account for it. As such, the expectation is that higher
GM and lower WM flow values will be obtained with the inclusion of deblurring as part
of the total PV correction method.
This investigation characterised the 1D PSF for an eight shot 3D GRASE acquisition, for
the particular sequence parameters used. It is important to recognise that the width of
the PSF is a direct consequence of how the echo amplitude decays across k-space. This
is influenced by the resolution along all axes, the acquisition bandwidth, and RF pulse
duration, to name a few factors. This is the reason that the PSF can differ for sequences,
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even using the same number of shots.
The simulation study showed that the Richardson-Lucy deconvolution algorithm is
effective at removing signal blurring due to the PSF, although this is sensitive to correct
characterisation of the PSF. The simulated data was blurred and deblurred using the
same PSF, when in practice, the estimated PSF for a sequence will always be an
approximation. This is a potential source of error.
The use of a multi-shot acquisition does reduce the amount of blurring in the partition
direction, although we have shown that it is still present and contributing to partial volume
effects. For the sequence used here, the FWHM of the PSF was 1.3 voxels, or 4.9 mm,
given the resolution of the voxels. This means that the signal from an individual voxel
is contributing to the signal in the voxels around it - the blurring due to the PSF is larger
than the voxel size of 3.8 mm in the partition direction.
Deblurring the perfusion map prior to PV correction resulted in a mean GM CBF of 60.7
ml/100g/min, compared to 53.4 ml/100g/min when PV correction is performed without
deblurring. This suggests that correcting for the tissue fraction effect alone still leads to
an underestimation in GM perfusion levels and an overestimation of WM CBF levels. As
expected, a decrease in mean WM CBF level was observed, from 21.8 ± 9.2 to 19.3 ±
10.1 ml/100g/min. This is not as dramatic as the change in GM CBF, as the WM as a
whole is less affected by blurring as it is a much larger region than the GM parcellations.
However, an overestimation is still present.
A limitation of this technique is that it is heavily dependent on the correct characterisation
of the PSF. It may be possible to estimate the PSF based on the autocorrelation of the
residuals from fitting to the general kinetic equation, although this requires more than
one measurement. The EPG algorithm is an alternative method used to estimate the PSF,
which requires knowledge of the T1 and T2 values of the tissue. Literature values were
used for the T1 and T2 of arterial blood and subsequent PSF estimation. The effective
relaxation times are known to vary according to the specific sequence used [77], which
may affect accuracy of the PSF estimate.
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Additionally, the deblurring technique introduces noise into the image, as manifest by
an increase in the S.D. for all the ROIs after deblurring. This means that the deblurring
technique makes GM and WM flow estimates more accurate, but potentially more noisy.
However, this potential problem can be ameliorated by smoothing of the separate GM and
WM maps to increase SNR, should it be required.
7.6 Conclusion
In order to fully correct for partial volume effects in ASL perfusion imaging using 3D
GRASE acquisitions, it is both appropriate and relatively straightforwards to include a
deblurring step as part of a complete partial volume correction strategy.
Either Hennig’s EPG algorithm or Chappell’s autocorrelation of residuals method can be
employed for estimation of the 1D PSF in the partition direction. Once characterised, the
PSF can be deconvolved from the data, which has the effect of returning GM and WM
signal to the appropriate part of the image volume.
PVC performed on deblurred data is more meaningful, as the correction for tissue fraction
provided by linear regression using anatomical information is more likely to be accurate.
In other words, the spatial location of the perfusion levels corresponds more readily to
the anatomical structures causing the perfusion signal to arise, after deblurring. This is
manifest by the increase in GM and reduction in WM CBF levels seen with the inclusion
of the additional processing step in the form of deconvolution of the PSF.
In conclusion, this chapter has extended the PV correction technique using linear
regression for ASL data which only corrects for tissue fraction effect to include the
additional pre-processing step of deblurring via deconvolution of the PSF.
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Chapter 8
Application of PVC to dementia data
This chapter describes the application of the methods developed in earlier chapters as
a novel complete solution fo PVC. The method is applied to two challenging, clinical
cohorts.
8.1 Imaging in neurodegenerative disease
Neurodegenerative disease is typified by progressive dysfunction and neuronal loss and
represents a major clinical challenge. The risk of suffering from dementia usually
increases with age. In addition, there is a certain degree of neuronal loss associated with
‘healthy ageing’. In fact, longitudinal studies show cerebral atrophy rates of 0.5%
volume reduction per year in the 65-75 years age group. Rates of volume loss in
Alzheimer’s Disease (AD) patients is around 2% per year [78].
The cause of the two types of atrophy may be quite different, but in the early stages of
disease it is remarkably difficult to differentiate between the two and sophisticated image
processing techniques tend to be employed [79].
As well as loss of neuronal tissue, some types of dementia also produce an accumulation
of proteins known as amyloid-β plaques and neurofibrillary tangles (NFTs). However,
these lesions tend not to be readily visible on examination of structural MR images by
radiologists. Consequently, structural MRI has limited diagnostic value in detecting
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neurodegeneration in its early stages.
A pan-European task force was initiated in 2008 with the goal of arriving at a consensus
for a recommended protocol for the diagnosis and management primarily of AD [80].
This committee was concerned with revising previous European Federation of
Neurological Societies (EFNS) guidelines with a specific consideration in mind. The
question being addressed was, is there new evidence that imaging biomarkers derived
from MRI and PET modalities can increase confidence in the clinical diagnosis?
The conclusions reached by the group was that structural imaging should be performed
at least once in order to exclude other non-AD pathologies, which may be treatable.
However, whilst MRI may be useful to monitor changes over time, it is
fluorodeoxy-glucose- (FDG-) PET and single positron emission tomography (SPECT)
imaging that have been nominated as imaging modalities most likely to increase
confidence in diagnosing dementia.
These imaging modalities are invasive and expensive, and therefore not readily applicable
to control populations. However, if new disease modifying treatments are to be the subject
of clinical trials, repeatable, cost-effective and non-invasive imaging techniques will be
required. If such techniques were available, they could also be employed to screen healthy
populations in order to detect pathological changes in pre-symptomatic subjects.
As described in chapter 2, it is the stated aim of the European Cooperation in Science
and Technology (eCOST) Arterial Spin Labelling in Dementia (AID) 1 to coordinate ’the
development of an alternative and cost-effective tool based on an MRI technique, Arterial
Spin Labelling (ASL), to obtain reproducible brain perfusion measurements in dementia
patients’. The hope is to replace nuclear medicine techniques as the gold standard for
imaging and staging of dementia.
1http://www.aslindementia.org
186
8.1.1 ASL as an early stage biomarker of dementia
The coupling of CBF and brain metabolism facilitate the use of brain perfusion as a
quantitative biomarker of function. As such, there is great interest in the use of perfusion
measurements in the diagnosis and staging of neurodegenerative disease.
There is a large body of work demonstrating the variations in perfusion due to
neurodegenerative disease using FDG-PET and SPECT imaging to detect changes in
glucose metabolism and perfusion [81]. There is consensus in the literature that
functional impairment occurs before advanced neuronal loss, which means that perfusion
imaging may potentially detect neurodegeneration before tissue loss has occurred [21].
This would enable identification of patients at risk at an early stage of the disease, paving
the way for therapeutic intervention. Moreover, most neurodegenerative diseases exhibit
a characteristic pattern of modified perfusion, allowing for a differential diagnosis.
A description of two types of dementia and their signature patterns of perfusion follows.
These two are selected for discussion as clinical data from patients populations with these
dementias is utilised in this chapter.
8.1.1.1 Alzheimer’s Disease
Alzheimer’s Disease (AD) is associated with progressive cognitive impairment and is
the most common form of dementia, affecting 1 in 5 over the age of 80 and costs the
UK £26.3 billion a year 2. With an ageing global population, the impact of this disease
will only increase. There is no effective treatment for AD and it is thought that when
patients manifest clinical symptoms, substantial neuronal damage has already occurred
[82]. Therefore it is of vital importance that early biomarkers of the disease are developed.
There are a number of studies which have investigated the patterns of brain perfusion in
AD and an overview of these is presented in [83]. These studies report a characteristic
profile of hypoperfusion which is supported by findings in PET and SPECT studies. This
2http://www.alzheimers.org.uk/
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pattern consists of hypoperfusion in the parietal, temporal and posterior cingulate cortices.
It is also found that the extent of the hypoperfusion is correlated with severity of AD
symptoms, which offers evidence that ASL can be used to stage the disease.
It was initially a concern that the pattern of hypoperfusion was in fact merely a
consequence of cortical atrophy, which AD is tightly associated with. However, this
concern was laid to a rest by a study which corrected for atrophy [53] and found that the
same regions of hypoperfusion existed post-correction. Indeed, an important finding was
that the extent of regional hypoperfusion was unaltered by atrophy correction,
demonstrating a decoupling of structure and function in AD.
8.1.1.2 Frontal Temporal Dementia
Frontal temporal dementia (FTD) is a comparatively rare form of early onset dementia,
primarily affecting those in the 45 to 65 years age bracket, although it can also occur
earlier or later in life. This can be decades earlier than the onset of sporadic AD and these
patients typical present with behavioral problems as the frontal lobe is implicated.
Differential diagnosis between AD and FTD can be difficult to achieve purely on a clinical
basis as aspects of FTD can mimic AD, in particular memory impairment. Structural MRI
can highlight the differing patterns of atrophy, but as the disease progresses and atrophy
encompasses more of the brain, it is difficult to distinguish between the two. Conversely,
studies measuring perfusion using PET, SPECT and ASL have shown that the differential
diagnosis between FTD and AD is improved as compared to structural MRI alone [21].
The characteristic profile of abnormal perfusion in FTD patients is that of hypoperfusion
in the right superior and middle frontal gyri, with normal perfusion levels in parietal and
occipital lobes. Again, this pattern is preserved after atrophy correction and correlates
well with the observed functional deficits such as poor judgement and problem solving.
In some cases, the differing patterns of abnormal perfusion between FTD and AD can be
more readily visualised in perfusion images, rather than structural scans, as depicted in
figure 8.1 [19].
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Figure 8.1: Representative structural and ASL images for a cognitive normal subject (CN), FTD
and AD patient. There is an area of reduced perfusion in the frontal lobe for the FTD patient,
compared to reduced perfusion in the posterior brain region for the AD patient (marked with
arrows). This can facilitate a differential diagnosis. From [19].
8.2 Clinical cohort
All of the previous studies in this thesis have utilised the data of healthy controls. This
data came from young people without any evidence of tissue atrophy or perfusion
abnormalities. Patient cohorts which exhibit cortical atrophy are more likely to benefit
from an improvement in the accuracy of perfusion estimates after PV correction, yet are
also more challenging to apply the techniques to, as segmentation algorithms are largely
developed for healthy brains. In addition, these patients are less likely to tolerate the
scanning procedure in itself particularly well, and are more likely to produce motion
artefacts.
Therefore, this chapter tests the methodologies developed throughout this thesis to two
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clinical populations, each displaying differing patterns of cortical atrophy. These two
groups are referred to as the GENFI and AVID cohorts.
8.2.1 GENFI
GENFI is an acronym for Genetic Frontal Temporal Dementia Initiative3. Patients from
the GENFI cohort are being studied with a view to understanding more about genetic
FTD, particularly subjects with mutations in the progranulin (GRN),
microtubule-associated protein tau (MAPT) and chromosome 9 open reading frame 72
(C9ORF72) genes. FTD is a strongly inherited disease, with a third of sufferers
exhibiting a mutation in one of the three genes above. Previous studies on other genetic
dementias were able to show imaging changes before symptom onset; the GENFI study
aims to do the same for FTD [84, 85].
The participants to the study were either known carriers of the one of the three gene
mutations or possessed a first degree relative who was a known symptomatic carrier.
We have been fortunate enough to be given access to some of this data, although this is a
blinded study and the only clinical information known about the patients is their sex. We
do not know whether the subjects are symptomatic, or even at risk for FTD. Nonetheless,
cortical atrophy is readily apparent in some of the data provided, and as such provides a
challenging dataset to apply the PVC techniques developed throughout this thesis.
8.2.2 AVID
The AVID data 4 comes from a group of patients who has been diagnosed as suffering
from Posterior Cortical Atrophy (PCA). This is a progressive condition in which there is
notable tissue loss from posterior regions of the brain and the most common symptom for
individuals suffering from PCA is a selective deterioration in higher visual processing and
other posterior cortical functions, such as spelling and calculation [20]. PCA is frequently
3http://genfi.org.uk
4http://www.ucl.ac.uk/drc/research/current-studies/pca
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considered to be a variant of AD due to the histopathological finding of amyloid plaques
and tau tangles, despite the disparity in which regions display cortical atrophy.
The AVID cohort is involved in a longitudinal study to improve diagnosis and
charaterisation of PCA, with a particular focus on visual processing. The aim of the
study is to understand what causes this variation on classical Alzheimer’s Disease, and to
develop strategies which may help to alleviate symptoms. Figure 8.2 shows a structural
and FDG-PET scan from a patient suffering from PCA. Note the reduced metabolism in
the posterior of the brain on the PET scan and cortical atrophy in the structural scan, and
how it differs from the classical presentation of AD.
Figure 8.2: Structural and FDG-PET scan from a PCA patient. Note the presentation of posterior
cortical atrophy in the structural scan, and reduced posterior metabolism in the FDG-PET scan.
Adapted from [20].
8.3 Methods
The imaging acquisition parameters for the GENFI and AVID studies differ slightly from
those used for the previously described control subject studies. Perfusion data were
acquired using pulsed ASL (FAIR Q2TIPS) with an 8-segment, background-suppressed
3D GRASE imaging readout. The parameters can be seen in table 8.1.
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8.3.1 GENFI/AVID data acquisition
Parameter Value
Matrix 128 x 128 x 30
Resolution 1.875 x 1.875 x 4.0 mm3
TI1 800 ms
TI2 2000 ms
Turbo factor 23
Segmented acquisition 8 segments
Background Suppression 754 ms, 1610 ms
Saturation recovery pulses 1000, 2000, 5000 ms
Table 8.1: Summary of perfusion imaging parameters
Unlike the previous perfusion data, the GENFI and AVID data is acquired on a 64 x 64
matrix but zero-filled to produce a 128 x 128 x 30 resolution. The saturation recovery
sequence also differs in that the middle saturation pulses of the series is timed at TR =
2000 ms, rather than 3000 ms. Parameters for the anatomical MPRAGE sequence are
listed in table 8.2.
Parameter Value
Acquisition matrix 208 x 256 x 256
Resolution 1.1 x 1.1 x 1.1 mm3
TI 900 ms
TR 2200 ms
TE 2.9 ms
Flip angle 10 ◦
Table 8.2: Summary of MPRAGE imaging parameters
8.3.2 Partial Volume Correction
CBF maps were calculated from the perfusion data using the general kinetic model as in
equation 2.7. Only one measurement of the control and labelled images was provided, so
it was not possible to perform any averaging to improve SNR.
Unfortunately the FRASIER/SEPARATE method for generating PV maps could not be
employed as only three timepoints were acquired in the saturation recovery sequence.
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Therefore the method for generating the PV maps from anatomical data described in
chapter 4 was utilised.
A combined deblurring and tissue fraction PV correction algorithm was employed.
Firstly, the PSF was estimated using the Extended Phase Graph Algorithm for the
sequence parameters used for these studies and found to have a FWHM of 1.5 voxels.
This PSF was used in a Richardson-Lucy deconvolution algorithm to remove the
blurring, as described in chapter 7. Secondly, the linear regression method for correction
of tissue fraction effect using a 3D 3 x 3 x 3 kernel, as described in chapter 5 was applied
to the deblurred data.
Cortical parcellations were created using Freesurfer, which were then downsampled to
ASL space and overlaid on the GM CBF map. Voxels with less than GM PVF of 10%
were excluded, and a mean value for the 9 Freesurfer regions were calculated.
8.4 Results
8.4.1 GENFI cohort
The GENFI cohort contains FTD patients, and those potentially at risk of genetic FTD
because a first degree relative is a carrier. As the study is blinded, the researchers are
unaware of the clinical history of the subjects, which means that there may be some
subjects who are ’normal’. As such, it does not make sense to perform any sort of group
analysis on the GENFI cohort and the subject results must be considered on their own.
The same post-labelling delay is used in the GENFI/AVID studies as was used for the
healthy control studies on young people described in chapters 5 and 6. Due to the
blinding on the study, the age of the participants is not known. The post-labelling delay
is a parameter which should be adjusted with age, with older subjects requiring a longer
delay.
It would seem that the delay used was insufficient for some of the GENFI subjects, and
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CBF maps were produced like the one shown in figure 8.3. It can be seen that there
is little to no signal in the WM area of the brain. The WM transit time is longer than
that to the GM, and either the perfusion weighted image was acquired before the labelled
protons had reached the imaging volume, or the signal had decayed away. This makes
quantification inaccurate, and is a reminder that sequence parameters must be adapted to
suit the application.
Figure 8.3: Insufficient post-labelling delay: there is little to no signal in the WM regions. Either
the labelled protons have yet to reach the WM, or the signal has decayed before arriving.
The expectation for the GENFI cohort is that there will be reduced perfusion in the frontal
lobe if the subjects are exhibiting FTD. Additionally, it is hypothesised that this pattern
will remain after PVC, and that there is a genuine reduction in metabolism, which is not
merely a consequence of tissue atrophy.
Figure 8.6 shows the mean CBF and GM CBF after PVC on a regional basis for the six
GENFI subjects. Of the six, two subjects stand out from the group. Subjects 01-006 and
01-010 display reduced perfusion in the frontal lobe, relative to the other regions. This
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pattern remains after PV correction for both subjects. For subject 01-006 PV correction
elevates the CBF in the central lobe most of all, followed by the parietal lobe. This
suggests there may be age-related atrophy in these regions and the low perfusion pre-
correction is not a genuine metabolic finding. For subject 01-010, overall perfusion is
high, with mean regional GM CBF values like those found in healthy subjects (range 56
to 73 ml/100g/min), other than for the frontal lobe, which is 33.3 ml/100g/min before
correction and 42.2 ml/100g/min after. (See figure 8.5).
Figure 8.4: Subject 01-006, top row: CBF prior to PV correction, bottom row, after PV correction.
PVC correction elevates perfusion in parietal and central lobes, but no increase is seen in the
frontal lobe. GM CBF masked at GM PVF > 0.1.
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Figure 8.5: Subject 01-010, top row: CBF prior to PV correction, bottom row, after PV correction.
Reduced CBF is seen in the frontal lobe both before and after PV correction. GM CBF masked at
GM PVF > 0.1.
The deep GM and hippocampal regions also showed low perfusion for these subjects,
before and after correction. The mean hippocampal GM CBF was 21.3 and 24.4
ml/100g/min before correction and 27.6 ml/100g/min for both subjects after correction,
for subjects 01-006 and 01-010 respectively. Both sets of values are incredibly low for
GM perfusion which tends to be around 60 ml/100g/min for young healthy subjects. The
hippocampal region is small and only contains around 150 voxels, and it is tempting to
explain these low results as being unreliable due to the small number of voxels.
However, subjects 01-004, 01-009 and 01-019 present with GM perfusion values
towards the expected range. These 3 subjects display mean regional GM values like
those previously presented for healthy controls. All values are summarised in figure 8.6
and table 8.3.
Subject 01-011 differs from the others, in that there is a consistently low perfusion across
all regions prior to PV correction with perfusion around 30 ml/100g/min (other than the
hippocampus which is 15.9). The PV correction has a huge effect on the initial perfusion
values, with the ratio of corrected to uncorrected perfusion ranging from 1.9 (frontal lobe)
to 1.5 (hippocampus). This suggests that the low uncorrected perfusion values are a direct
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consequence of tissue atrophy, and post-correction brings this values to a more usual
physiological range. This concurs with a PET study carried out by Meltzer et al [43]
where it is proposed that the usual reduction in CBF seen in elderly populations is a
consequence of tissue atrophy, and that after correction no reduction is seen.
8.4.2 AVID cohort
As the AVID subjects are all diagnosed as PCA patients, we expect to see similar
patterns of perfusion across the group. Given the PET finding displayed in figure 8.2, the
expectation is that we will see reduced perfusion in the occipital lobe, which remains
after atrophy correction. Figure 8.9 shows the mean regional CBF and GM CBF for the
AVID subjects, which is also given in table 8.4.
In fact, there is only one subject for which the mean occipital lobe perfusion is markedly
reduced compared to the other regions, that is subject AV-003, with mean GM CBF 42.7
ml/100g/min in the occipital lobe. Figure 8.7 shows 3 slices from the both the CBF and
GM CBF maps. Both maps shows substantial bilateral regions of reduced perfusion in
the occipital lobe. Subject AV-004 displays the same pattern of reduced perfusion in
the frontal lobes compared to the other regions as the GENFI subjects 01-006 and 01-
010. Subject AV-002 displays a mean occipital lobe CBF of 30.7 ml/100g/min before
correction and GM CBF of 47.2 ml/100g/min, with a correction ratio of 1.5, compared to
ratios of 1.2 - 1.3 for the other regions. This suggests that there is occipital lobe atrophy,
but not reduced perfusion. Subjects AV-001, AV-005 and AV-006 show mean occipital
lobe GM CBF of 64.8, 54.0 and 59.8 ml/100g/min respectively, which is within healthy
parameters.
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Figure 8.6: GENFI cohort: GM regions before and after PV correction using a combined
deblurring and tissue fraction effect algorithm. Ratio column shows ratio of corrected to
uncorrected. All CBF measurements in ml/100g/min, error bars show 95% confidence intervals.
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Figure 8.7: Subject AV-003, top row: CBF prior to PV correction, bottom row, after PV correction.
There is substantial reduced perfusion in the occipital lobe which persists after PV correction. GM
CBF masked at GM PVF > 0.1.
Figure 8.8: Subject AV-004, top row: CBF prior to PV correction, bottom row, after PV correction.
There is reduced perfusion in the frontal lobe compared to other regions, both before and after
PVC. GM CBF masked at GM PVF > 0.1.
8.5 Discussion
This is the first study to apply a combined deblurring and tissue fraction correction for PV
correction of ASL data to patients groups suffering from dementia. Two separate patient
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Figure 8.9: AVID cohort: GM regions before and after PV correction using a combined deblurring
and tissue fraction effect algorithm. Ratio column shows ratio of corrected to uncorrected. All
CBF measurements in ml/100g/min, error bars show 95% confidence intervals.
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groups were investigated. The first of these is the GENFI cohort, which is a blinded
study and potentially contains some healthy subjects who are not suffering from nor are
at risk from FTD. It appears that 3 of the 6 subjects analysed are may be healthy or not
at risk subjects, as their perfusion ’profile’ is like that of a healthy control. One subject
presents like an elderly subject, with relatively low perfusion, which is elevated to normal
physiological levels after PV correction. The remaining two subjects exhibit reduced
perfusion in the frontal lobe before and after PV correction, which suggests that there
is a reduction in metabolic activity in this region and shows a decoupling of structure
and function. It would be interesting to discover if the hypothesis that this group of six
subjects is composed of two FTD patients, one healthy elderly person and two younger
healthy subjects is correct.
The second group is a cohort of patients suffering from posterior cortical atrophy which
is variant of Alzheimer’s disease, with atrophy primarily occurring in the posterior
region and affecting visual processing. It was expected that there would be reduced
perfusion in the occipital lobe which would remain after PV correction for these
subjects, as PET studies have observed a metabolic reduction in AD patients after PVC
[45]. This expectation is only met for one subject, with one subject showing a similar
pattern of perfusion as a patient from the GENFI cohort, and the others displaying
healthy levels of perfusion across the brain after PV correction.
No clinical information was communicated to me about these patients, such as how long
they have been diagnosed with PCA and what the severity of their symptoms is. As such,
it may be that some of these subjects are early on in the disease trajectory and have yet to
show abnormal metabolic changes. A longitudinal assessment of changes in CBF would
be very valuable for this group.
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8.6 Conclusion
This chapter has shown the importance of using PV correction strategies for decoupling
structure and function. Whilst this is a small study and a much larger number of subjects
is needed for validation, it seems that genuine metabolic changes remain after atrophy
correction, whereas age-associated tissue loss does not cause a reduction in cerebral
perfusion.
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Chapter 9
Conclusion
9.1 Summary and conclusions
This aim of this thesis was to develop a partial volume correction strategy for ASL
images. The partial volume effect is known to significantly degrade the accuracy of
perfusion estimates, yet it remains uncommon to account for it. In particular, a strong
goal was to incorporate a deblurring technique into the correction strategy, in order to
remove the effect of the point spread function, which had not previously been considered
in PV correction techniques for ASL data.
A summary of the chapters contained within this thesis and the main conclusions to be
drawn from each follows below.
In chapter 5, a novel modification is made to the linear regression method for PVC which
reduces spatial blurring and improves quantification. The 3D kernel for linear regression
is introduced, which has the effect of reducing the kernel radius whilst maintaining the
same volume, and therefore available information. This was proven to reduce the spatial
blurring in PV corrected map of GM perfusion and therefore, improve quantification.
A Bayesian PV correction tool is applied to single time point ASL data, for the first time,
with the finding that spatial priors are heavily relied upon when few imaging volumes are
available which results in an overly smoothed result. The tool was designed for multiple
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time point data, where numerous averages are available.
Finally, a comparison is made of the difference between applying PVC methods directly
to a CBF map, or to the constituent images, namely the difference and equilibrium
magnetisation images. It was found that there is no significant difference in applying the
technique directly to a CBF map, rather than separately to the difference and M0 images.
This is an important finding as some vendors (GE, for instance) do not provide access
the difference and M0 images without a research key. However, the lack of a control
image as a registration target could prove problematic.
Chapter 6 presents a new method for creating PV estimates from saturation recovery
data acquired using a 3D GRASE readout. This new method is termed SEPARATE and
uses a voxelwise estimation of the longitudinal relaxation time of GM to improve upon
existing estimates of the GM PV fraction in the deep GM. Existing methods such as
FRASIER utilise a global value for the T1 of GM which results in an underestimation of
the concentration of GM in the deep GM regions as the T1 in this region differs from that
of the cortex.
Registration and downsampling of high resolution anatomical data to low resolution
perfusion space is a major challenge for PV correction methods. The use of saturation
recovery data at ASL resolution for PV estimates avoids this problematic step. An
investigation of the accuracy in applying SEPARATE derived PV maps, compared to
maps from high resolution data is undertaken. Fractional segmentation methods are
found to introduce less registration error and provide a more consistent GM CBF across
the entire PV range.
Chapter 7 introduces the concept of the point spread function (PSF) in ASL imaging
and provides a description of its origin from the 3D GRASE sequence. The PSF arises
as a consequence of T2 decay throughout the echo train, which leads to blurring of the
acquired signal. Segmented acquisition schemes help to minimise this effect, but this
chapter shows that the effect is still present, which causes a suppression of GM CBF
values, whilst elevating WM CBF, even for an 8-shot scheme.
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The width of the PSF is estimated from the extended phase graph algorithm. As
simulation study is performed to investigate the the optimal number of iterations to use
for a Richardson-Lucy deblurring algorithm. This found is to be 25, after which the error
between the ground truth and deblurred digital phantom plateaued.
Conventional partial volume correction strategies for ASL only correct for tissue fraction
effect and are unable to remove deblurring due to the PSF. These methods usually make
use of PV estimates from high resolution anatomical data, downsampled to perfusion
space. These PV fractions maps will be inaccurate unless the perfusion data is
pre-processed to remove blurring.
In chapter 8, a complete solution for PVC which incorporates a deblurring component
in addition to a correction for tissue fraction effect is applied to two clinical cohorts of
dementia patients. We believe this is the first time this has been done. Within this chapter,
the importance of choosing appropriate sequence parameters for the population under
study is demonstrated. An example is shown of a CBF map produced when an insufficient
post-labelling delay has been used, which leads to little or no signal in the WM.
It is shown that reduced perfusion, relative to other regions of the brain, in the frontal lobe
remains after PV correction for Frontal Temporal Dementia patients and in the occipital
lobes of Poster Cortical Atrophy patients. This is evidence of reduced metabolism in these
regions and is a genuine reduction in perfusion. In healthy, elderly subjects, an apparent
decrease in perfusion is removed after the application of a PV method.
9.2 Summary of significant findings
The significant findings of this thesis are summarised below:
• A 3D kernel for linear regression is introduced and evaluated. This is found to
reduce the inherent spatial blurring of the linear regression method for PVC
• The application of Bayesian methods for PVC to single timepoint data was
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investigated, and whether Bayesian methods offer any advantage over linear
regression techniques when no tissue kinetic information is available. It was found
that Bayesian methods rely heavily upon spatial priors to estimate GM and WM
CBF when few averages are available, resulting perfusion images which lack gross
spatial detail.
• A new method for creating PV estimates from the fractional segmentation of 3D
GRASE data using a voxelwise estimation of the T1 of GM is presented. This
produces more accurate estimations of the concentration of GM in deep GM
regions.
• The PSF for the 3D GRASE sequence used in our studies is estimated using an
Extended Phase Graph algorithm. Perfusion maps are deblurred using a
Richardson-Lucy deconvolution algorithm. This procedure is shown to reduce
blurring even in the case of an 8-shot acquisition scheme for the 3D GRASE data.
• A complete solution for PVC of ASL data is proposed which combines a correction
inadequate resolution caused by blurring due to the PSF and tissue signal mixing
due to voxel grid size.
9.3 Further work
The new method of applying a correction for blurring and tissue fraction effect should be
fully validated, as well as a thorough investigation of the validity of applying deblurring
techniques to the CBF maps in preference to the raw data. This technique is both
dependent on accurate characterisation of the PSF and reliable estimates of PV fraction.
It would be useful to perform a simulation study to investigate how estimates of GM
CBF deviate from a ground truth when the registration of PV maps is poor, and to fully
characterise the impact this has.
The saturation recovery curve acquired during the SEPARATE development was
comprehensively sampled 31 times, with TR ranging from 100 to 8000 ms. The early
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part of the curve which changes rapidly was sampled more densely. An extension to this
study would be an investigation to ascertain the optimal sampling interval, in order to
strike a balance between sufficient data points to sample the curve and obtain fractional
segmentation information, yet few enough that the imaging time is short enough to be
acceptable in a clinical environment. Limited conclusions can be drawn from the
application of the PVC method to the clinical cohorts described in chapter 8. Both
cohorts that were analysed consisted of only 6 subjects, with the GENFI group more
than likely containing healthy control data as well as images from FTD patients.
The application of this complete PVC method for ASL data is potentially of great clinical
utility in separating cases of actual reduced regional metabolism in patient populations,
compared to age-related tissue atrophy producing an apparent decrease in perfusion. This
could be validated through assessment of a large patient longitudinal dataset, which could
lead to the development of a perfusion-based biomarker for dementia.
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Appendix A
Publications and Proceedings
The following publications and proceedings have arisen as a result of
this thesis:
A.1 Conference Proceedings
"Improved Partial Volume Correction of ASL images using 3D kernels", R.A. Oliver, D.L.
Thomas, X.Golay. British Chapter ISMRM Cambridge 2012.
"Improved Partial Volume Correction of ASL images using 3D kernels", R.A. Oliver,
B.Thomas, D.L. Thomas, X.Golay. Proc ESMRMB Lisbon 2012, Oral presentation.
"Comparison of Bayesian and Linear Regression based Partial Volume Correction in
single time point ASL MRI", R.A. Oliver, M.A. Chappell, D.L.Thomas, X.Golay. Proc
ISMRM Salt Lake City 2013.
"Comparison of Bayesian and Linear Regression based Partial Volume Correction in
single time point ASL MRI", R.A. Oliver, M.A. Chappell, D.L.Thomas, X.Golay. Proc
ESMRMB Toulouse 2013, Oral presentation.
"Partial Volume Correction of 3D GRASE ASL images using T1 maps acquired with the
same readout scheme", R.A. Oliver, E. De Vita, X.Golay, D.L. Thomas. Proc ISMRM
Milan 2014, Oral presentation summa cum laude.
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A.2 Papers
"Diagnostic classification of arterial spin labelling and structural MRI in presenile early-
stage dementia", Bron EE, Steketee RME, Houston GC, Oliver RA, Achterberg HC, Loog
M, Van Swieten JC, Hammers A, Niessen WJ, Smits M, Klein S. Human Brain Mapping,
35(9), 4916–4931.
The above paper uses the partial volume correction software developed during this thesis
as part of the processing pipeline.
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